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Point of care diagnostics is hailed as a potential revolution which could lower the
significant cost of diagnosis, lead to earlier interventions and lower the mortality and
morbidity of a variety of diseases. In spite of the early promises made and notable
breakthroughs such as the glucose biosensor, the field of biosensors has yet to achieve the
commercial and societal gains it promises. One of the primary reasons for this is the cost of
testing a remaining obstacle in biosensor development. The work in this thesis aims to
address different approaches to address this which may help accelerate the development
of impedimetric immunosensors and enhance their adoption in diagnostic and field
applications.
Initial work in this thesis has focussed on the development of a biosensor which could be
regenerated, permitting repeated use. This work was done using a previously
demonstrated biosensor where the signal behaviour was known and the process of
regeneration could be studied in isolation. This proof-of-concept work it was discovered
that regeneration and therefore re-use of impedimetric immunosensors was possible
The biosensors throughout this thesis were constructed using electropolymer to which
proteins were attached before interrogating the sensor using electrochemical impedance
spectroscopy (EIS). The fully constructed sensors were then incubated with analyte of
increasing concentrations before repeating interrogations. EIS was used to monitor
receptor - analyte binding and provide a method of sensor calibration.
Later work in this thesis explored the role of the bioreceptor in signal generation in EIS.
The recent move towards the use of antibody mimetic receptors may have profound
implications for biosensor development. There is however, limited demonstration of their
use in biosensors and even less so in EIS based sensors. In this thesis nanobodies have
been used to fabricate biosensors. They have also been re-engineered to include oriented
peptide spacer arms with terminal cysteines to allow both oriented conjugation onto the
transducer surface and precise positioning above it. This work has highlighted the
importance of spacing and physical constraints at the nanoscale which may be important
for determining signal generation in reagentless impedimetric immunosensors.
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1 Chapter One:
Introduction
21
1.1 Overview
Despite the increasing volume of research into biosensors, there have been
disappointingly few sensors which have achieved commercial success (Luong et al., 2008).
Though the glucose biosensor accounts for ~80% of the market (Newman & Turner, 2005)
it does not satisfy the wider needs of the research, diagnostic and sensing fields.
Immunosensors, a much more widely applicable type of biosensor, have enabled the
discovery of a large array of relevant biomarkers (Luppa et al., 2001). Within the literature,
a commonly identified method for improving the quality of a sensor is to modify the
receptor, found at the biosensor interface either by altering it chemically or replacing it
with another category of receptor for the same analyte. This crucial component dictates
the sensors specificity and sensitivity and has been widely proven to have a large impact in
sensor performance (Zourob, 2009).
One trend within the field of biosensors and more widely in biochemical research is the
adoption of antibody mimetics. Whilst this is hailed as a revolution in terms of both
fundamental research and in applied fields such as diagnostics and therapeutics there is
still fairly limited published output on the application of such binding proteins (Gilbreth &
Koide, 2012; Skottrup, 2010).
Much attention has been devoted to the development of antibody mimetics with the aim
of reducing the use of animals. The work in this thesis focusses on the application of such
binding proteins, in particular on their use in biosensors. Nanobodies, essentially re-
engineered camelid antibodies have been used in impedimetric immunosensors; this is a
promising technique but has yet to prove its commercial viability. Work in this thesis has
additionally re-engineered the nanobodies to optimise them for biosensor applications.
Work has also been carried out to investigate the possibility of biosensor regeneration,
another approach which may help to reduce the cost per test. Whilst this has been
previously demonstrated for a number of biosensor systems, it has only achieved limited
success in reagentless impedimetric immunosensors.
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1.2 Biosensors
A biosensor is a three component system comprising a biological recognition element; a
transducer and a signal processing unit (Figure 1-1). Typically the analyte which interacts
with a receptor is part of a complex mixture such as in blood or other biological fluids.
The biosensor must therefore generate signal specific only to the analyte given the large
number of non analyte proteins which may be present in a given sample. The biosensor
should also be sensitive in detecting the analyte at an appropriate level, e.g. to determine
between physiological and pathological levels for a disease biomarker. These ranges are
from pico-molar up through to nanomolar concentrations. Though this range will change
for different diseases this is a technically achievable range and one which is often relevant
to distinguish a biomarker and help determine where it is within the physiological (normal)
or pathological (disease) range for a given illness or disorder.
Figure 1-1: Schematic of a biosensor
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Whilst in-vitro tests have been around for many decades now, the idea of developing
biosensors is fairly recent and a brief search of the literature shows just how much growth
in the field has accelerated in the last thirty years (Figure 1-2). It is important to note that
whilst the landmark paper was published in 1962(Clark & Lyons, 1962), the term biosensor
was coined at a later date and has since grown into its own field.
The field of biosensors and In-vitro diagnostics has become increasingly diverse, in an aim
to meet the expanding needs of researchers, within industry and by medical professionals.
This has been additionally driven by discoveries in molecular medicine which have
identified previously unknown biomarkers for a wide host of diseases and disorders. These
potentially enable more stringent diagnostic tools to be developed, reducing mortality and
morbidity by hastening positive intervention.
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Figure 1-2: The number of publications including “biosensor” in the title. Data obtained by
using Science Direct
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1.2.1 Optical biosensors
One of the most widely demonstrated biosensor categories are optical biosensors. They
include methods such as surface plasmon resonance, interferometry and ellipsometry.
Optical biosensors have enjoyed particular success due to the fact that binding can be
monitored in real time, generating data which does not suffer from electrical interference
(Albert et al., 2002). Optical sensing can be broadly grouped into methods which require
the use of chromophores or fluorophores and label-less sensing. Label free detection is
often considered the preferred option as it does not require the time and labour intensive
steps associated with the use of tagging protocols. These steps may also adversely affect
molecular interactions between receptor and analyte (Giepmans et al., 2006). In addition
to operational difficulties, optical biosensor systems are often instrumentally complex and
expensive to establish.
SPR based sensors operate using the principle that light travelling through biological
materials will travel at a different speed than when travelling through a buffer or air. This
causes a change in the refractive index which is used to assess binding of the analyte at the
surface (Homola et al., 1999). The SPR chip is covered in a thin metal film coupled to a
glass prism. When light is beamed at the prism total internal reflection occurs. As the light
is diffused through the prison, a spectrum of wavelength is reflected across a range of
angles. At a given angle, the energy of the incident photons interacts with the energy
levels of evanescent waves at the prism -metal interface resulting in the propagation of
plasmons. This process means that energy from the incident light is absorbed and that the
intensity in reflected light is reduced, a diagram of a typical SPR setup is shown in Figure
1-3.
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Figure 1-3: Typical SPR Instrumentation. As more biomaterial is attached at the surface,
the plasmon generated absorbs light at a different angle causing the point of minimum
intensity at the detector to shift; this change in shift is used to monitor binding in real
time.
As the angle of reflected angle corresponds to the wavelength, the changing energy of the
evanescent wave can be detected by a change in the SPR Angle. This is controlled by a
number of parameters, the critical one being the refractive index at the film. Therefore,
any change in refractive index at will result in a changing SPR. The change in this angle (δθ) 
is used to generate SPR binding data in real time angle (Barnes et al., 2003; Suzuki et al.,
2008).
Though SPR is a well-established method with successful commercialisation by Biacore
and the Texas Instruments ‘Spreeta’ system (Karlsson, 2004), SPR equipment remains
expensive and applications are primarily towards the investigation of binding phenomena
rather than the development of clinical diagnostic tools.
Interferometry, another widely-used method of optical detection of biomolecules, is often
achieved using fibre optic probes. By conjugating the receptor at the end of an optic
probe, a biosensor surface is created which is perpendicular to the incident light. As the
change in refractive index between the fibre and the buffer are so large, a proportion of
the light is reflected back down the fibre as in Figure 1-4 .
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When white light is shone down the fibre optic probe a different pattern of wavelengths
and intensities may be reflected back to a photodiode. Using a similar principle as in SPR
the more matter that is bound at a surface, the thicker the reflecting surface will become.
This leads to changes the constructive and destructive interference of both incident and
reflected beams of light through the probe which can be measured. This is used to
calculate an effective change in thickness at the biosensor interface, which can be
measured in real-time. As with SPR, successful commercialisation of this has been
achieved with the Fortebio Blitz and Octet systems. Again, many applications are research
lead and the main use of these systems is to investigate binding parameters rather than
for diagnostic sensors.
Another category of optical biosensor uses ellipsometry, a technique which can investigate
the dielectric properties of surfaces and thin films. This technique exploits the fact that a
given dielectric surface, with a refractive index much greater than the medium (either air
or water), will reflect a proportion of light at a given angle (Bally et al., 2006). At a
particular angle, known as the Brewster’s angle, polarised light will be perfectly
transmitted through the dielectric and there will be no light reflected. By shining a beam of
Wavelength (nm)
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Figure 1-4: Principles of Bio-Layer interferometry. Incident white light is shone down a fibre
optic probe(A) to which bioreceptors are covalently attached(B), the change in intensity
across the various wavelength (C) can then be used to calculate an effective thickness as
more matter binds at the sensor surface this thickness increases(B).
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polarized light at the surface at an angle similar to the Brewster’s angle, any changes in the
surface will alter the amount of light reflected. This reflected light can be then detected
using a photodiode. As the data is generated by the interaction of light over a surface, the
surface must be very regular to generate high quality data. This method therefore requires
highly ordered flat surfaces to operate and commonly uses ordered tethering layers such
as self-assembled monolayers (Demirel et al., 2008).
As data obtained using this method provides information on the refractive index and
thickness of any optical layer at the interface, any binding data must be calculated
indirectly. This often requires lengthy calculations in order to achieve good simulation of
binding processes at the sensor interface. In a variety of studies such simulation has
resulted in successful calibration for biosensors for a variety of analytes including DNA
(Demirel et al., 2008), toxins (Nabok et al., 2011) and bacteria (Gonzalez-Martinez et al.,
2007) as well as proteins (Bombarová et al., 2015) and peptides such as amyloid peptide
(Mustafa et al., 2010).
1.2.2 Mass based biosensors
Mass sensing biosensors, include piezoelectric methods such as the quartz crystal
microbalance (QCM) and micro-cantilever based sensors. These sensors operate by
exploiting the piezoelectric nature of the transducer. In QCM, a harmonic oscillating
frequency is established in the material which is maintained. The QCM chip has the
transducer layer of the biosensor attached covalently and so as there is any change on the
transducer surface, this affects the oscillating wave through the piezoelectric substrate. As
the mass at the surface increases, the input frequency is slowed to maintain the harmonic
frequency through the substrate. The change in frequency can be converted using the
Saurbrey relation into mass on the binding surface (Kankare, 2002). As analysis can be
done in real time, QCM is an effective way for studying binding events.
∆ࢌ= − ૛ࢌ૙૛
࡭ඥ࣋ࢗࣆࢗ
∆࢓
Equation 1-1: The Sauerbrey equation
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Where:
∆ =݂ change in frequency (Hz)
0݂ = Resonant frequency (Hz)
ܣ = Piezoelectrically active crystal area (cm2)
ߩݍ = Density of quartz (2.648 g.cm-3)
ߤݍ = Shear modulus of Quartz (2.947ₓ10
11 g.cm-1.s-2)
∆݉ = Change in mass (g)
Whilst QCM is a useful and relatively low cost method, as signal is based on mass
detection, it IS particularly difficult to detect small molecules using QCM. Because the data
collected is affected by the dissipation of the harmonic oscillating wave, a modified
method known as dissipation monitoring QCM, or QCM-D, was established in which the
mechanical properties of the interface can also be ascertained. This is achieved by
monitoring the dissipation of the harmonic wave when the applied frequency is withdrawn
as the time taken for the material to no longer oscillate is dependent on its viscoelastic
properties.
The other principal mass based method is force spectroscopy. This is commonly achieved
using piezoelectric cantilevers such as those used in atomic force microscopy (AFM).
Though this sensing method is instrumentally more complex, it may allow the observation
of individual binding events and direct data can be obtained on the strength of interactions
between receptor and analyte proteins (Neuman & Nagy, 2008). Though piezoelectric
systems have been widely demonstrated, their practical deployment in diagnostics are
limited to applications such as HIV testing (Haleyur Giri Setty & Hewlett, 2014). The most
successful biosensors have been demonstrated where analyte recognition results in a large
change in mass at the biosensor interface (O’Sullivan & Guilbault, 1999).
1.2.3 Electrochemical biosensors
Electrochemical biosensors have been established as market leaders and account for a
large proportion of the market share (~85%) (Grieshaber et al., 2008; Joseph, 2006; Laschi
& Mascini, 2006; Lazcka et al., 2007; Pohanka, 2008). They are preferred to other methods
due to their practical simplicity, speed and low capital costs (Caygill et al., 2010). It is for
these reasons that electrochemical sensors are the focus of this thesis.
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The field of electrochemical biosensors has been steadily developing since the creation of
the first biosensor by Clark and Lyons (Clark & Lyons, 1962). This early sensor was for
glucose and operated by confining glucose oxidase in a membrane bound dialysis chamber
and monitoring the consumption of oxygen in the system, the reaction is outlined in Figure
1-5.
These first generation sensors were unreliable as varying oxygen concentrations in the
local environment commonly caused errors and a high potential (voltage) was needed to
detect the oxygen generated in the sample (Habermüller et al., 2000).
In the 1980’s, second generation sensors were developed which operated at much lower
potentials, allowing greater specificity. This was enabled by the use of electron mediators
(Cass et al., 1984; Kulys et al., 1980) in these sensors, the liberated electron from the
glucose could be directly transferred to the transducer (Cass et al., 1985) . This prevented
non-specific redox of other species at the electrode surfaces. These electron mediators
were either mixed into the sampling solution, or directly tethered to the transducer
surface. These sensors were then superseded in the 90’s by third generation biosensors
where the enzymes used could directly transfer electrons to the surface of the electrode
allowing direct specific signal. This was often achieved using materials such as conducting
polymers. Whilst mediating electron transfer through the polymer matrix, the polymer
could also itself be used to immobilise the enzyme. This is the form in which most
amperometric sensors are found today (Gerard et al., 2002; Reiter et al., 2001;
Schuhmann et al., 2000). The development of the glucose sensor over a period of 22
years, since the release of the first commercial sensor is shown in
Figure 1-6.
Figure 1-5: The enzymatic oxidation of glucose
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The early types of metabolic biosensors were often enzyme based. This proved a powerful
approach for analytes which had appropriate oxido-reductase enzymes available.
However, as the needs for developing sensors have become more diverse, sensors are
required for analytes which do not have a relevant enzyme specific to the analyte.
This has led to the expansion of the field of affinity based sensors. Whilst technologically
less developed, lateral flow devices have been a large sector of the market in binding
based assays to date (Luppa et al., 2001). A well-known example is the pregnancy test
which is a biosensor for chorionic gonadotropin, a hormone which is immediately and
greatly elevated in pregnancy (Cole, 2015). Whilst lateral flow devices are good for some
analytes, they have intrinsic limitations in that they give a qualitative measure of an
analyte and use a large amount of both receptor and sample (del Campo, 2014). This
makes them unsuitable for a large range of analytes. In particular, their qualitative nature
limits their application in medical diagnostics where the differences between physiological
and pathological ranges of a biomarker cannot be distinguished using a lateral flow
device(Singh et al., 2014).
Figure 1-6: 22 years of glucose biosensor evolution (1983-2005). (Commons, 2014). A
Reflolux S, by Boehringer Mannheim, introduced 1991. This device offered a 2 minute read
time, based on reflectance. B: ExacTech Card, by MediSense introduced 1987 was capable
of a 30 second read time using an electrochemical test strip which used much less blood
as it operated using a capillary. C: FreeStyle, by TheraSense, Introduced 2003. A drop of
blood could be assayed in 15 seconds electrochemically. D: Freestyle Mini, by Abbott.
Introduced 2004, this is a smaller version of the FreeStyle and the interrogation time was
reduced to 7 seconds.
A B
C
D
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1.3 Construction of the biosensor
When constructing a biosensor there are many aspects which must all be considered as
the large number of variables and lack of established standards in the field mean that each
biosensor system may give different data. Thus the fabrication process must be considered
when analysing data.
1.3.1 Transducer surface
The electrode surface is a primary consideration when fabricating a biosensor. A number
of factors must be considered including: stability, both mechanical and chemical, surface
texture, surface chemistry and the ability to undergo conjugation reactions, cost,
conductivity, quality and reproducibility of signal, and ease of use.
The transducer architecture (both size and shape) as well as relative position of other
necessary electrodes in the electrochemical cell are also key parameters. Some electrodes
are built into a system with external counter and reference electrodes which must be
manually assembled upon use. This may not be ideal as it can introduce a level of
variability into the system before experimentation even begins. Therefore, the aim is to
develop an integrated transducer including the relevant electrodes which could result in
more reproducible properties at the biosensing interface.
Over the years, many different electrodes have been proposed. In established biosensor
fields such as the GOx sensor, a clear leader exists, in this case the carbon ink screen
printed electrode (Niu et al., 2012). In developing areas such as in the field of reagentless
impedimetric sensors, there are yet to emerge any optimum solutions. Indeed only a
limited sample of the wide range of transducers has been successfully demonstrated for
use in impedimetric sensors. Within the scope of this thesis, many electrodes have been
trialled and a comprehensive list is given in Appendix 1. Though the majority of work has
been done on Dropsens electrodes, it must be highlighted that this was also a compromise
as the screen printing of the gold electrodes introduced a larger than optimum surface
roughness and variability within the electrodes.
1.3.1.1 Sputter coated silicon wafer
A particularly good sensor substrate is a sputter coated silicon wafer. Silicon wafers are
routinely produced for use in the semiconductor industry and have virtually atomically flat
surfaces (typically RMS ≤1 nm) making them very useful as substrates for electrode 
construction. To achieve this, the wafer is placed in a vacuum chamber attached to which
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is an ion accelerator. This ionises gas atoms such as argon or nitrogen which are the n
released into the main chamber where they are draw towards a metal target. When they
hit the target, it results in the displacement of gold particles which travel through the
vacuum and collide with the substrate to condense and forma gold film. The design of the
electrode can be controlled by doing this through a template, known as a mask shown in
Figure 1-7 (A). Though this provides an excellent surface it often requires bespoke
templates to be made and requires skilled technicians and expensive clean room
instrumentation. This often results in prohibitively expensive electrodes, typically ≥£5 per 
chip for even a basic design (Millner et al., 2009).
1.3.1.2 Screen printed surfaces
One way of producing cheaper electrodes is to use screen printed electrodes (SPEs). These
are produced by printing a suspension of carbon, metal or polymer particles. A suspension
is held in a reservoir which runs over the flexible template and the ink or suspension is
then squeezed through the template Figure 1-7 (B). As this relies on the use of a
particulate suspension which is later heated in order to remove any organic components
and sinter together particles, it often produces electrodes with a very rough surface which
has more of an agglomeration of smaller particles than one continuous smooth surface
(Alonso-Lomillo et al., 2010; Li et al., 2012; Niu et al., 2012). Carbon SPEs are often used
for the creation of amperometric sensors as they allow direct coupling of an electroactive
enzyme and the nano-topology does not prevent the small metabolite analyte molecules
from reaching the receptor sites.
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Figure 1-7: Comparing different electrode production techniques. Sputter coating of a
resist for electrode manufacture (A) in which charged gas atoms (magenta) accelerate
towards the metal target (yellow) this causes a displacement of metal particles which
travel through the vacuum chamber (green arrows) and pass through a mask (red) where
thy condense upon the substrate (blue) . In Screen-Printing (B) of electrodes, a slurry or
liquid conducting ink is held in a reservoir (green) which is passed over a flexible mask
(red) the ink is then deposited on the substrate (blue) either approach can be achieved for
the patterning of a printed electrode material on an inert substrate.
Screen printing of electrodes often uses carbon inks as carbon is a good semiconductor
which is cheap and can readily be made in a suspension form to enable screen printing.
Though basic graphite slurry can be made which is then cured, most screen printed
sensors use polymer binding agents or particles. These can have preferential conduction
mechanisms such as with conducting polymer particles like polyaniline (Caygill et al.,
2012). Gold particles may also be held in a suspension and printed in a similar way before
heating to remove organic solvents (van Noort & Mandenius, 2000). This results in
electrodes with superior conduction and the gold surface may be used for conjugation
pathways (e.g. the Gold thiol interaction) which may be an advantage when fabricating
biosensors.
One approach which has been tried to rectify the issue of surface irregularity when using
screen printed electrodes is to fill in the surface with a conducting polymer, for example by
electropolymerisation (Caygill et al., 2010; Gerard et al., 2002; Vakurov et al., 2009). This
is advantageous as it can not only fill in voids, helping to make a more regular surface, but
also it can incorporate tethering moieties to permit conjugation of the bioreceptor
A B
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Other improvements have been achieved by coating the surface of the electrode in
nanotubes (Barsan et al., 2015; Boujtita, 2014; Yang et al., 2015). Applying nanotubes to a
biosensor surface may aid in obtaining very high analyte specific responses as their highly
conducting nature means that any signal generated can be easily relayed. However,
creating an oriented array of nanotubes as in Figure 1-8 (B) may still be expensive and
technically difficult (Zhu et al., 2013). Work involving an uncharacterised “tangle” of
carbon nanotubes, as in Figure 1-8 (A), has still proven to be beneficial in a wide number of
applications. In particular amperometric and enzyme based assays have benefitted from
this approach (Boero et al., 2011; Manso et al., 2008; Wan et al., 2011).
1.3.2 Tethering layer
The bioreceptor component is commonly tethered to the transducer surface using an
intermediary layer. This is done to prevent direct contact between the bioreceptor and
the electrode surface. Early sensors worked on the primitive method of direct protein
adsorption, in which the metal surface would bind the protein in a thermodynamic process
driven by the interaction of the high surface energies with charge groups on the receptor.
Often this would lead to the unfolding of the receptor protein and a consequent inhibition
of its catalytic activity or binding capacity (Rushworth, Goode, et al., 2014; Millner et al.,
2009).
It is for this reason that the use of a tethering layer has been widely adopted in biosensor
construction and is a common theme across the field. This can be achieved in a number of
ways (Abbas et al., 2011; Göpel & Heiduschka, 1995; Millner et al., 2009).
10 µm
Figure 1-8: Deposition of nanotubes on a gold transducer surface. Though Ideally CNTs grow
axially from the surface (centre) a forest formation as in (B), they often form a random
tangle on the surface(A), Images adapted from (Delong America, n.d.; Ewels, n.d.;
Willamson, n.d.).
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1.3.2.1 SAM based biosensors
Self-assembled monolayers (SAMs) are well-defined “liquid-crystal” films which allow
immobilisation of biomolecules (Bain et al., 1989). These structurally defined layers form
spontaneously when given time to assemble to provide well-ordered arrays of molecules
as illustrated in Figure 1-9. There are many strategies that can be exploited to form SAMs
for the fabrication of successful biosensors such as the interaction of silanes with hydroxyl
groups (Bhatia et al., 1989; Song et al., 2007) or thiol—gold interaction (Ghindilis et al.,
2009; Losic et al., 2001; Schuhmann et al., 2000).
Figure 1-9: Comparison of typical alkane-thiol SAM's. From left to right monolayers of; (A)
4-aminothiphenol, (B) mercaptohexanol, (C) mercaptohexadecanoic acid and (D) a mixed
SAM layer of mercaptohexane with a branched amino alkane. SAMs provide accessible
functional groups for conjugation chemistry on the biosensor interface.
Typically, SAM formation has two kinetic steps. The first is binding of the SAM-forming
agent to the surface e.g. alkane thiol to gold electrode. This stage typically occurs within
minutes. It is followed by a slower phase (typically hours) in which the SAM reagents order
themselves into a well-defined molecular array. This leads to maximising the Van der
Waals interactions between adjacent alkyl chains which completes the SAM and makes it a
much more stable tethering layer which may also be highly insulating.
Biosensors have also been constructed using mixed-SAMs (mSAMs) based on this thiol-
gold interaction (Billah et al., 2010; Davis & Higson, 2005; Hays et al., 2006; Rodgers et al.,
2010). One crucial aspect of the electrode which must be considered when constructing
the mSAM is the surface. Continuous SAMs are only usually successful on a surface which
is planar within the nanometre domain. Any roughness will interrupt the SAM, rendering
the biosensor useless (Gerard et al., 2002).
A B C D
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SAMs are a dynamic system which behaves as a mobile film. This has consequences for
analyte recognition as the relative sizes of the SAM and the analyte must be considered.
The tethering forces of the sensor must also be considered as, when analysing small
molecules, the force required to tether to the surface is relatively small compared to the
forces holding the mSAM together. However, as the size of analyte increases, not only
does the mass of the analyte but also the possibility that the analyte may have multiple
binding sites. If this happens on a mobile SAM surface, binding may cause strain in the
SAM and potentially in the development of nano- fissures which interrupt the mSAM and
destroy the tethering layer as shown in Figure 1-10. (Arya et al., 2009; Billah et al., 2010;
Caygill et al., 2012).
1.3.2.2 Thiol - Gold Interaction
Although gold is often considered to be unreactive it can conveniently undergo a specific
reaction, the oxidation of sulphur groups. If a thiol group is present, it will be oxidised to
form a gold-sulphur bond which is dative, a form of covalent bond so is therefore
particularly strong. This bond has an associated energy of ~ 425 kJ .Mol-1 Making it very
stable and useful for the construction of biosensors (Evans & Ulman, 1990). Whilst this
reaction is not exclusive to gold (other transition metals may undergo the same reaction)
Small
Monovalent
Analyte
Large
Multivalent
Analyte
Figure 1-10: Disruption of mSAM by binding of a large analyte. For example a bacteria or
virus where the paratope motif may be repeated many times or may attach something of a
significantly larger size than the receptor. This can cause strain in the Tethering layer
(magenta) and potentially a disruption in the SAM tethering layer.
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gold is particularly useful owing to its low reactivity with other chemicals and high
electrical conductivity.
1.3.2.3 Polymer based biosensors
To overcome the problems of dealing with larger analytes, an alternative is to construct
biosensors based on a conducting polymer matrix base layer (Ates, 2013; Barlett & Cooper,
1993; Gerard et al., 2002). This can be achieved by selectively electro-polymerising
monomers onto the working electrode, typically using cyclic voltammetry (Hwang et al.,
2001). When choosing the polymer, its electrical properties must be considered as well as
its chemical features. A particularly good conducting polymer which is well characterised is
polyaniline (Hwang et al., 2001; Lacroix et al., 2000). Many of its derivatives have also been
polymerised(Kennedy et al., 2007). The analogue 2-aminobenzylamine (2-ABA) has been
found to be particularly useful for the construction of biosensors when co-polymerised
with aniline (Raffa et al., 2006) as it provides pendant amine groups to enable tethering of
the bioreceptor. In using a polymer it is also possible to coat fairly rough surfaces evenly,
reducing surface roughness as well as providing a solid structure. A wide variety of
polymers have been used in the development of biosensors as shown in Table 1-1.
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Polymer Used Structure Sensor type(s) References
Polypyrrole
Amperometric
Potentiometric
Capacitive
(Lawal & Adeloju, 2013; Ramanavicius et al.,
1999; Reiter et al., 2001; Schuhmann et al., 2000;
Warriner et al., 1997)
Polyaniline
*
Amperometric
Potentiometric
(Chawla et al., 2011; Jin et al., 2001; Sergeyeva et
al., 1996; Trojanowicz & Krawczyński vel 
Krawczyk, 1995)
Poly-2-
aminobenzylamine
Impedimetric (Caygill et al., 2012)
Polytyramine
Impedimetric
Capacitive
Amperometric
(Labib et al., 2010; Pournaras et al., 2008; Tsuji et
al., 1990)
Polyphenylinediamine
Potentiometric
Amperometric
(Chirizzi & Malitesta, 2011; Windmiller et al.,
2011; Zain et al., 2010)
Polythiophene
Piezoelectric
Amperometric
(Giannetto et al., 2006; Nien et al., 2009)
Poly tert-thiophene-3′ 
-carboxylic acid
Amperometric (Darain et al., 2003)
Polyphenylene Amperometric (Gerard et al., 2002)
Table 1-1: Polymers used as biosensor tethering layers. * Polyaniline is shown as three structures as it has a different electronic configurations, the fully
reduced form pernigraniline (A), the half oxidised, half reduced form emeraldine(B) and the fully oxidised form leucoemeraldine (C)
A
B
C
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1.4 Bioreceptor conjugation
Once the transducer has been chosen and an appropriate tethering layer has been
deposited the bioreceptor may then be attached to the surface. The tethering of the
receptor is a crucial step as the bond must be robust, long lasting and resistant to the
interrogation method as well as any further processing steps in the manufacture of the
biosensor. There are a number of strategies which have been employed to ensure that the
bioreceptor is fully integrated with the biosensor assembly.
1.4.1.1 Matrix entrapment
To provide both a spatial and energetic barrier between the electrode surface and the
receptor, some early worked focused on matrix entrapment. In this method a large
polymeric matrix was deposited in conjunction with the bioreceptor to enable attachment.
One particular example was the use of separate matrices of opposing charge which led to
the electrostatic entrapment of the biorecognition component (Cosnier, 2005) as outlined
in Figure 1-11.
Figure 1-11: Electrostatic entrapment of bioreceptor. Either using a bilayer (A) or multi-
layer approach (B) the receptor can be held between polymer layers of opposing charge in
both approaches polymers of opposing charge, commonly a positive polymer (blue) such
as polydiallyldimethyl ammonium chloride (PDADM) is used which attaches to the negative
electrode, an opposing negatively charged polymer (red) such as polystyrene sulphonate
(PSS) can then be used to entrap the bioreceptor between layers. This can be repeated to
gradually fabricate a multi-layer tethering component.
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Multipoint electrostatic entrapment is a similar approach whereby polymeric layers of
opposing charge can be bonded to multipoint charges within the bioreceptor itself. This is
a particularly effective way of localising the receptor at the interface very gently. Bonding
is achieved by soaking the electrode in a polycationic polymer such as polyethylenimine
(PEI), polydiphenyldiazomethane (PDDM) or polydiallyldimethyl ammonium chloride
(PDADM) along with the bioreceptor (Millner et al., 2009; Vakurov et al., 2009). The
polymer forms many salt bridges with the receptor and attaches it to the electrode
surface. By then soaking in a polyanionic polymer such as polystyrene sulphonate (PSS) the
surface can be epitaxially grown and a stable sensor surface can be fabricated complete
with embedded bioreceptors.
1.4.1.2 Carboxyl to amine coupling
Some of the most commonly used chemical moieties for conjugation employ the COOH
and NH2 groups. These are either at unmodified N and C termini or, more commonly, as
external residue side chains (Asp, Glu providing COOH, and Lys providing NH2 moieties).
Therefore, they are a readily available route for the conjugation of receptor to the
transducer surface.
The carboxyl group is often functionalised using 1-ethyl-3-(3-dimethyl aminopropyl)
carbodiimide (EDC) as shown in Figure 1-12. This compound readily activates any COOH
groups, making them more reactive and thus encouraging conjugation of the NHS Ester.
This creates an acyl-isourea intermediate which is then susceptible to nucleophilic
attachment from the lone pair of electrons located on the amine functional group. This
causes the formation of an amide bond and an iso-urea by-product which is a chemically
stable good leaving group (Hermanson, 2008).
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Figure 1-12: Conjugation of carboxyl group to amine group using EDC. The activation of the
COOH moiety by EDC (i) is followed by the nucleophilic attack from the amine functional
group (ii) resulting in a stable amide bond and the iso-urea leaving group. Scheme adapted
from (Hermanson, 2008)
This provides an easy method for the conjugation of a carboxyl to an amine group, forming
an amide bond which is chemically very stable. Though this method is commonly used it
does have limitations including the fact that the optimum pH for the reaction is ~pH 4.5
which is potentially damaging the receptor protein. If the protein of interest includes many
amine groups, which due to their hydrophilicity are often located on the protein surface,
conjugation can occur at any of these sites. This makes it difficult to control orientation
using this conjugation pathway.
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1.4.1.3 Thiol coupling chemistry and heterobifunctional linking
agents
Another functional group which is commonly exploited in conjugation chemistry is the
thiol group. This group is particularly useful as it allows cysteine residues in a protein
structure to be targeted. As cysteine residues tend to be relatively rare, even in native
proteins the number of sites available to undergo this conjugation pathway is restricted
and this may help to limit the orientation possibilities of a conjugated protein on the
biosensor surface.
One way of further enhancing the receptor orientation is to engineer the protein and
introduce a cysteine residue at a defined position, such as at the end of a peptide spacer.
This enables the spatially controlled conjugation of the bioreceptor and ensures that all
receptors are attached in a coherent manner. The orthogonal chemistry involved in amine
to thiol chemistry is often mediated using heterobifunctional cross-linkers which allow
specific oriented tethering.
One of the most widely used linkers, is sulfo-SMCC (Figure 1-13) which is an amine to thiol
linker and is usually used in a two stage coupling process. First, the cross linker is
incubated with the amine containing partner (in the case of this thesis, the polymer
surface). This results in nucleophilic attack which causes the N-Hydroxysuccinimide group
to leave and covalent linking between the amine containing surface and the crosslinker
which is left with a labile –SH reactive maleimide group. When the bioreceptor thiol group
is later introduced, the maleimide undergoes nucleophilic addition and a covalent carbon –
sulphur bond is formed.
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Figure 1-13: Conjugation of Thiol group to Amine group using SMCC. The primary amine is
attached to the SMCC via nucleophilic attack resulting in the loss of an NHS leaving group
(i). The amine is then covalently attached to a maleimide moiety which is susceptible to
nucleophilic addition by a thiol functional group (ii). This results in thio –ether linking of
the amine and thiol groups with a spacer arm length ~8.3 Å. Scheme adapted from
(Hermanson, 2008).
Amine to thiol coupling is particularly effective since it is easy to ensure amine groups are
incorporated into the transducer surface and also because exposed surface thiol groups
are fairly rare in a protein’s structure. Cysteines are commonly located deep within a
protein structure and play a critical role in the structure or function of the protein. Though
the amine coupling step of this occurs most rapidly at a similar pH as in EDC: NHS coupling
(pH 4.5) coupling of the maleimide to a thiol group is optimal at pH ≥7 which is beneficial 
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in minimising damage to the receptor protein. This is useful as the amine crosslinking
reaction is commonly used to attach SMCC to the tethering layer so; the receptor is not
exposed to the high pH buffer at all. The use of Sulfo-SMCC allows the specific and
oriented tethering of receptors to the biosensor interface. Using this principle many
sensors have been constructed (Billah et al., 2010; Caygill et al., 2012; Makaraviciute &
Ramanaviciene, 2013; Spitznagel & Clark, 1993; Tajima et al., 2011).
Sometimes it may be preferable to couple the thiol group to a carboxylated surface, for
example when amine surfaces are unavailable or when the use of an intermediary such as
di-glycine would add undesired steps to a conjugation reaction. One easy way of doing this
it to use the crosslinker 3-(2-pyridyldithio) propionyl hydrazide (PDPH).
PDPH has a primary amine group which can be coupled to the carboxylated surface using
EDC-NHS coupling as in Figure 1-12. As the PDPH is then covalently bound via an amide
bond to the surface, it can undergo further reactions. The pyridyl disulphide group may
then react with a thiol containing group in a step which may require cleavage with DTT.
This is a nucleophilic substitution which results in a pyridyl-2-thione leaving group and the
formation of a disulphide bond between the crosslinker and the target molecule.
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Figure 1-14: The conjugation of a carboxyl moiety to a thiol group using PDPH. In two
stages the PDPH is first joined using routine EDC/NHS chemistry before reaction with the
thiol group. DTT (blue),may be used to cleave the pyridyl-2-thione leaving group, the thiol
group is then introduced by nucleophilic substitution and a covalent bond is formed is
shown in blue the spacer arm is ~9.2 Å. Adapted from (Hermanson, 2008)
As well as using conjugation routes which have been developed within the organic
chemistry field, a number of interactions between proteins and other molecules can be
used for constructing biosensors.
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1.4.1.1 Biotin - avidin interaction
A commonly exploited high affinity interaction is the biotin-avidin interaction. Biotin
vitamin H can be easily tagged onto a biomolecule using previously mentioned pathways.
Commonly employed reagents include, biotin-NHS and biotin–maleimide for attachment
to NH2 and SH groups respectively. Avidin is a glycoprotein which is found in eggs; it has a
hetro-tetrameric structure where each monomer binds a single molecule of biotin. Overall,
the binding sites are arranged as two pairs separated on either side of the avidin complex,
as in Figure 1-15. Biotin and avidin bind with an affinity of
Kd= 1.3 x 10-15 M-1, which is approaching the strength of a covalent bond (Hermanson,
2008). Due to the relative orientation of the binding sites, when binding at one of the sites
occur it often occludes the other in the pair and it can therefore act as a biomolecular
cross-linker.
Figure 1-15: The structure of avidin homo tetramer, with 4 molecules of bound biotin
(magenta) in two pairs of distally separated sites. Image created using PDB: 2AVI. From
RSC PDB (http://www.rcsb.org/pdb/home/home.do)
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In order to exploit this interaction, a biotin moiety must be tagged onto both antibody and
substrate. The biotin group may be introduced by the reaction of an amine group with
commercially available reagents such as biotin-N-Hydroxysuccinimide (NHS). As in Figure
1-12, the NHS –carboxy ester is attacked by the amine group on either the antibody or
polymer substrate. It is important to note that this is an undirected reaction so any
exposed primary amine groups will undergo this chemistry. When biotinylating a protein
using biotin-NHS, the location of biotinyl groups will therefore depend on the amino acid
sequence of a protein. This leads to uncertainty concerning the orientation of bound
proteins on the sensor surface. As mentioned, biotin maleimide can alternatively be used
to target the biotin modification towards cysteine sites in an engineered or reduced
protein.
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1.5 Bioreceptors
Integral to the biosensor is the receptor used. Once again there are a number of
parameters which must be considered when choosing the receptor subsystem. Ideally, the
receptor should be specific to the biomarker of interest and allow the generation of
enough signal to develop a biosensor which is sensitive enough for the given application.
Within this thesis a considerable effort has been dedicated to investigating different
receptors and assessing ways in which they can be optimised in order to permit the
fabrication of improved biosensors. This is an attractive approach as it may improve the
quality of the sensor whilst circumventing the need to develop new fabrication techniques
for electrodes which would be a more expensive approach to take. This approach also
allows the use of tools such as chemical modification and re-engineering of proteins via
molecular biology procedures which may again help achieve cheaper, more sensitive
biosensors. Within the broad field of biosensor development there are a wide variety of
receptors which have been used, the major types are outlined in brief below.
1.5.1 Oligonucleotides
DNA has been used as the bioreceptor in a wide range of electrochemical sensors for a
range of analytes, including other oligonucleotides which exploit base pairing between
complementary DNA. These sensors can be used to quickly and highly accurately probe for
a given sequence and have even been shown able to detect single point mutations along a
DNA sequence (Bonanni & del Valle, 2010; Levine et al., 2009; Liu et al., n.d.).
Nucleotide bioreceptors may also be evolved to bind proteins. These are known as RNA or
DNA aptamers and exploit the vast range of possible DNA structures. These structures are
exceedingly stable as they are self-encoded by the aptamer so may be denatured and
reformed many times. The aptamers can be very rapidly evolved using systematic
evolution of Ligands by exponential enrichment (SELEX) (Darmostuk et al., n.d.). Aptamers
developed in this way have been successfully used for the fabrication of biosensors for a
variety of protein analytes including enzymes and cell surface markers (Levine et al.,
2009; Queirós et al., 2013; Withey et al., 2008).
As well as being raised to bind to proteins, DNA aptamers may be raised towards small
molecule targets including drugs (Hilton et al., 2011; Yun et al., n.d.) and pesticides
(Barthelmebs et al., 2011; Chen & Yang, 2015; March et al., 2009). They are advantageous
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relative to antibodies which often fail to bind small analytes stringently. A classic example
of this is an aptamer raised against theophylline which shows almost no cross reactivity to
caffeine which is identical bar the removal of a methyl group (Jiang et al., 2015; Zhao &
Yang, 2010). When using antibodies to distinguish between these two analytes, even the
best monoclonal antibodies show a cross reactivity of around 15% (Mounié et al., 1990).
An additional benefit of using nucleotide based receptors is that they can raised to bind
toxic compounds. In this case, production of antibodies may not be possible as
immunisation using toxins may result in death of the host or cytotoxicity in receptors
expressed from. For this reason nucleotides are particularly useful as receptors as they can
be screened and enable the creation of stringent binding receptors to otherwise toxic
analytes (Castillo et al., 2015; Eissa et al., 2015; Luo et al., 2014). One critical
disadvantage of nucleotide receptors is their reliance on charge - charge interactions, as
their binding conformation is often held by polar bonds between nucleotides and also
charge interactions. This may make their binding conformation very sensitive to change in
the environment. This may mean that whilst they are good binders in principle which work
well in simple systems such as testing in ground water or simple sample media, testing in
more complex and often more relevant sampling matrices such as blood, plasma or urine
may render the receptor useless. Limited work has been done to stabilise nucleotide
receptors including the inclusion of artificial nucleotides or fluorescent nucleotide moieties
which can shield the binding region of the aptamer in more complex chemical
environments, this may make them more suitable (Seok Kim et al., n.d.).
1.5.2 Proteins
The other major category of bioreceptors is proteins. This broad category includes some of
the most important biosensor systems which are widely used and have been extensively
demonstrated.
1.5.2.1 Enzymes
Enzymes are commonly used in the measurement of metabolites and small analytes where
an appropriate enzyme may be obtained (Wilson & Turner, 1992). The highly successful
glucose biosensor uses glucose oxidase as its receptor (Newman & Turner, 2005; Wilson &
Turner, 1992). Enzymes are mostly used in amperometric or potentiometric sensors. In
the case of amperometric sensors interaction between the enzyme and the analyte causes
a change in current, by either oxidation or reduction (Dzyadevych et al., 2008) which can
be quantifiably measured and translated into a signal output. For potentiometric sensors,
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the enzyme usually catalyses a reaction which consumes or produces an ion (e.g. NH4+) and
affects the potential of the electrochemical cell as discussed in section 1.7.3.
Whilst these biosensors may be more easily produced than other types, they can only be
achieved for analytes for which a suitable enzyme exists (Scognamiglio, 2013). This
practically limits the use of enzymes as bioreceptors for metabolite and small molecule
sensors including glucose (Cass et al., 1984; Reiter et al., 2001; Scognamiglio, 2013),
ethanol (Manso et al., 2008; Ramanavicius et al., 1999), cholesterol (Vidal et al., 2004),
lactate (Hirst et al., 2013; Palmisano et al., 2000) and similar metabolic analytes
(Trojanowicz & Krawczyński vel Krawczyk, 1995).  
1.5.2.2 Antibodies
Antibodies are the primary agent for the biorecognition of pathogens and toxins in the
immune system and have been widely adopted in the development of immunologically
based sensors. Antibodies’ in vivo function is to bind a perceived pathogen which enables
the immune system to respond and defend against illness and disease. A diverse binding
repertoire is achieved due to gene shuffling in plasma B cells which produce new
antibodies after initial infection exposure or immunisation. The binding of the antibody to
a selected protein target or biomarker can be used as the interaction for signal generation
in a biosensor. Within the structure of the IgG molecule, the Fc, constant region varies very
little whereas the Fab region, which is where the binding occurs, has a very variable amino
acid sequence. This results in an enormous range of structures and range of charge
distributions which is vital for antigen binding. This variety allows the generation of
antibodies to a wide range of targets and it is estimated that humans have a library of
around 1010 distinct antibodies recognising distinct epitope regions (Fanning et al., 1996).
As antibodies are highly versatile and easily sourced they were adopted in the creation of
the earliest affinity based biosensors(Bright et al., 1990; Taylor et al., 1991; Vadgama &
Crump, 1992; Leech, 1994). Though antibodies are useful, they are not without their
drawbacks. They can be unstable, require animal use and show batch to batch variance.
Though this can be counteracted to some extent by using monoclonal antibodies which
require only one immunisation before the establishment of hybridoma culture and allow
for continual expression, the associated methods are very expensive and still rely initially
on animals in order to harvest the spleen and isolate B cells for fusion.
51
1.5.2.3 Modified antibodies
Whilst many biosensors have been constructed using whole IgG as the bioreceptor, a
number of studies have modified the antibodies prior to application to the transducer
surface. This has enabled the modified antibodies to be deposited in a more oriented
manner which has enhanced the function of the overall biosensor (Ahmed et al., 2013;
Billah et al., 2010; Makaraviciute & Ramanaviciene, 2013; Spitznagel & Clark, 1993; Tajima
et al., 2011).
The IgG molecule consists of 12 immunoglobulin (Ig) fold domains. This fold is a common
motif which is largely conserved and found in many proteins. The 12 domains found in the
IgG are comprised of 4 polypeptide chains (2 light and 2 heavy chains) which are all held
together by disulphide bonds.
There are principally two ways of achieving the modification of whole antibodies, using
either chemical cleavage or enzymatic digestion (Zourob, 2009), as summarised in Figure
1-16. Using the chemical approach, disulphide bonds can be selectively reduced using
gentle reductants such as either TCEP (Billah et al., 2010) or MEA (Caygill et al., 2012)
which break only the disulphide bonds linking Fc domains. Whilst it may be preferable to
use the milder TCEP and prevent the complete fragmentation of the protein, some of the
disulphide bonds may be partially shielded and thus require the slightly stronger MEA to
be used.
When using enzyme based techniques, either pepsin or papain may be used (Harlow &
Lane, 1999). In the case of pepsin, the antibody is digested just below the disulphide bonds
which hold the two heavy chains together. This results in two Fab’ fragments which remain
bound. These fragments can then be subsequently cleaved using TCEP to generate Fab’
fragments with a basal cysteine residue which is particular useful for conjugation
chemistry (Holford et al., 2012). One drawback of using pepsin, however, is that it is a
proteolytic enzyme which has evolved to function in gastric, acidic conditions, and its
optimum operational is at pH 3. Such a low pH is typically damaging to antibodies (Kindt et
al., 2006). Accordingly there is therefore a trade-off between the extent of digestion and
damage caused to the antibody by the acidic environment. The other enzyme which may
be used for antibody digestion is papain which is extracted from papaya. Papain is a
cysteine protease and when used with antibodies, it digests just above the disulphide
bonds holding the two heavy chains together. This generates two individual Fab
fragments. The optimal conditions for papain are much milder than those of pepsin,
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meaning that antibodies tend to be less damaged during processing. The primary
disadvantage of this method is that it leaves no labile cysteine residues for further
conjugation as reduction would result in full fragmentation and reduced recognition
activity (Gopinath et al., 2014).
The modification of antibodies has been demonstrated in the development of successful,
biosensors (Makaraviciute & Ramanaviciene, 2013) including the use of half antibodies
(Ahmed et al., 2013; Billah et al., 2010) as well as the use of antibody fragments, both Fab’
(Brogan et al., 2003) and Fab (Bonroy et al., 2006) fragments has been demonstrated.
Whole IgG
Half IgG
F ab
F ab’
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Figure 1-16: Modification of IgG for biosensor applications. The two enzyme based
techniques of papain (blue) and pepsin (orange)digestion, generation of half antibodies as
well as Fab’ fragments is achieved using a reducing agent (red)
1.5.2.4 Antibody mimetics
In a move away from the reliance on animal sources many synthetic proteins have been
developed as an alternative. Typically these proteins use a conserved protein scaffold with
a separate evolved complementary determining region (CDR). They can often be quickly
evolved and screened for binding capacity using standard panning techniques. In Table
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1-2, a selection of the main antibody mimics is shown, alongside structural data. This table
is far from exhaustive, as there are now over 50 scaffolds that have been demonstrated.
Synthetic binding proteins may be categorised according to their similarities with standard
antibodies. Single-chain variable fragment proteins (ScFv’s) were initially adopted as an
alternative to antibodies. From monoclonal technologies, the two isolated binding
domains from heavy and light chains of the antibody are isolated and fused using a small
peptide. Once the DNA has been isolated, the proteins can be screened by phage display.
Because they are a combination of two Ig domains, ScFv’s have limited stability and can be
more difficult to express than other antibody mimetics. Another antibody-like binding
protein which originated from animal immunisation are nanobodies. These are produced
by isolating the single chain antibody mRNA from an immunized camelid, details of which
are discussed in more detail below. These two structures are based on the
immunoglobulin fold which comprises 2 ‐four stranded β‐sheets which align and present 
the CDR in the peptide loops between sheets.
Other types of antibody mimetics use protein motifs other than the Ig fold. Another similar
protein scaffold has been used to create a β‐sheet structure which displays a CDR. In the 
example of Adnectin®, which is based on the combination of two four stranded β‐sheets,  
presenting three CDR regions (Lipovsek, 2011). As well as β‐sheet based antibody mimetic 
structures, some structures include α‐helices as in the case of Adhirons (Tiede et al., 2014) 
a scaffold based on a plant phytocystatin which comprises a four stranded β‐sheet and a 
single α‐helix. Other antibody mimetics rely more heavily on the presence of alpha helices 
such as the Anticalin, based on the lipocalin structure which has two-four stranded beta
sheets and four‐α‐helices (Richter et al., 2014; Skerra, 2008). There are also examples of 
synthetic binding proteins which rely entirely on the α‐helix for structure such as the 
DARPin (Boersma & Plückthun, 2011; Stumpp et al., 2008).
In all of these structures the CDR is located in the non-structural portion of the peptide
chain. Whilst in the more antibody-like structures it often forms a binding pocket for a
target protein, in the case of DARPins, and structures based on α‐helix repeats a binding 
surface may also be found which increases in size with the number of repeat helix groups.
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Table 1-2: Antibody mimetic systems. This list is not exhaustive but shows the variety of protein scaffolds which have been developed. The structures are
shown in order of resemblance to conventional IgG or its fragments. CDR position indicated by the red dashed box. PDB reference is to structural data
accessed via RCSB Protein data Bank (http://www.rcsb.org/pdb/home/)
Name Structure Parent Protein Category Size Randomisation PDBid Ref.
ScFv Fused heavy and lightchain from IgG
Isolated IgG
binding domains 30 KDa 25-30 residues 4NKM (Kalyoncu et al., 2014)
Nanobody Camelid hcIgGantibodies
Isolated Ig binding
domain 12-13 KDa
3 CDR regions total 20
residues 1MEL (Nicholls, 2007)
Adnectin Humanfibronectin β‐sheet structure  10 KDa 
3 CDR regions total
20-25 residues 1TTG (Lipovsek, 2011)
Adhiron Plantphytocystatin
Mainly β‐sheet 
with 1‐ α‐helix 
12-13 KDa 2 CDR regions, 9residues each 4N6T (Tiede et al., 2014)
Anticalin
Lipocalin
β‐ barrel structure 
with external α‐
helices
20 KDa
4 CDR regions up to a
total of 24 residues 1LNM (Gebauer et al., 2013)
DARPin Ankyrin repeat proteins Repeated α‐helix  10‐20 KDa 8 residues per repeat 4DUI
(Boersma & Plückthun, 2011;
Stumpp et al., 2008)
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1.5.2.5 Camelid Nanobodies
Nanobodies are a particularly interesting antibody derivative which are isolated following
animal immunisation. As a result of convergent evolution, the families of Camillidae
(camels, llamas, alpacas, dromedaries etc.) and Chondrichthyes, which includes sharks and
rays, have both evolved a class of antibodies in addition to the normal mammalian iso-
types (Flajnik et al., 2011). These smaller, heavy chain only antibodies appear to have a
wider operational temperature and greater molecular stability (De Genst et al., 2006; L.
Huang et al., 2010; Vincke & Muyldermans, 2012). In recent years, the isolation of their
binding domains has led to the development of nanobody based technologies by
companies such as Ablynx (Desmyter et al., 2015; Kolkman & Law, 2010). Nanobodies are
very stable small recognition proteins (≤13‐KDa) based on a single β‐sheet with 3 CDR 
loops.
Nanobodies are typically produced by immunising alpacas. After initial immune response,
blood is extracted and the lymphocytes are isolated. cDNA from these lymphocytes is then
taken (Abbady et al., 2011; De et al., 2009; Schotte et al., 2012) and a phage display library
is constructed in which the displayed protein is the nanobody. This library can then be
screened to identify strong binding candidates for nanobody expression. At this stage the
binders can also be screened against known cross-reactants to ensure target specificity in
a competitive assay. The DNA is then sequenced and subcloned into a stable plasmid
(Honda et al., 2003). As this plasmid codes for a monoclonal binder, any batch -to- batch
variance is removed and only one immunisation is necessary for a potentially endless
source of nanobodies which are proving both cheaper and more reliable in the long term
than traditional antibodies (Muyldermans et al., 2009). This approach also dramatically
reduces the number of animals required for development of reagents, which is a key goal
Figure 1-17: A comparison of the domains in IgG antibodies and camelid antibodies, IgG
antibodies (A), 150KDa, camelid heavy chain only antibodies (B),75Kda and the isolated
nanobody (C), ~13Kda.
A B C
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of current life science research. Nanobodies are currently being developed for a wide
array of immuno-based therapeutic reagents for oncology (Behdani et al., 2013; De Meyer
et al., n.d.; Oliveira et al., 2013; De et al., 2009) as well as in the field of diagnostics (Fodey
et al., 2011; Hassanzadeh-Ghassabeh et al., 2013; L. Huang et al., 2010)
1.5.2.6 Re-engineered Nanobodies
In this study, recombinant DNA techniques have been employed to generate nanobodies
with spatially defined tethering groups as well as a variable length amino acid spacer.
In this thesis, a plasmid was designed to include a His6-Tag for easy purification, as well as
a peptide spacer arm of 5, 10 or 15 amino acids with a cysteine at the N-terminus. The
inclusion of the cysteine residue was in order to allow for facile conjugation via its side
chain thiol in an oriented manner. Along with orientation, this peptide spacer arm allows
for variation of the distance of the bioreceptor from the transducer surface. If the
bioreceptor is attached onto or very close to the biosensor interface then steric hindrance
may limit analyte binding. By providing a physical spacer, we aimed to minimise the steric
hindrance and promote optimum orientation to encourage specific binding of the analyte
to the sensor surface. This is an effect which has been previously investigated (Lu et al.,
1996; Mitchell, 2010; Piro et al., 2007) and it is hoped that the use of nanobodies will
underline the importance of orientation of the bioreceptor. As a comparison to the novel
nanobody based biosensors to detect rabbit IgG, data has been collected on traditional
antibody systems. The variety of bioreceptors used in this report is shown in Figure 1-18.
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Whilst work in this thesis focuses on the use of nanobodies the lessons learned can
hopefully be applied in the application of other similar antibody mimetics. As biosensors
are an emergent field there are currently a number of candidate proteins for biosensor
development such as darpins (Kummer et al., 2013), Adhirons (Tiede et al., 2014) and
affimers (Johnson et al., 2012) the benefits of these systems have been demonstrated
mainly using optical biosensor systems (Miranda et al., 2011).
1.5.3 Validating receptors for use in biosensors
To ensure that the receptor to be used in the biosensor will be effective, a range of
methods are used to assess crucial binding parameters including Kd, limit of detection and
the selectivity to the target analytes by testing the receptor with suspected cross
reactants. This can be done using a number of techniques including ELISA, radioisotope
tagging and optical methods such as SPR and Biolayer interferometry. In this thesis, bio-
layer interferometry (BLI) has been used to validate the specificity of nanobodies and
assess the effect of peptide spacer inclusion on key binding parameters. A schematic of the
Fortebio system used is shown in Figure 1-4.
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Figure 1-18: An Illustration
of different bioreceptors
used in impedimetric
immunosensors throughout
this thesis. (A) non- oriented
antibody based biosensors,
constructed using biotin
avidin crosslinking (B) non-
oriented nanobodies, again
fabricated using biotin avidin
cross-linking and (C)
oriented nanobodies with
engineered peptide spacer
arm of 5, 10 and 15 amino
acids, (1,2 and 3
respectively) conjugated
using sulfo-SMCC crosslinker
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Though the binding data obtained from BLI experiments is typically expressed in nm, which
represents the change in the thickness of the optical layer, it can be analysed using
standard binding kinetic equations. In the case of antibodies, the binding model is
conventionally considered to be high affinity; fast-on, slow-off, which ideally should be
true for receptors in immunosensors where the analyte rapidly binds to the receptor and
remains in-situ throughout interrogation of the sensor. Using this model, data can be
interpreted using one site saturation binding and de-binding equations, shown in Figure
1-19, the principal equations of which are discussed more thoroughly below.
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Figure 1-19: Binding data in a typical interferometry experiment. Both binding (blue) and
debinding (red) portions of the experiment are displayed.
From these experiments, the measured signal can be used to fit the equations and
calculate values for Kon and Koff. This is achieved by rearranging equations in Figure 1-19 to
those below (
Equation 1-2 and Equation 1-3), inputting the measured data.
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࢑ܽ = ࣔ [࡭࡮]࢚ࣔ = ࢑࢕࢈࢙− ࢑ࢊ[࡭]
Equation 1-2: Calculating On rate from one site saturation curve
Where:
ࢇ݇ = association rate constant (M.s-1)[࡭࡮] = concentration of analyte receptor complex (M)
ݐ= time (s)
݋ܾ݇ ݏ = Observed linear binding rate. (M)
݇݀ = dissociation constant. (s-1)[࡭] = Concentration of analyte (M)
࢑ࢊ = ࢒࢔ ൬ࢅ− ࢅ૙࡭ ൰.࢚−૚
Equation 1-3: Calculating Off rate from one site binding
Where:
݇݀ = dissociation rate constant
ݐ = time (s)
ݕ = binding signal at time t (nm)
ݕ0 = Minimum binding signal achieved (nm)
These two equations can be then used to give the overall binding constant using the
relationship:
ࡷࡰ = ࡷࢊࡷࢇ
Equation 1-4: Calculation of affinity from rate constants
This method has been used to assess the affinity of the nanobodies produced in this thesis
and compare them to commercially available antibodies raised against the same targets. It
merits noting that whilst antibodies commonly display affinities within the range of
10-6.M-1 down to 10-8.M-1 it is however possible to obtain antibodies which can have KD
down to 10-12.M-1. This may be achieved using techniques such as affinity maturation in
which error-prone PCR is used in combination with phage display techniques to slowly
refine a population of antibodies and identify the strongest binders (Harlow & Lane, 1999).
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1.6 Biosensor regeneration
In theory, regeneration of biosensors enables repeated continual sampling of a given
analyte. This is important as it may allow a several fold reduction in the cost associated
with consumables, but also it may help to provide higher quality data as it removes sensor-
to-sensor variance. The regeneration of the sensor is controlled by the forces which govern
analyte binding and these can be categorised into the two competing thermodynamic
qualities of enthalpy and entropy.
1.6.1 Enthalpic interactions
Enthalpy is defined as the total energy of a thermodynamic system (Atkins, 1998). This
energy can be distributed in a number of ways including heat (kinetic energy) and
potential energy which can take on many forms such as ionic charge or chemical energy.
According to the first law of thermodynamics, a system will equilibrate to reduce potential
energy.
Figure 1-20: A schematic of biosensor regeneration. After exposure to a sample the
analyte is bound before interrogation. An active regeneration step is then required in
order to return the sensor to its basal state before the cycle can be repeated. (Goode et
al., 2014)
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∆ܪ = ∆ܷ − ݌∆ܸ
Where:
ܪ = Enthalpy (Kj.mol-1)
ܷ = Internal Energy (Kj.mol-1)
݌= pressure (pA)
ܸ = Volume (m3)
N.B: - in the case of receptor analyte binding pressure and volume will remain
constant.
When considering interactions involved in biosensor operation, the differences in potential
energy are a crucial force in bioreceptor to analyte binding, which are often mediated by
charge-charge interactions. At any pH the various amino acids in solution may be either
positively or negatively charged, depending on the iso-electric point (pI) of the amino acid
residue. Under physiological conditions e.g. blood at around pH 7.4, there are acidic,
negatively charged amino acids such as aspartate and glutamate, as well as corresponding
basic or positively charged residues such as lysine, arginine and histidine (Voet, 1998).
Interactions between charged side groups may be crucial in forming the tertiary structure
of the paratope (Yokota et al., 2003) along with other forces such as hydrogen bonding
and Van der Waals interactions (Schwarz et al., 1995). As the charge on each residue is
dependent on the solvent environment, factors such as ionic strength, pH and the
presence of competitor ions within the solvent can alter the relative strength of the charge
interactions to effectively screen enthalpic interactions between the analyte and the
bioreceptor which assists in biosensor regeneration (Tsumoto et al., 1996). In the case of
antibody - antigen binding, these interactions are often optimised to minimise the
potential energy. Typical changes in enthalpy upon antigen binding range from changes as
small as – 26 kJ.mol-1 down to more enthalpically driven interactions where the change
may be -130 kJ.mol-1 in the most extreme examples (Schwarz et al., 1995). This is a
considerable change in enthalpy when compared to typical values for covalent bonds
which range from 200-400 kJ.mol-1 (Atkins, 1998). It is crucial to note that at very low ionic
strengths, the binding of an antibody can be promiscuous as any charge differential may
mediate binding and lower the stringency of the receptor. Conversely, high ionic strength
environments may screen the antigen - antibody interaction to reduce binding entirely
(Reverberi & Reverberi, 2007).
Equation 1-5: Calculation of system enthalpy
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1.6.2 Entropic Interactions
Entropy is defined as the inherent chaos or disorder of a system (Atkins, 1998). The second
law of thermodynamics states that the entropy of a system will always increase, creating a
more disordered system. This acts to lower the potential energy of the system overall,
according to Gibb’s Law which states that a process will be spontaneous if the Gibb’s free
energy is negative and where Gibbs free energy is the change in entropy minus the change
in enthalpy (Atkins, 1998).
∆ܩ = ∆ܪ − ܶ∆ܵ
Where: G = Gibb' s free energy (Kj.mol-1)
ܪ = Enthalpy (Kj.mol-1)
ܶ = Temperature (K)
ܵ= Entropy (Kj.K-1)
Though analyte binding may be assumed to cause a decrease in the entropy of a system,
there is also entropic compensation by processes such as solvent displacement. To explain
this we must consider the role of solvent molecules in the system. In most systems, the
unbound state is the high entropy system as the free analyte is highly disordered and
although there is a decrease in entropy when the analyte binds, this is outweighed by the
change in enthalpy which this contributes negatively, and overall there is a negative Gibb’s
energy change which explains why this is a spontaneous process. Though this case is the
most frequent, there are certain systems in which the entropy is increased upon binding,
particularly when dealing with hydrophobic analytes. This is due to the fact that
hydrophobic analytes lead to ordered water caging at the solvent interface. Upon binding,
these interactions are interrupted and the solvent molecules are then free in solution
leading to a rise in entropy overall. Certain amino acids are known for their hydrophobic
properties such as tryptophan, valine, leucine, methionine, phenylalanine, cysteine and
isoleucine. In some systems, hydrophobic interactions are key to the antibody - antigen
interaction and it has been identified that apolar surfaces are often buried at the binding
interface and may have a large impact on the analyte binding and subsequent
regeneration of a biosensor (Sundberg et al., 2000). At the protein level, biosensors have
been developed for the detection of hydrophobic analytes such as fibrin, which have been
subsequently regenerated (Choi & Chae, 2009).
Equation 1-6: Calculation of Gibb’s free energy
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In reversing these interactions, entropically driven binding must be reduced by negating
the effects of hydrophobic regions; consequently aliphatic detergents are often used. In
aqueous solution, this allows the interruption of water caging and minimisation of the
hydrophobic effect (Cserháti & Szögyi, 1995) at the interface of the analyte and
bioreceptor. A summary of typical approaches for regeneration is shown in Figure 1-21.
1.6.3 Role of pH and electronic environment
As discussed, the solvent environment at a sensor interface is a key determinant for the
binding of an analyte to the bioreceptor. It is for this reason that the most widely used
approach for regenerating biosensors is to alter the solvent environment. This is easily
done by placing the sensor in a regeneration buffer and typically requires common
reagents therefore making it a low cost approach to sensor regeneration. Though a crude
technique, deployment of regeneration buffers can be easily refined by the use of a fluidic
system to bring more precise control of reagent delivery and exposure of the biosensor to
regeneration buffer.
Figure 1-21: Forces governing analyte: receptor binding and regeneration. Electrostatic
Interactions (green) along with Hydrophobic regions (yellow) (not to scale) The use of
chaotropes, point charges and detergents is also shown (Goode et al., 2014)
64
1.6.3.1 Acid/Basic Regeneration
In many reports, regeneration has been achieved by the application of high (Michalzik et
al., 2005; Steegborn & Skládal, 1997) or low pH (Bright et al., 1990; Lazerges et al., 2006;
March et al., 2009; Queirós et al., 2013) buffers to the system. Typically a low pH buffer
such as glycine will go no lower than pH 2 in order to prevent irreversible damage to the
bioreceptor. Conversely, a high pH buffer will often be employed with a pH around 11 for
the same reason (Fortebio, 2007). This has a twofold effect on the system. First, a change
in pH alters the enthalpic state of the system by changing the relative charge on the
analyte and the bioreceptor. The structural denaturing induced by this effect aids
decoupling of the analyte from the bioreceptor (Blanchard et al., 1990). It also contributes
to the ionic strength of the environment which screens receptor - analyte interactions
(Novotny & Sharp, 1992; Sahin et al., 2010). The ionic strength can also be altered by using
strong electrolytes such as Ca2+ (Sahin et al., 2010) and NaCl (Radi et al., 2005). If a system
is particularly sensitive to a change in pH, this may offer a preferable alternative to prevent
irreversible denaturation of components of the sensor such as the bioreceptor or altering
the electronic state of the transducer. Though the use of acidic and basic regeneration has
been widely reported, one disadvantage is that it can only be used in systems where
charge does not affect the baseline signal of the sensor itself.
1.6.3.2 Use of Detergents
Detergents are often used at low concentrations in the regeneration of biosensors
(Albrecht et al., 2008; Fortebio, 2007; Mattos et al., 2012). Detergents are hetero-
bifunctional molecules which comprise two distinct regions, a polar head which is highly
soluble, and an aliphatic non-polar tail. The hydrophobic tails interact with similar regions
of the bioreceptor or analyte in an entropically-driven process. The polar head group then
extends into the aqueous phase and encourages solubility of the analyte (Giorgos J, 1979).
In certain biosensor systems, hydrophobicity may be a key force in the interaction of the
bioreceptor with the analyte such as in the detection of hydrophobic analytes including 2-
naphthol and3-isobutyl-2-methoxypyrazin (Cserháti & Szögyi, 1995; Van Oss, 1995).
Typically, mild detergents such as Tween are used for this (Anderson et al., 2007; Fortebio,
2007) although low concentrations of harsher detergents such as SDS have been used
(Albrecht et al., 2008; Mattos et al., 2012; Oliveira et al., 2013). Whilst detergents are
useful at low concentration and to avoid extremes in pH, they may interrupt systems such
as SAMs and so should be used only in systems with a detergent resistant tethering layer.
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1.6.4 Electrochemical regeneration
In a limited number of studies, biosensors have been regenerated using direct
electrochemical methods. In these studies, reductive desorption of the analyte or receptor
has been achieved via application of a negative potential to the sensor surface (Bhalla et
al., 2010; Choi & Chae, 2009; Choi & Chae, 2009; Liron et al., 2002). Though there are only
a few reports of this approach, it is an elegant solution for regeneration as it provides a
highly localised environment which can be precisely controlled and requires no further
reagents outside of the electrochemical components of the biosensor itself.
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1.7 Electrochemistry
Electrochemistry is the study of phenomena caused by charge separation and the flow of
charge carriers (Bard & Faulkner, 2001; Brett & Brett, 1998). It is the interface between
electronic physics and chemistry. Within this thesis, electrochemical methods have been
used to provide an insight into biophysics at the biosensor interface, following the
accepted ideas that electrochemistry can be used to monitor changes at the electrode
interface (Wang, 2006).
The charge carriers generated or accepted at the sensor are crucial to the generation of
electrochemical signal at the interface. Within the electrical system, charge is carried by
electrons; this charge is then transferred to chemical carriers at the electrode, in this case,
ions in the solution. This generation of ions is mediated by the reduction or oxidation of an
ionic species at the sensor interface. The charged ions then move under an applied field,
transporting charge through the solution before relinquishing the energy at the opposing
electrode. This establishes a flow of both negatively and positively charged ions, both to
and away from the respective electrodes in the system.
Electrodes in an electrochemical system tend to be metallic or a conducting metalloid such
as carbon (Niu et al., 2012) or a conducting polymer (Barsan et al., 2015; Gerard et al.,
2002). It is therefore important to consider the processes that occur when using such
electrodes before fabrication of the sensor is approached.
1.7.1 The three-electrode system
By using a three electrode system, the flow of charge between two different electrodes
can be measured relative to a third reference electrode. First, there is the working
electrode (WE) which is the electrode where any changes are to be monitored. It is often
the anode and it is the point of reduction where ions gain an electron before travelling to
the cathode. As the surface of this electrode is modified, this may make this process
easier or more difficult, allowing a change in signal to be monitored.
The cathode in this system is known as the counter electrode, this electrode is often a
large, unreactive, conducting metal electrode which readily oxidises ions causing them to
surrender an electron and promoting current flow across the closed circuit,. Because it is
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unreactive and large it generates minimal signal itself via reaction with any components in
the solution and the charge can transfer easily around the circuit.
To monitor the flow of charge between the working and counter electrodes a reference
electrode is also used. This is typically an Ag/AgCl cell in which a stable voltage is
established (Scott & Lukehart, 2007). This ensures that any changes in bulk do not affect
the signal between working and counter electrode as well as creating a base signal over
which the signal from the working electrode can be effectively monitored. Other
references such as calomel or mercury electrodes may be used but are not favoured due
to instrumentational complexity, potential toxicity and the difficulty of incorporating them
into a three electrode composite chip as is the case for Ag/AgCl (see Appendix 1).
Since it is possible to monitor the changes in the ability of the working electrode surface to
reduce ions and convert from electrical to chemical energy, electronic processes at the
surface can be monitored. Changes on an electrode surface may dramatically affect the
electrochemical properties of a system. Though this preceding text describes the basic
process at the electrochemical interface there are a few key approaches for accurately
interrogating the electrochemical process. These can be grouped into amperometry,
voltammetry and impedance and will be considered in sections 1.7.2- 1.7.5.
1.7.1 Double layer theory
As the electrode in the electrolyte containing solution interacts with ions, it is important to
consider the processes which occur at the interface. Commonly ions are reduced or
oxidised at the electrode in a Faradaic process. In order for this to occur, the ions must
travel across the solution. This process is mediated by the mass transfer of ions across the
bulk electrolyte solution. As ions get closer to the electrode interface, they encounter a
number of defined electrochemical regions which are modelled by Guoy-Chapman theory;
a schematic of this is shown in Figure 1-22.
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Guoy Chapman theory identifies a number of regions encountered by an ion travelling
from a bulk solution to the electrode surface where the ion can be oxidised or reduced.
The first region encountered is the diffusion layer, where the ion is driven across a
concentration gradient. This is due to ion depletion or accumulation at the electrode
surface. The ion then encounters a region known as the Debye layer, which is the point of
maximum flux between ion concentrations for the respective processes and describes the
net electrostatic effect of the ions travelling to or from the electrode.
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Figure 1-22: A schematic of Guoy-Chapman theory. Showing processes at the electrode
interface in a DC system which contains electron mediator, in this case both Fe(CN)6-3 and
Fe(CN)6-4 ions. Moving away from the transducer surface, the inner and outer Helmholtz
layer are followed by the Debye layer in which a depletion of ions can be observed, this is
followed by the diffusion layer before the concentration equilibrates and is the same as
the bulk electrolyte. N.B. This is a simplified model and the inclusion of tethering layer and
the surface roughness mean that there are commonly local variations in the layers
observed in a real scenario.
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The relative sizes of these two layers is dependent on several factors including
temperature, viscosity, surface area, ionic strength and the combination of electrode and
electrolyte used. The equations which govern the thickness of these two layers are the
following:
ࣄ−૚ = ඨቈࢿ࢘.ࢿ૙.ࡾࢀ
ࡲ૛.∑ࢉ࢏.ࢠ࢏૛቉
Equation 1-7: The Debye layer equation
Where:
κ = Debye layer, normally 0-5 nm
 εr= Relative dielectric permittivity of the solution
 ε0 = Permittivity of vacuum.
R= Gas Constant
T= Temperature
F= Faraday constant
ci= Concentration of charged species ‘i’
zi= Ionic charge of charged species ‘i’
More intimately associated with the electrode interface is the Helmholtz layer which has
an inner and outer layer. These two layers are broadly analogous to a plate capacitor
where the inner Helmholtz plane is a thin layer of adsorbed reactant species whilst the
outer plane is formed of product charge carriers. Their opposing charge causes an
immediate spatial separation which leads to the bilayer capacitive properties.
1.7.2 Amperometry
Amperometric biosensors operate by monitoring a change in electron flow or current
when the potential is static. These biosensors typically exploit an electroactive enzyme,
such as oxidase or reductase which is coupled to the transducer surface. When the
substrate is present, the enzyme catalyses the reaction, resulting in a change in electron
flow (current) across the surface. This current is proportional to the concentration of the
analyte and allows a direct calibration to be performed (Grieshaber et al., 2008;
Sapelnikova et al., 2003). This relationship can be determined using Faraday’s Law:
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ࡵ= ࢔.ࡲ.࡭.ࡶ
Equation 1-8: Faraday’s Law
Where:
I = current, typically in the nA-mA range
n= number of Electrons transferred at the electrode
F= Faraday constant
A= Area of the electrode
J= Flux coefficient, the transfer of the substrate or analyte to the electrode surface
One drawback of this system is that it requires an enzyme which reduces or oxidises an
electroactive analyte specifically, or an enzyme whose catalytic activity can be modulated
by incubation with the analyte (Vakurov et al., 2005). This enzyme must be chemically
stable to resist processing techniques deployed during the construction of the biosensor. A
further problem arising from the use of oxidases is the resulting H2O2 generated. Reduction
of the H2O2 can be achieved on the electrode, however, this occurs at a relatively high
potential (+0.7 V) and leads to undesirable side reactions. A common approach is to use an
electron mediator such as ferrocene or ferrocyanide as in the case of Prussian blue (Hirst
et al., 2013; Pchelintsev et al., 2009; Ricci & Palleschi, 2005) which catalyses the reduction
of H2O2 at 0 V.
In spite of these technical difficulties, the most widely known electrochemical biosensor,
the glucose sensor, is amperometric and uses glucose oxidase (Newman & Turner, 2005;
Reiter et al., 2001; Scognamiglio, 2013; Wilson & Turner, 1992). This allows glucose levels
to be easily measured in diabetic patients and it currently account for ~85% market share
in the biosensor industry (Newman & Turner, 2005). As well as the glucose sensor a
number of other amperometric biosensors have been developed for similar molecules/
metabolites where a suitable enzyme is readily available. These include sensors for lactate
(Hirst et al., 2013; Palmisano et al., 2000), cholesterol (Vidal et al., 2004) and ethanol
(Manso et al., 2008).
1.7.3 Potentiometry
Potentiometric sensors operate by monitoring the voltage when no current is passed
through the system. This technique may be used to measure specific ion concentration by
using ion selective membranes; this is the theoretical basis for modern pH probes which
operate using a H+ permeable membrane. The first potentiometric sensor measured the
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change in potential resulting from a similar change in the concentration of protons (H+).
The principle equation which determines operation for a potentiometric sensor is the
Nernst equation:
ࡱ = ࡱࡻ − ൬૛.૜૙૛ࡾࢀ
࢔.ࡲ ൰.࢒࢕ࢍ૚૙ [ࡾࢋࢊ]࢈[ࡻ࢞]ࢇ
Equation 1-9: The Nernst equation
Where:
R = Gas constant
n= number of electrons transferred at the electrode
F= Faraday constant
T= Temperature
It can be seen from this equation that as the ionic concentration of either reduced or
oxidised species changes, so will the potential (E) of the system. Again these sensors rely
on the availability of a robust enzyme, often a hydrolase which limits their applicability for
many analytes. Voltammetric interrogation can also be carried out using potentiometry. In
this case, the interrogation is passive as it is the generation of potential is measured. As an
enzyme reaction occurs ions are produced, typically H+ or NH4+ which establishes a
measureable potential across the system and allows a signal to be calibrated (Tang et al.,
2010), successful sensors have been constructed for analytes including cholesterol (Israr et
al., 2010) and urea (Dhawan et al., 2009; Ramesh et al., 2015).
1.7.4 Voltammetry
Voltammetry is the investigation of monitoring current when an applied potential (V) is
varied. Voltammetry can be additionally used in the construction of biosensor systems as it
allows for the initiation of chemical reactions including reductive cleaning of electrodes or
polymer deposition by electropolymerisation (Barlett & Cooper, 1993; Choi & Chae, 2009;
Lacroix et al., 2000). Within the field of voltammetry, three commonly used techniques are
potential step, linear sweep and cyclic voltammetry. In potential step voltammetry the
applied potential (voltage) is suddenly switched between two predetermined points and
the corresponding change in current is monitored. In linear sweep voltammetry, the
potential is applied over a range which moves in one direction only and the current is
measured over time as the potential is changed.
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Cyclic voltammetry is the most commonly used technique, where the linear potential
sweep is reversed when a set potential is reached and again, current is monitored over
time. This application of increasing and decreasing potential can be cycled multiple times
and generates meaningful data on the properties of both solution and electrode as well as
any changes which occur at the interface. By sweeping the potential in both directions
data can be generated on both reduction and oxidation (Fisher, 1996). The flow of current
across the electrochemical cell is the signal that is measured. This is dependent on the
mass transfer of charge carrying species to the electrode surface. For applications in this
study, the redox change of Fe(CN)6 -3/-4 was measured using cyclic voltammetry, which is
described more fully in Chapter Three.
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Figure 1-23: CV obtained in the ferri- ferrocyanide system. This sample data is labelled
with the key information that can be given from a CV, where the potential has been cycled
between the two points (●) at ‐0.6 V and + 0.75 V. Both oxidation (upper) and reduction 
(lower) of electrolyte species is shown. Each process has a potential (Epc Ox and Epc Red,
respectively) at which it occurs most readily and the peak current (ipa and ipc, respectively)
is observed. The processes of reduction / oxidation are shown alongside and these are the
reactions which occur at the peak cathodic (reduction) and peak anodic(oxidation)
voltages.
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When Fe(CN)6-4 ions donate an electron, Fe(CN)6-3 is generated at the sensor surface, the
increased concentration around the electrode establishes a concentration gradient
between Fe(CN)6-3 ions at the interface and in the bulk. Thus diffusion occurs between the
electrode and the bulk solution. This gradient will continue until generation of Fe(CN)6-3 is
reduced at the surface and eventually will reach a stage where the concentration of
Fe(CN)6-4 ions will be lower at the interface than at the bulk, so diffusion will occur in the
opposite direction.
For both reduction and oxidation processes, there is an associated potential at which
either process is favoured and the diffusion of the relevant carrier is at a maximum for the
given system. At this potential, a corresponding peak current is observed. A peak is
observed for the oxidation, (ipa) as well as reduction (ipc). As the reaction is reversible, the
size of the peaks for both reduction and oxidation should be the same.
Cyclic voltammetry is the most popular method by which redox processes are studied as it
allows a direct, quantitative correlation of the data and redox phenomena. For systems
the ferri/ferrocyanide system used, the electron transfer is quick and current flow is
limited only by the diffusion of the species to the electrode surface. We can therefore
monitor the presence of any surface coatings which may slow current flow across the
surface or have their own associated redox peaks.
The resulting concentration gradient as well as the mass transfer processes which occur
during CV are described by Fick’s Law, which states that the current is a quantitative
measure of how rapidly a species is reduced or oxidised at the electrode: electrolyte
interface. Using data obtained from voltammetric experiments, a vast wealth of data can
be obtained regarding the surface and processes which occur at the electrode: electrolyte
interface. As well as providing qualitative data, values can be used to calculate important
parameters such as the effective surface area. As it is uncommon to find electrodes which
are perfectly flat, their effective surface area may be much larger than their geometric
surface area. The difference can be calculated using the Randles Sevçik, Equation 1-10.
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࢏࢖ = ૙.૝૝૟૜࢔.ࡲ.࡭.࡯ඨ࢔ࡲ࣏ࡰࡾࢀ
Equation 1-10: The Randle’s- Sevçik equation
Where:
ip = current maximum in amps
n = number of electrons transferred in the redox event (usually 1)
A = electrode area in cm2
F = Faraday constant in C.mol−1
D = diffusion coefficient in cm2.s-1
C = concentration in mol.cm-3
ν = scan rate in V.s-1
R = Gas constant in V.C.K−1.mol−1
T = temperature in K
This under standard conditions simplifies to:
࢏࢖ = ૛.૟ૡૡ× ૚૙૞ ૜√࢔.࡭.√ࡰ .࡯√࣏
And this equation can subsequently be rearranged to give:
࡭ = ૛.૟ૡૡ× ૚૙૞ ૜√࢔.࡭.√ࡰ .࡯√࣏
࢏࢖
Equation 1-12: Calculating area from Randle's Sevçik equation
Using Equation 1-11, typical values give a larger electrode area than by physically
measuring the electrodes, for screen printed electrodes the actual surface area may be 5-
10 times larger than the geometric surface area a phenomenon explained by surface
porosity in addition to superficial roughness of the interface (Alonso-Lomillo et al., 2010;
Niu et al., 2012; van Noort & Mandenius, 2000).
Equation 1-11: Simplified Randle's-Sevçik equation
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1.7.5 Impedance
Impedimetric biosensors directly exploit the binding of the analyte to the bioreceptor by
observing the difference in conductivity across the electrode: electrolyte interface.
Impedance is the ratio between changes in measured current when a changing voltage is
applied. In electrochemical impedance spectroscopy (EIS), the current is measured when
an oscillating AC voltage is applied. In the example of Immunosensors, analyte binding at
the sensor interface results in addition of matter to the electrode surface; it is this that
affects its resistive and capacitive properties. This is a more suitable approach for many
analytes as it is often much easier to obtain binding proteins for a wide variety of analytes
than an electroactive enzyme. For these reasons IgG has traditionally been used as their
wide availability and well-defined binding kinetics and reasonable chemical stability make
them particularly attractive for the development of biosensors (Barton et al., 2009; Billah
et al., 2010; Conroy et al., 2009; Joseph, 2006; Kaláb & Skládal, 1997; Konstantinov et al.,
2009; Millner et al., 2009). Impedimetric immunosensors have also been demonstrated
using other types of binding proteins (Conroy et al., 2010; Rodgers et al., 2010) as well as
oligonucleotides (Queirós et al., 2013; Yun et al., n.d.) and lectins (Hu et al., 2013).
When the electrode is interrogated in an impedimetric sensor, both capacitive and
resistive data is generated giving bulk Impedance |Z|. This bulk impedance can be de-
convoluted into real (resistive, Z’) and imaginary (capacitive, -Z”) components.
It is important to consider the mechanistic origins of this signal at the interface. The
resistance is generated by the interface opposing the flow of current and effectively
slowing down charge carriers at the interface. The capacitance is the ability of the system
to store up charge after the initial application of the potential. Usually, both components
are affected upon analyte binding although either may dominate. The way these processes
are investigated, is by subjecting the electrochemical cell to an alternating oscillating wave
of potential, this is usually a small perturbation (typically ~±10mV) around a set potential
at which the electrochemical system may be active. The electrode is subjected to a wide
range of frequencies to fully characterise processes which occur at the electrode:
electrolyte interface. Impedance is calculated from the ratio between the applied voltage
and the measured current across the electrochemical cell. As seen in Figure 1-24
impedance takes account of changes in both modulus and phase shift of the measured
current.
76
By assessing the change in current through the cell, the impedance can be calculated using
Ohms Law. In its normal format, this law states:
ࡾ = ࢂ
ࡵ
Equation 1-13: Ohm's Law
In order to use this equation, we must consider the voltage and the current measured
when in AC. The voltage at a given time can be calculated using the equation:
ࢂ࢚= ࢂ࢓ ܑܛܖ࣓ ࢚
Equation 1-14: Calculating voltage in an AC circuit
E (mV)
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π ω/ 4 /π ω (4 + )/π θ ω
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Figure 1-24: Phase shift in complex impedance. Applied oscillating voltage (blue) is modulated
by a small perturbation voltage (±10mV is typical) and the change in current (magenta) is
then measured. The current will be different in both, phase angle (π+θ) and amplitude. This  
change forms the basis for impedance measurements. Figure adapted from (Bard &
Faulkner, 2001)
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Where:
t=time in sec
 ω= angular frequency, rad.sec‐1  
    This is equal to 2πf 
f= frequency in Hz
Vm= amplitude
V= voltage at time t
As well as potential, the current can be calculated using the equation:
ࡵ= ࡵ࢓ ܑܛܖ(࣓ ࢚+ ࣂ)
Equation 1-15: Calculating current from phase shift
Where:
t=time in sec
 ω= angular frequency, rad.sec‐1  
    This is equal to 2πf 
where f= frequency in Hz
Im= maximum current
 θ= Phase angle, rad   
V= current at time t
By using Ohm’s Law with the identities established for both resistance and impedance, the
total impedance can be calculated using the following equation:
ࢆ = ࢂ(࢚)
ࡵ(࢚) = ܸ݉ sin߱ ݐ݉ܫ sin(߱ ݐ+ ߠ)
Equation 1-16: Total impedance from potential and current
Where Z= total Impedance
If the system is considered in both extremes, where it either behaves as a capacitor or a
resistor we can see the origin of both real and imaginary components of impedance
respectively. In a resistor system Ohm’s Law states that:
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ࡵ= ࢂ
ࡾ
= ࢂ࢓ ܑܛܖ࣓ ࢚
ࡾ
= ࡵ࢓ ܑܛ ܖ࣓ ࢚൤ࡵ࢓ = ࢂࡹࡾ ൨
Equation 1-17: Ohms Law in a resistor subject to oscillating potential
Whilst in a pure capacitor, there is no current (I) and the capacitance is the ratio of charge
to voltage which can be rearranged to give Equation 1-18, when considering the wave
diagram, a pure capacitor would lead to a phase shift of π/2 rad, explained below:  
ࡽ = ࡯.ࢂ = ࡯.ࢂ࢓ ܑܛܖ࣓ ࢚
Equation 1-18: Calculating charge from capacitance and potential
If this is then integrated with respect to time:
ࡵ= ࢾࡽ
ࢾ࢚
= ࢾ(࡯.ࢂ࢓ ܑܛܖ࣓ ࢚)
ࢾ࢚
= ࡯.ࢂࡹ ࢾࢾ࢚(࢙࢏࢔ ࣓࢚) = ࡯.ࢂࡹ ࣓ࢉ࢕࢙࣓࢚= ࢂ࢓
૚
࣓ .࡯ൗ ܑܛܖቀ࣓࢚+ ࣊૛ቁ
Equation 1-19: Integrating charge with respect to time
As 1/ω.C is known as capacitive reactance (often expressed in Ohms) in the case of a 
resistor:
ࡵ= ࡵ࢓ ܑܛ ܖቀ࣓࢚+ ࣊૛ቁ
Equation 1-20: Emergence of capacitance in observed current
From Equation 1‐20, we can see that in the case of a pure capacitor the phase shift (θ) has 
been replaced by π/2.  
Alternatively, the wave can be considered as a combination of sine & cosine functions,
which are analogous to the resistive and capacitive properties respectively (with cosine
being (π/2 phase shifted with respect to the sine wave). Using Euler’s relationship, the 
combination of these two waves can be used to derive the phase angle as well as total
impedance using Equation 1-23 which is equivalent to “gain” or signal. This allows the
output at each frequency to be represented on a Nyquist plot.
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ࢋ࢏ࣂ = ࡯࢕࢙ࣂ+ ࢏ࡿ࢏࢔ࣂ
Equation 1-21: Euler’s identity
ࣂ = ࡭࢘ࢉ࢚ࢇ࢔൬࢏ࡿ࢏࢔ࣂ
࡯࢕࢙ࣂ
൰= ࡭࢘ࢉ࢚ࢇ࢔ቆ−ࢠ′ ′
ࢠ′
ቇ
Equation 1-22: Calculation of phase angle|ࢆ| = ඥ(ࢠ′)૛ + (−ࢠ′′ )૛
Equation 1-23: Calculation of total impedance
The Nyquist plot is a commonly used method to represent impedance data from a range of
frequencies. In the Nyquist plot (Figure 1-25) the different frequencies to which the
electrode has been subjected are displayed as different data points on axis of a real and
imaginary parts of impedance (Z’ and –Z’’ respectively). The coordinates of each point are
a product of real and imaginary parts which correspond to the phase shift (θ) and change 
in amplitude between potential and current. This means that over a range of frequencies
points can be plotted and the Nyquist plot is constructed.
From this plot, the relationship between real and imaginary components of impedance
can be shown across a range of frequencies. This provides data about the electrified
interface and the charge transfer across the electrode. In a typical metal electrode system,
there are a number of features of the Nyquist plot of particular interest.
At high frequencies, signal is mainly generated by kinetic processes whereby the change in
charge direction occurs faster than the solution can compensate. In the ferri/ferrocyanide
system used in work within this thesis, i.e. Fe(CN)6-3↔ Fe(CN)6-4, there is an intrinsic limit
to the speed at which species can be generated and reduced at the surface. If the direction
of current through an electrochemical system is switching very rapidly, this speed becomes
the limiting factor and slows charge transfer across the electrode. This is the basis for
solution resistance (Rs) in an electrochemical cell.
At marginally lower frequencies, the input potential matches the responsive capabilities of
the electrode: electrolyte system in question and resistance is minimised. This generally
leads to a flattening of the curve. It is in this frequency range that data on the capacitance
of the system can be obtained; as there is negligible resistance, any change between
applied and measured signal originates from associated double layer capacitance at the
electrode (CDL). In some models, this element can be replaced with a constant phase
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element (CPE) which is similar to capacitance, but accounts for non-ideal behaviour, when
the capacitor shows partially resistive properties. When considering the normal
electrochemical model of capacitance based on ideal-surface plate capacitors, this
deviation can be explained by differences in surface texture or charge distributions on the
electrode surface.
At lower frequencies still, information on the charge transfer resistance (RCT) is obtained.
At these frequencies, the transfer of charge across the electrochemical cell is slowed only
by surface species e.g. bound analyte or polymer. This frequency range (typically 0.1 Hz-
10Hz) therefore often generates the most interesting data in binding events at a biosensor
interface.
In other cases, particularly when using clean metal surfaces which have a very thin
diffusion layer, Warburg Impedance is seen as a large linear tail on the arc Figure 1-25. This
signal is generated by the diffusional limitations of the system which occurs at low
frequencies (Lvovich, 2012). The signal generated by Warburg Impedance is its own
complex impedance of capacitance in parallel with a resistive element. This is a result of a
depletion of charge carriers close to the electrode, often when wavelength of the
perturbation signal is larger than the diffusion later. This establishes a diffusion gradient
meaning that more charge carriers must travel to the electrode in order to permit further
charge transfer across the cell, as the diffusion speed of the species concerned limits the
process, the effect becomes more pronounced at lower frequencies and thus more signal
is generated resulting in the increasing linear trace.
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Figure 1-25: The Nyquist plot schematic. The overall plot is a combination of real (Z’) and
imaginary (-Z”) impedance and allows us to interpret The vital parameters of the system,
charge transfer resistance (RCT), solution resistance (RS) And the constant phase element
(CPE) which in turn may permit the calculation of the double layer capacitance (CDL).
Warburg impedance (W) is also included for illustrative purposes.
In order to obtain values for these essential electrochemical parameters, often the
measured data is simulated using an equivalent electrochemical cell model. For impedance
on metal electrodes, this is commonly based on the Randle’s circuit (Figure 1-26). From
this circuit, the individual components can be seen to contribute to the overall impedance
and signal observed when interrogating the electrode impedimetrically.
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Another way which in data may be displayed from impedimetric interrogation of an
electrode is the Bode plot in which the signal is plotted as a function of the log of the
interrogation frequency. The Bode plot provides useful data about the behaviour of the
electrode and can help to identify frequencies at which the surface behaves more as a
capacitor or a resistor. This may help in the development of a biosensor as it can help
identify the optimum frequency with which to interrogate which would reduce data
acquisition time. One way of ascertaining the optimum frequency at which to analyse a
binding event is to interpret the impedance data using a Bode plot as in Figure 1-27. The
Bode plot is constructed of two individual plots, both analysing the change in total
impedance (|Z|) and phase angle shift (δθ) as a log of frequency.  
If the plot for phase angle is first considered, the Bode plot can very easily display the
frequencies at which the electrode surface is behaving as a capacitor. As previously shown
from mathematical principles, this is when there is the maximum phase shift (δθ= π/2). In 
the Bode plot a peak is commonly seen at a distinct frequency.
Figure 1-26: The Randles’ equivalent cell, key sources of impedance signal for a metal
electrode in an electrolyte solution; RS, solution resistance generated by movement of
charge carries through the solution; CDL double layer capacitance experienced at the
electrochemical double layer around the electrode; RCT charge transfer resistance
encountered by charge carriers at the electrode interface and Warburg impedance which
is a frequency dependent effect
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Figure 1-27: A sample Bode plot. The phase angle shift (magenta) can be seen to peak
around a maximum value where the surface behaves as a capacitor. When considering the
total impedance (blue), the regions where it is horizontal correspond to frequencies where
the surface is behaving as a resistor.
Of more use practically are the regions of the plot where the surface behaves as a resistor.
As previously discussed at the high frequencies this resistance is generated by limitations
in the electrolytic solution which will not be altered by analyte binding.
The Bode plot therefore isolates the frequencies at which the impedance data gives
information primarily on the charge transfer resistance across the sensor. This is useful in
the generation of a commercial biosensor as it allows for much more simple
instrumentation to be employed and fixed frequency analysis to be used. In order for this
to be used however the system interrogated must be reliable to the point where any
change in signal is due to analyte binding fixed frequency analysis is therefore rarely used.
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1.8 Project aims
The main aim of this project is to progress the understanding and development of
biosensor function. Biosensor regeneration will be investigated using a previously
developed myoglobin sensor. This will demonstrate the possibility of re-using
impedimetric immunosensors which could be a critical step in lowering the cost per test
and promote their wider adoption.
A further aim is to develop a novel biosensor system using nanobodies as bioreceptor. This
will enable investigation of alternative receptor type and will enable comparison between
traditional antibody based sensors and smaller binding proteins.
The use of the small recombinant binding proteins will enable investigation of receptor
spacing phenomena at the biosensor interface with the aim of improving the
reproducibility and sensitivity of sensors. In principle, spacing can be varied in the X-Y
plane by varying the concentration at which the receptor is loaded. In addition, the spacing
of the receptors in the Z-plane is proposed by re-engineering the receptors to possess a
variable length peptide spacer.
This study will aid the understanding of processes at the biosensor interface and inform
the fabrication of nanobody based immunosensors as well as those fabricated using other
antibody mimetics.
2 Chapter Two:
Materials & Methods
86
2.1 Materials
2.1.1 Inorganic materials
K3Fe(CN)6 ,(K4Fe(CN)6.3H2O and H2O2 were purchased from Sigma Aldrich (Poole, UK).
H2SO4 (95% v/v) was purchased from Merck (Hoddeson, UK). All other inorganic chemicals
were purchased from BDH laboratory supplies (Poole, UK).
2.1.2 Organic materials
Biotin-N-Hydroxysuccinimide, mercaptohexanol, mercaptohexadecanoic acid, aniline and
2-ABA were purchased from Sigma Aldrich (Poole, UK). 1,2 dipalmitoyl-sn-glycero-3-
phosphoethylamine-N- (Sodium salt) was purchased from Avanti Lipids Inc. (Alabaster,
USA). NeutrAvidin was purchased from Pierce biotechnology (Rockford, USA). All other
organic chemicals were purchased from BDH laboratory supplies (Poole, UK).
2.1.3 Antibodies
Antibodies used in the project were sourced as outlined in Table 2-1.
Table 2-1 : Sources for antibodies and sera for purification studies. Antibodies were
purchased pre purified from these companies
2.1.4 Plasmids for nanobodies
Nanobodies were sourced from AbCam Plc, under licence from Ablynx GmbH. P8D8
Vectors (screened against rabbit IgG) were ligated into pHEN6 Vectors using Novablue
E.Coli cells from Merck Millipore. This enabled the use of restriction enzymes BstII and PstI
to be used, both purchased from New England Biolabs Ltd.
2.1.5 Agarose gels
Oligonucleotide fragments were isolated using 2% w/v agarose E-gels , containing Sybr®
Green and purchased from Invitrogen.
Antibody Origin Source
Anti- Myoglobin
Anti-Digoxin
Anti- Rabbit-HRP
Immunised Sera
Naïve Sera
Anti –Sox9
Anti – Rabbit
Rabbit polyclonal IgG
Sheep polyclonal IgG
Mouse polyclonal IgG
Immunised rabbit sera
Non-immunised rabbit
Rabbit Polyclonal IgG
Sheep Polyclonal
GenScript Ltd.
Therapeutic Antibodies UK Ltd.
AbCam Plc.
Cocalico Ltd.
Biogenes GmbH
AbCam Plc.
Abcam Plc.
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2.1.6 Bacterial strains
Novablue E.Coli strains were purchased from Merck Millipore for plasmid amplification
and WK6 E.Coli cells were purchased from New England Biosciences Ltd for protein
expression.
2.1.7 Growth media for bacteria
Bacteria were cultured in LB (Luria-Bertani) media for transformation. This media
contained tryptone (10 mg.ml-1), NaCl (10 mg.ml-1) and yeast extract (5 mg.ml-1). For
the production of agar plates, agar (15 mg.ml-1) was added to LB medium as well as
ampicillin at 50 μg.ml-1 to inoculate non transformed cultures. TB (Terrific Broth)
media was used for expression of nanobodies, it contained tryptone (12 mg.ml-1), yeast
extract (24 mg.ml-1), glycerol (0.4% v/v) and TB salts (0.17M KH2PO4 and 0.72M
K2HPO4).
2.1.8 Buffers and solutions
A full summary of buffers used throughout can be found in Appendix 2.
2.1.8.1 SDS-PAGE
10 x Tris-Glycine SDS-PAGE running buffer was purchased from National Diagnostics and
Coomassie Instant blue was purchased from Generon. PBS was made up from 1x PBS
tablets (100 ml.-1) purchased from Fisher Scientific. Pre-cast gels were purchased from
Invitrogen®. Broad range protein markers were purchased from Bio-Rad and other
inorganic buffers were made from salts purchased from Sigma Aldrich (Poole, UK).
2.1.8.2 Western blot
The Western blotting transfer buffer used was 25 mM Tris, 92 mM Glycine, 20 % (v/v)
methanol. Nitrocellulose membrane, Ponceau stain and 20x transfer buffer was
bought from Invitrogen®.
2.1.8.3 TES buffer
Periplasmic extraction was done using TES buffer (0.2 M Tris-HCL, 0.5 M Sucrose, and 0.5
mM EDTA pH 8)
2.1.9 Consumables
Slide-a Lyse dialysis units and PD-10 columns were purchased from Thermo Scientific.
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2.1.9.1 Electrodes
A variety of transducers were investigated (Appendix 1-1). P3 silicon based electrodes
were purchased from Tyndall Institute (Cork, Ireland). 12 WE electrodes were purchased
from Phillips N.V., Netherlands. CX2220AT dual electrodes were purchased from Dropsens
(Oviedo, Spain). 8 and 12 WE electrodes were purchased from Kanichi Ltd (Manchester,
Uk). AC9C.W1.R1 electrodes were purchased from BVT (Brno, Czech Rep.). Transducers,
with their respective electrode geometries are shown in Appendix 1.
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2.2 Methods
2.2.1 Synthesis of nanobodies
In this project, Nanobodies were synthesised from existing stable ‘P8D8’ plasmids. The
plasmid was coded for a nanobody top rabbit IgG which had been isolated from the
lymphocytes of an immunised alpaca. Isolation and panning was done by Abcam Plc.
2.2.1.1 Ligation of DNA into P8D8 containing PHEN6 vector
Initially, 15 µl of the plasmid was thawed before adding 2.5 μl 10x Cut Smart buffer (New 
England Biolabs) as well as the 2.5 μl PstI 20,000 U.ml-1 (New England Biolabs) and 5 μl 
BstEII, 10,000 U.ml-1 (New England Biolabs) restriction enzymes. This was incubated at 37
⁰C for 1 hr before adding 1μl ‘FastAP’ 1 U.ml-1 (Thermo) alkaline phosphatase to prevent
recombination. Fragment identity was confirmed and fragments were isolated by running
a 2% (w/v) agarose gel. This was achieved using E-gels cartridges (Thermo) for 8 min at 200
V. The desired insert was then removed from the gel before being incubated with the
vector overnight at 4 ⁰C in the presence of 1 μl T4 Ligase. 3,000 U.ml-1(New England
Biolabs). The stable plasmid was then stored at ‐20 ⁰C.  
This ligation allowed the same restriction enzymes as above (the PstI and BstEII) to be used
to ligate the insert into the vector. The pHEN6 Vector also conferred ampicillin resistance
allowing for selection of the transformed E.Coli.
2.2.1.2 Transformation of E.coli using heat shock treatment
The Novablue® cells were gently thawed on ice and aliquotted into 50 μl samples before 
being mixed with 3μl of the plasmid at 100 ng.ml-1. After a further 30 min on ice, the cells
were exposed to a heat block for 45 s at 42 ⁰C before being returned to the ice for 1 min. 
The Cells were then added to 500 μl SOC Media and incubated at 37 ⁰C in an Infors® HT 
Multitron shaking incubator (220 rpm) for 1 hr. To select successfully transformed
plasmids 200 μl of the cell suspensions were spread on LB: ampicillin plates (100 µg.ml-1)
and grown overnight.
2.2.1.3 Plasmid isolation & nanobody synthesis
Colonies were selected and grown up the following day in 5 ml LB: ampicillin (100 µg.ml-1).
Qiagen® Miniprep kits were used according to the manufacturer’s protocols in order to
isolate the plasmid and the concentration of the plasmid was assayed using a Nanodrop
(Thermo). The plasmid, 10 µl at ~100ng.ml-1 was then sent to Source Bioscience® for
sequencing to ensure the plasmid contained the nanobody, spacer arm and the terminal
90
cysteine. M13 primer was used in both F and R directions to ensure complete sequencing
of the linker region. Nanobodies were then produced by transforming E.coli cells as above
into competent WK6 cells. Cells were plated onto TB‐ampicillin plates incubated at 37 ⁰C 
overnight. The following day, colonies were selected and added to 5ml LB+ ampicillin
which were incubated at 37 ⁰C overnight. These were then added to 500 ml LB+ ampicillin.  
Once optical density had reached 0.6 cultures were induced using IPTG (100 mM) and
incubated at 37 ⁰C overnight in an Infors® HT Multitron shaking incubator (220 rpm).
2.2.1.4 Extraction of periplasm & purification
The periplasm was extracted by decanting cells into centrifuge flasks and collected by
centrifugation at 3,000 xg for 30 min. Supernatant media was discarded and cells were re-
suspended using TES Buffer which had been stored at 4 ⁰C. After mixing on a shaker  for 30 
min on ice, a further 75 ml TES buffer was added and shaking on ice was continued for a
further 30 min. Samples were then split into 50ml falcon® tubes and centrifuged at 6,800
xg for 3 min to separate the periplasm extract from the cell bodies. The periplasm extract
was then ready for purification in order to isolate the nanobodies.
Owing to the engineered His6-tag, the nanobodies could be easily purified. This was
achieved using an Akta explorer fitted with a GE Histrap® Ni+ chelating column. Periplasm
was run through the column at a rate of 1 ml.min-1 followed by copious rinsing with wash
buffer containing 10 mM imidazole, 20 mM Tris base and 0.5 M NaCl. This was
immediately followed with 5 ml elution buffer compromising 0.3 M imidazole, 20mM Tris
base and 0.5 M NaCl, A280 was monitored using an in-line spectrophotometer and fractions
containing eluted protein were pooled before dialysis.
2.2.1.5 Dialysis of proteins
Buffer exchange was then carried out to remove excess imidazole against DW Buffer (PBS
+ 50 mM NaCl). This was achieved using Thermo Scientific Slide-A-Lyze® chambers
according to manufacturer’s instructions. 1000x volume of buffer was changed three times
over a 15 hour period.
2.2.2 SDS- PAGE and western blots
The SDS-PAGE gel was run with MOPS, MES or TA buffer (Table 2.2) systems depending on
the molecular weight of the target protein. Gels (3-8% Tris Bis, (v/v) Nu-Page for MES and
MOPS and 5% (v/v) Tris-Acetate for TA) were removed from their packaging and rinsed
with the correct buffer before being placed into an electrophoresis tank. The buffer was
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then added to the tank at 1x concentration and 500 µl antioxidant (Sigma PCG3007) was
added to the core tank.
To confirm the identity of protein present in the eluates from immunoprecipitation
experiments, the fractions were subjected to gel electrophoresis using non-reducing SDS-
PAGE. Pre‐cast gels (4‐12% MES) were purchased from Invitrogen to which 8 μl Sample 
Buffer (50 mM Tris‐HCl pH 6.8, 2% SDS, 10% glycerol,1% β‐mercaptoethanol 12.5 mM 
EDTA,0.02 % bromophenol blue) containing approximately 1 μg of the protein of interest 
was added into each well and electrophoresis was continued at 200 V for 50 min under
constant voltage. Gels were then either stained using Instant Blue Coomassie stain
according to manufacturer’s instruction or used for western blotting. For western blots,
the gel was carefully placed between felt pads and a nitrocellulose membrane in a transfer
cassette before being closed tightly and placed back into the electrophoresis tank. The
cassette was then soaked in transfer buffer (25 mM Bicine, 25 mM Bis-Tris, 1 mM EDTA
20% Methanol (v/v), pH 7.2) before being subjected to 30 V for 70 min. Proteins were
imaged by soaking the membrane for two minutes in Ponceau stain (1 g.l-1 in 5% acetic
acid (v/v)) .
After the protein transfer had been confirmed, the Ponceau was rinsed off using 1x TBST
Buffer until the pink colour had faded. Membranes were then blocked using 5%(w/v) BSA
in TBST (50 mM Tris, 150 mM NaCl, 0.05% (v/v) Tween 20, pH 7.6) for 30 min and probed
with the appropriate antibody conjugates (1:10,000) in blocking buffer and left to incubate
for 1 h. Membranes were then washed thoroughly (2x 15 min PBST-T plus 1x 15 min PBS)
before adding ECL HRP-Substrate and imaging using a Syngene G:Box System to record the
chemiluminescent signal. Blots were then analysed using GeneSnap software (Syngene).
2.2.3 Immunoprecipitation experiments
N-Hydroxysuccinimide (NHS) and Sulfolink® sepharose beads were purchased from GE and
Sigma respectively and proteins were conjugated according to manufacturers’ protocols.
The standard nanobody was conjugated to NHS beads and all of the modified spacer
containing nanobodies were conjugated to Sulfolink beads using the labile cysteine
residue. A negative control was varied out by conjugating the amino acid cysteine only
from a cysteine containing buffer (50mM cysteine in 50 mM Tris-
Hydroxymethylaminomethane plus 5 mM EDTA).  Beads were incubated with 100 μl 
diluted rabbit sera (10% Sera: PBS) for two hours. After binding, a mild acid wash was
completed using pH 4 100 mM sodium citrate and a final RIPA Buffer (50 mM NaCl, 1%
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(v/v) IGEPAL CA-630®, 0.5% (w/v) sodium deoxycholate, 0.1% (w/v) SDS and 50 mM Tris,
pH 8.0) in order to remove any non-specifically bound protein from the beads.
For elution, a two stage procedure was adopted .Firstly, a 100 mM glycine elution buffer at
pH 2 was used in order to interrupt nanobody: antigen binding. A second elution was
performed using PBS plus 100 mM DTT to investigate cleavage of the nanobody form the
Sulfolink beads.
2.2.4 Biotinylation of antibodies
Antibodies were produced to a concentration of 1 mg.ml-1 in PBS. Any azide was removed
via dialysis to prevent interference with conjugation chemistry. Then 1 mg.ml-1 biotin NHS
in DMSO:PBS solution was prepared as per the previous section. The two were combined
and allowed to react for 30 min. The bound and unbound biotin was then separated by
centrifugal filtration.
Millex centrifuge separation tubes with a molecular weight cut off of 10 KDa were used; 2
ml of the biotin: antibody mixture was added and the tubes were centrifuged at 8,900 xg
for 3 min. Biotin-containing buffer was then discarded and 300 µl fresh PBS was added.
This process was repeated five times to remove the unbound biotin from the mixture. The
biotinylated antibodies were then pipetted onto the NeutrAvidin containing electrode
surface, and left for 1 h to react. The electrode was then rinsed thoroughly using PBS to
complete biosensor fabrication.
2.2.5 Reduction of nanobody dimers
Nanobody dimers, were treated with 50 mM 2-mercaptoethylamine (2-MEA), in degassed
PBS buffer plus 10 mM EDTA for 90 min at 37 ⁰C. The reduced proteins were then applied, 
to Amicon filters (3,000 MWCO) and centrifuged at 16,000 xg to remove excess MEA.
Buffer was replaced with previously degassed 1×PBS plus 10 mM EDTA three times. The
proteins were then used immediately to prevent recombination by disulphide bond
formation between the reduced proteins.
2.2.6 Electrode preparation
2.2.6.1 mSAM construction
Some electrodes allowed self-assembled monolayers to be created. This was achieved by
dissolving 10 mg mercaptohexadecanoic acid (MHDA) in 1 ml chloroform then aliquotting
144 µl into 10 ml EtOH. Then 52 µl of biotin-capyrol-DPPE (Supplied by Avanti Polar Lipids
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Inc. at 10 mg.ml-1 in chloroform) was added to create a 1:1 molar ratio of MHDA: Lipid.
Electrodes were submerged for 24 hours to create the mSAM (Billah et al., 2010; Conroy et
al., 2010).
2.2.6.2 Polymer deposition
For some electrodes, electrodeposition of polymer was employed. This was achieved by
connecting the electrodes to an Autolab electrochemical workstation running GPES
software (with a separate counter & reference where necessary).
For deposition of PANI:2-ABA copolymer, the electrochemical cell was set up and CVs were
run for 20 scans between 0 and 1 V at a scan rate of 0.05 V.s-1 in a 1:1 mixture of 50 mM
of aniline and 2-ABA in 50 ml 1 M HCl.
In the case of Polytyramine deposition, two scans were executed from 0 to 1.6 V at a scan
rate of 0.2 V.s-1 in a solution of 25 mM tyramine dissolved in methanol plus 0.3M NaOH to
serve as a counter ion.
2.2.6.3 Bioconjugation of the receptor to the sensor surfaceBiotinylation of the sensor surface
1 mg Biotin‐NHS was dissolved in 100 μl dimethyl sulphoxide (DMSO) and added to 900 µl 
PBS, 10 µl of which was then pipetted onto the electrodes. This enabled biotinylation of
primary amines, the electrodes were incubated for 1 hr in a moist environment to prevent
drying, before being thoroughly rinsed in PBS to remove unlinked biotin.Addition of NeutrAvidin
NeutrAvidin at 4 μg.ml-1 in PBS was pipetted onto the electrodes. This was left for 1 h in a
moist atmosphere to react before being thoroughly washed.Oriented conjugation using Sulfo-SMCC
The polymer-modified electrodes were incubated with 5 mM sulfosuccinimidyl 4-[N-
maleimidomethyl cyclohexane-1-carboxylate (Sulfo-SMCC) solution in 10 mM PBS-EDTA
pH 7.2 for 1 h, as described previously (Billah et al., 2010; Bonroy et al., 2006; Lu et al.,
1996). The freshly reduced proteins, either half antibody or nanobodies, were then added
to the sulfo-SMCC modified electrode and incubated for 1 h. These electrodes were
incubated for 30 min in PBS to rinse away any non-specifically bound proteins and ensure
baseline signal stability. The sensors were interrogated electrochemically prior to analyte
detection to obtain a baseline sensor signal.
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2.2.1 Electrochemical instrumentation
All electrochemistry experiments were based on a three electrode system in an
electrochemical cell. This was true for both early experiments involving external reference
and counter electrodes to the working electrode and later experiments using transducers
that integrated all three onto one sensing chip. The working electrode used was always
gold, the external reference was Ag/AgCl (Metrohm AG, Herisau, Germany) and the
external counter electrode was a platinum rod. The three electrode system was controlled
by an EcoChemie μAutolab Type III with a frequency response analyser (FRA‐2) 
potentiostat (Windsor Scientific Limited, Slough, Berkshire, UK). was used to apply a
current to the electrochemical cell through the counter electrode. The voltage difference
between the working electrode and the reference electrode was then measured. The
Autolab measured the difference between the cell voltage and the desired voltage and
completed a feedback loop, causing an amplifier to drive current into the cell to maintain
the voltages. Autolab software was used to acquire electrochemical measurements and for
further data analysis. All electrochemical interrogation was done at room temperature and
in a Faraday cage.
2.2.1.1 Working electrodesGold
Gold was chosen as the working electrode material due to its availability, ease of
preparation (electrodeposition, sputtering and physical vapour deposition) and patterning
using screen printing. This is advantageous as fabrication does not require clean room m
so is comparatively cheaper.Electrode design and production
The Working electrodes used were screen printed gold electrodes designed and produced
by Dropsens (Asturias, Spain). These comprised of two gold working electrodes fired onto
a ceramic base (Appendix 1). The counter and the Ag/AgCl reference electrode were also
printed on the same transducer base.
2.2.1.2 Reference electrode
An Ag/AgCl reference was integrated into the transducer chip. Reference electrodes
are chosen due to their ability to maintain a stable double layer, and therefore
potential, against which other potentials may be compared. Typically, a reference will
measure the potential difference between the working electrode and the counter
electrode. This allows the system to maintain a controlled applied voltage to the
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working electrode throughout experiments (Bard and Faulkner 2001; Wang 2006).
Ag/AgCl electrodes are commonly used in electrochemistry due to their well-studied
and highly efficient redox mechanism and low toxicity.
2.2.1.3 Counter electrode
The counter or auxiliary electrode is the final electrode in the three electrode system.
Its purpose is to complete the circuit by providing current to the working and
reference electrodes and should be comprised of an inert conductor. The counter
electrode must be at least ten times the surface area of the working electrode to allow
efficient exchange of electrons such that the electrochemistry is not limited(Brett &
Brett, 1998). For some experiments an external counter electrode was provided,
comprising a platinum rod. In most experiments, a gold counter was integrated on the
Dropsens chip.
2.2.2 Interrogation of sensors
The sensors were incubated with a given concentration of analyte for 30 min, starting with
the lowest concentration before sequential increase. The sensors were electrochemically
interrogated with an Autolab III Module (Eco Chemie B.V.) Electrodes were placed in a cell
containing 10 mM K3Fe(CN6), K4Fe(CN6) and 10 mM PBS, pH 7.2.
2.2.2.1 Cyclic voltammetry
For CV, GPES software was used, the electrodes were scanned either from -1 V to + 1 V or -
0.4 V to +0.7 V, the wider range representing a full analysis of the chemical nature of the
electrodes at strongly reductive and oxidative potentials respectively.
2.2.2.2 Electrochemical impedance spectroscopy
After sensor assembly, electrochemical impedance spectroscopy (EIS) was used to monitor
analyte recognition using NOVA software on a FRA-2 AUTOLAB type III electrochemical
workstation. The impedance analysis was performed over a frequency range from 0.25 Hz
to 25 kHz using a modulation voltage of 10 mV at an applied voltage of 0.0 V with respect
to Ag/AgCl2. All impedance experiments were performed in an electrolyte solution of 10
mM K3[Fe(CN)6]/ K4[Fe(CN)6] (1:1 ratio) in 1×PBS, pH 7.4. Fully fabricated immunosensors
were incubated with 10 μl analyte for 30 min prior to copious rinsing in PBS and 
electrochemical interrogation.
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2.2.2.3 Data handling
Using Autolab NOVA Software, the biosensor was modelled using a modified Randles’
Circuit in which the pure capacitor was replaced with a constant-phase element to more
closely simulate the non-ideal nature of capacitance at the biosensor surface (Bard &
Faulkner, 2001). As the effects of Warburg impedance were not observed in the data, this
component was also excluded from the model. This model allowed statistical estimation of
the solution resistance (Rs), charge transfer resistance (RCT) and constant-phase element
(Q). Using this analysis, the error of the data fit was found to have an average deviation of
2.887 %± 0.096 (n=64). For calibration, of the biosensor RCT is used as it is the most
sensitive to analyte binding and hence the most widely used measure for impedimetric
analysis of biosensors (Ahmed et al., 2013; Caygill et al., 2012; Lillie et al., 2001;
Prodromidis, 2010).
2.2.3 Regeneration of electrodes
To investigate the regeneration of biosensor electrodes, myoglobin sensors were
constructed on polymer substrates and a standard concentration of 10-8 M was tested.
2.2.3.1 Electroreduction of nitrate
To achieve localised alkali concentrations around working electrodes, the electroreduction
of nitrate ions was executed. Using 100 mM PBS with 100 mM sodium nitrate, electrodes
were connected to an Autolab electrochemical workstation running GPES software.
Chrono‐amperometric methods were used, with a voltage ≤ 2.0 V, time was modulated by 
the software.
2.2.3.2 Regeneration buffers
All acidic buffers were based on a 100 mM glycine solution with pH altered using HCl
within the range pH 2-4. For later incubations a fluidics chamber, designed by Dropsens
(DRP-CFLWCL-TG) was included. This allowed incubation parameters to be controlled as
the flow rate was set at 1 ml.min-1, allowing exposure of the sensor to the de-binding
buffer to be controlled precisely. The final buffer used was 100 mM glycine in 50%
propylene glycol at pH 2.75 with 1% DMSO.
2.2.4 Octet studies
To analyse the binding parameters of the nanobodies, kinetic analysis was executed using
a Fortebio® Octet Red system. For analysis of the basic nanobody and IgG, receptors were
bound to amine reactive probes (AGRP2) following manufacturers protocols using EDC/
NHS chemistry.
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For sulfhydryl conjugation of freshly reduced nanobodies, EDC/NHS conjugation was
initially followed by incubation with 10 mM PDPH in DMSO for 10 min. The PDPH activated
probe was then exposed to the reduced nanobody for 10 min before a 5 min wash in PBS
and baseline measurement. Binding data was then obtained, allowing 10 minutes for
binding and 1 h for debinding data to be collected.
2.2.4.1 Data handling
Initial analysis was undertaken, fitting a one site binding profile and global fitting to derive
initial values for the binding parameters for each of the bioreceptors. The equations which
govern this fast on slow off binding kinetics interaction:
ݕ= ݕ0 + ܣ(1 − ݁݇ܽ.ݐ)
Equation 2-1: One site saturation signal
Where the variables are as in
Equation 1-2.
ݕ= ݕ0 + ܣ.݁−݇݀ .ݐ
These two equations contribute to give the overall binding constant:
ܭܦ = ܭ݀
ܭܽ
Equation 2-3: Binding affinity
However due to inadequate simulation between the above equations and the measured
data the data was reanalysed, to obtain more accurate rates. . In the modelling of this
data, two distinct rates were used to modify the previous equations to:
ܾ݅ ݊݀݅݊ ݃ ܵ݅ ݈݃݊ܽ = ݕ0 + ܣ൫1 − ݁݇ܽ1 .ݐ൯+ ܤ൫1 − ݁݇ܽ1 .ݐ൯
ܹ ℎ ݁݁ݎ ܣ+ ܤ = 1
Equation 2-4: Two site saturation signal
Equation 2-2: One Site desaturation signal
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ܾ݀݁ ݅݊ ݀݅݊ ݃ ܵ݅ ݈݃݊ܽ = ݕ0 + (ܣ.݁−݇݀1 .ݐ ) + (ܤ.݁−݇݀2 .ݐ)
ܹ ℎ ݁݁ݎ ܣ+ ܤ = 1
Equation 2-5: Two site desaturation signal
3 Chapter Three:
Fabrication and
Regeneration of
Immunosensors
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3.1 Introduction
As described in Chapter Two, biosensors were fabricated on Dropsens composite
electrodes. This was achieved by electropolymerising a polyaniline (PANI)
2-aminobenzylamine (ABA) copolymer onto the working electrode. Polyaniline has been
widely used in biosensors as a conducting polymer. However, by itself polyaniline does not
contain sufficient tethering groups for efficient conjugation chemistry. ABA was therefore
included to incorporate the necessary amine groups for conjugation of the bioreceptor.
This tethering layer was then used to conjugate the bioreceptor to the surface using one of
two mechanisms either Biotin NHS in order to permit the cross linking with a biotinylated
receptor using NeutrAvidin®, the second approach used Sulfo SMCC to introduce a
maleimide group and enable oriented conjugation between the crosslinker and the thiol
moiety. Once biosensors had been fabricated and interrogated, regeneration of
impedimetric Immunosensors was approached.
As antibodies are a key tool across many fields, there has been intense research into the
bio-physics of antibody binding and its reversibility. The binding interactions for which
antibodies are used have different rate constants for both association and dissociation
(Ka and Kb, respectively). These can be very different; typically Ka is very fast whilst Kb is
much slower. These constants describe the “fast on/slow off” model of antibody binding.
It is often therefore necessary to partially denature the antibody to induce dissociation.
Partial denaturation and sensor regeneration is usually accomplished using pH alteration, a
detergent, or chaotropic agents (Blanchard et al., 1990; Giorgos J, 1979). This causes the
non-covalent forces between antigen and antibody to be screened and the enthalpic
interactions are reduced, additionally a slight distortion of the antibody structure may
occur, which allows the antigen to separate from the antibody. For biosensors, this may
allow the development of reusable sensors for both research and commercial
applications. Regeneration of antibodies used in non-electrochemical biosensors has been
successfully achieved (Kandimalla et al., 2004; Wijesuriya et al., 1994) including systems
using flow cells (Choi & Chae, 2009; Drake & Klakamp, 2011). Currently, there have been
only limited reports of the regeneration of electrochemical biosensors (Bhalla et al., 2010).
It has been reported that optical immunosensors can be regenerated up to ten times with
only a minimal loss in signal before a sudden loss in subsequent cycles (Wijesuriya et al.,
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1994). This is an important finding and one which must be considered in the development
of new biosensors. The effect of pH shifts on the electrochemical properties of the system
may cause charging or degradation of the baselayer which may interfere with subsequent
sensor operation.
3.1.1 Chemical regeneration
The most widely reported approach to regeneration uses chemical regeneration buffers,
where a low pH buffer such as glycine or a high pH solution such as NaOH is used. This
often has other components such as DMSO, Tween-20 or Ethylene glycol incorporated at
low concentration.
3.1.2 Electro-reduction of nitrate
Another proposed method of regenerating antibodies is by using electro-reduction. By
applying a negative voltage to the electrode, ions can be selectively reduced. One
particularly powerful instance of electroreduction is the reduction of nitrate ions. In this
process the ion gains electrons, which results in the generation of hydroxyl ions. This
causes a rapid and highly localised increase in the pH. The reduction of nitrate ions into
various species is described in Figure 3-1 along with the quantity of generated hydroxyl
ions.
As nitrogen has many oxidation states available, when electro-reduction is initiated there
is an abundance of electrons provided at the interface, the nitrate present is then available
to undergo a number of reduction stages which result in the release of hydroxyl groups.
The number of hydroxyl groups directly matches the number of electrons with which the
nitrate reacts, and, the change in oxidation number of the Nitrogen in the ion.
It can be seen therefore that by electrochemically providing a ready source of electrons a
very alkali region can be quickly generated at the electrode interface. This method can
therefore be used to provide transient pulses which may induce localised regeneration of
the biosensor interface.
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Figure 3-1: Electroreduction of nitrate ions. Upon the reduction of nitrate, many species
are produced owing to the many oxidation states of nitrogen (shown). The reduction of
nitrate into of each of these ions results in the generation of a vast quantity of Hydroxyl
ions (red)
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3.2 Results
3.2.1 Fabrication of myoglobin sensors
In order to fabricate myoglobin sensors, PANI 2-ABA copolymer was electropolymerised
onto the working electrode. This resulted in the gradual deposition of an electro-
conductive species which was gradually deposited over 20 scans. This polymer is not
soluble and is a more robust alternative to SAMs. Another reason for using conducting
polymer was that the electrodes used have significant surface roughness, meaning that
they were unsuitable for tethering layers such as SAMs which would possess defects.
For the fabrication of the tethering layer; a 1:1 monomer ratio of aniline:2-ABA was made
to 100 Mm with respect to each species in 1 M HCl. This was then electropolymerised onto
screen printed gold electrodes (DRP-CX2220AT) using cyclic voltammetry. Twenty scans
were run from 1.0 V to 0.0 V at a scan rate of 50 mV.s-1. The resulting CVs (vs. Ag/AgCl
reference electrode) are shown overlaid in Figure 3-2. The increase in peak heights with
corresponding scan number showed the increasing conductivity of deposited polymer as
each potential cycle was applied and more polymer was deposited. This is characteristic of
PANI as the polymer is deposited and molecular orbitals overlap to create conduction
pathways between the electrode and the bulk solution (Gerard et al., 2002).
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Figure 3-2: Electropolymerisation of PANI 2-ABA copolymer onto a gold electrode. 20
consecutive CV scans were conducted resulting in an increasing size of the plotted current,
this shows the deposition of polymer across scans as each repeat shows the greater
oxidation and reduction signal generated by a larger quantity of polymer on the electrode
surface.
After polymer deposition, the sensor was constructed using biotin- NeutrAvidin
crosslinker as described in chapter 2. Resulting impedance scans of each construction step
can be observed in Figure 3-3.
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Figure 3-3: Impedance scans of consecutive construction steps. Bare gold electrode
( ). Deposited PANI:2-ABA ( ) and fully constructed myoglobin sensor ( )
3.2.2 Interrogation of myoglobin sensors
After successful deposition of the PANI:2-ABA copolymer and attachment of both biotin
and Avidin, biotinylated myoglobin antibodies were conjugated to the transducer surface.
Non-specific sensors were also constructed using another biotinylated antibody, in this
case the anti-lysyl oxidase antibody.
Both specific and non-specific sensors were exposed to increasing concentrations of
myoglobin for 30 min duration before being rinsed and interrogated using electrochemical
impedance spectroscopy.
Interrogation was achieved by immersing the electrode in the mediator solution
containing Fe(CN)6-3/-4, at an applied voltage of 0V with respect to a Ag/AgCl reference
electrode. Data was taken at 51 frequencies between 0.25 Hz to 25 kHz as described in
Chapter Two.
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Data shown in Figure 3-4 shows the Nyquist plots of both specific signal and non-specific
signal. It can be observed that increasing analyte resulted in a larger Nyquist plot. This
corresponds to a larger resistance and capacitance across the sensor surface.
This change in resistance was assessed by obtaining values for the charge transfer
resistance (RCT), using Nova software as described in Chapter Two. This allowed a
calibration of the concentration of myoglobin vs. RCT as shown in Figure 3-5. There is a
clear signal generated by binding of the analyte to the biotinylated antibody.
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Figure 3-4: Nyquist Plots of a PANI-2-ABA myoglobin sensor. Bare sensor ( ),
increasing analyte concentration; 10-11 M ( ),10-10 M ( ),10-9 M ( ), 10-8 M
( ),10-7 M ( ),10-6 M ( ),10-5 M ( ).
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Figure 3-5: Charge transfer resistance of a myoglobin biosensor on PANI-2ABA. (n=5 ± SE)
This data has demonstrated that copolymer based immunosensors to Myoglobin were
successful at specific detection of the analyte and that RCT increased with concentration of
Myoglobin due to the binding of the antibody and analyte. Data from Non-specific sensors
has shown minimal binding.
3.2.3 Chemical Regeneration of myoglobin sensors
Initially regeneration was investigated using 100 mM Glycine buffered at a range of pH
values. After an initial 30 min binding with 10-6 M Myoglobin, the sensor was interrogated
using EIS. The sensor was then incubated with regeneration buffer for 15 s before allowing
rebinding, again with 10-6M myoglobin for 30 min. The sensor was again interrogated using
EIS to monitor signal over a number of regeneration cycles. Values for the change in RCT
after consecutive incubations are shown in Figure 3-6.
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Figure 3-6: pH study of myoglobin biosensor regeneration. RCT was normalised to original
sensor readings (run 0). After analyte binding and initial interrogation, samples were
incubated with 100 mM glycine buffer for 15 s before repeating analyte incubation and
repeating interrogation steps. Regeneration buffers used were 100 mM glycine at pH 4.0
( ), pH 3.0 ( ) and pH 2.0 ( ).
From this data, regeneration at pH 2.0 showed a rapid decrease in the signal yield from
successive interrogations. Where pH 3.0 and 4.0 were used, a steady but much slower
decrease in the signal yielded could be observed. Following a substantial consideration of
the literature, a common candidate identified was pH 2.75. This literature survey resulted
in the publication of a review paper (Goode et al., 2014), and work was continued using
the pH 2.75. After pH had been established, a study into incubation times was carried out.
Data was obtained by incubating sensors in 100 mM glycine at pH 2.75 for a range of
incubation times from 10 s to 90 s (Figure 3-7).
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Figure 3-7: Time study of myoglobin biosensor regeneration. After analyte binding and
initial interrogation, samples were incubated in 100 mM glycine at pH 2.75 for a range of
time before repeating analyte binding and interrogation. Times of incubation were: 10 s
( ); 30 s ( ); 60 s ( ); 90 s ( ).
From this data, it can be seen that when incubating the biosensor with 100 mM glycine at
pH 2.75 for 10 s the signal does not decrease dramatically as in previous experiments.
When increasing the incubation time beyond 10 s however, the signal quickly decays upon
regeneration. By the time a 90 s incubation with the low pH glycine was used, the signal
had decreased by ~45% after only one regeneration cycle. This demonstrates that
although the chosen pH of 2.75, near to previously successful pH 3.0 was suitably mild,
after an extended incubation the sensor does become damaged. This highlights the fact
that time is an important parameter which must be controlled precisely.
3.2.3.1 Use of Fluidics
In order to more stringently control the exposure of the sensor to the regeneration buffer,
immunosensors were mounted into a flow cell system as shown in Figure 3-8 to allow the
regeneration process to be controlled more accurately. By using the same pH 2.75 buffer
with a flow rate of 1 ml.min-1, the working electrode was exposed for 15 seconds, to allow
for lag, results are shown in Figure 3-9.
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Figure 3-8: The Dropsens microfluidics rig, which was used in order to control regeneration
of the sensor more precisely the oval gasket defines the flow chamber with lines in and out
which were used to change between electrochemical interrogation buffer and
regeneration buffer.
It is important to note that this data displays Z’, due to the large amounts of noise
encountered. Data obtained using RCT showed limited success in regeneration studies and
in addition, the reproducibility was unacceptable in this sensor system. By monitoring the
Z’ (real) component of the impedance, this gives us an approximation of the resistive
properties across the biosensor surface. Figure 3-9 demonstrates that when analysing at
individual frequencies, biosensors could be reused. By enabling regeneration, it may be
possible to reduce the variability between different interrogations as they could be
executed on the same sensor. It is also a good development when considering economic
factors in the biosensor market as would likely reduce the cost per test.
DROPSENS : CX2220AT
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Figure 3-9: Monitoring myoglobin biosensor regeneration across frequencies. Real
impedance (resistive element) was monitored over a range of regeneration cycles at the
following frequencies: 1 Hz ( ), 630 mHz ( ), 500 mHz ( ), 314 mHz
( ),250 mHz ( ).
3.2.3.2 Electronic Polymorphism of PANI
The highly variable nature of regeneration data on the sensors which had been
constructed using the pani:2-ABA polymer lead to an inspection of the literature (Hwang et
al., 2001; Kennedy et al., 2007; Lacroix et al., 2000; Raffa et al., 2006; Sergeyeva et al.,
1996) on the chemistry of poly aniline. It became apparent that the polymer in question
had a number of electronic states: the fully reduced form (pernigraniline), the mixed
reduced/ oxidised form (emeraldine) and the oxidised form (leucoemeraldine). It was also
discovered that by terminating electrodeposition at various potentials, the copolymer
could be observed in each of these three states. This was investigated and a number of EIS
scans of the polymer deposited at each electronic state were reviewed to assess the
electronic stability of the copolymer itself, data shown in Figure 3-10.
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Figure 3-10: Different electronic configurations of PANI: 2ABA copolymer. A, B and C were
subjected to 20 CV cycles as described in methods. The end potential was set at; A= 1 V,
B= 0.5 V and C= 0 V. In order to ensure that the polymer was in a defined electronic state.
Following this consecutive EIS scans were run, Nyquist plots are shown alongside
photographs of the surface and schematics of each of the three electronic structures.
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This data highlighted the variability of the polymer layer and showed the change in signal
generated from the polymer alone. It was due to this that a new polymer needed to be
chosen. Given the need for accessible moieties for conjugation and a stable signal in a
wide variety of chemical environments, there were only a few candidate polymers. From
these polytyramine was chosen as it had been previously demonstrated useful for
biosensor applications (Ahmed et al., 2013; Ates, 2013; Gerard et al., 2002; Labib et al.,
2010; Pournaras et al., 2008).
3.2.3.3 Operational stability of polytyramine vs. polyaniline
By exposing PANI:2-ABA to different pH buffers, the electronic variability of the polymer
could be compared between the inferior PANI:2-ABA and the PTyr. This was observed
clearly in both the Nyquist plots (Figure 3-11, Figure 3-14) and derived data For RCT (Figure
3-12, Figure 3-15).
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Figure 3-11: The stability of PANI:2-ABA. After electropolymerisation three separate
experiments were run to investigate electronic stability of the polymer. Consecutive EIS
scans (1-5) were run following sequential 10 s incubations in the following buffers: acid
100 mM glycine pH2.0 ( ), Alkali 10 mM NaOH :N2HPO4 Buffer pH 12.0( )and
10 mM PBS pH 7.4 ( )
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When considering the Nyquist plots of consecutive incubations in a range of environments,
the Pani was observed to display poor reproducibility. In particular in acidic environments,
where continual incubation in pH 2.0 buffer resulted in an arc which consistently became
steeper, this property of increasing signal in the imaginary component of impedance is
analogous to an increase in the capacitive properties of the interface. It is therefore
hypothesised that as the PANI polymer is soaked in acid, it becomes charged which causes
interference in RCT rendering sensor calibration impossible. Whilst capacitance is not
generally used in biosensor calibration, it is an important property of electrochemical
biosensors, in particular impedimetric ones where RCT is modelled using a Randle’s cell as
the large change in capacitance may cause an artefact when trying to simulate data.
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Figure 3-12: Analysed RCT on stability of PANI:2-ABA. The polymer coated electrode was
exposed to different conditions for increasing incubation times, acid 100 mM glycine pH2.0
( ), Alkali 10 mM NaOH :N2HPO4 Buffer pH 12.0( )and 10 mM PBS pH 7.4
( )
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Since this change is on an electrode with only polymer deposited and not a fully
constructed biosensor, this may be a great hindrance to the calibration of a successful
biosensor. As acidic regeneration had been previously pursued, these data may help
explain the limited degree of reproducibility observed. Polytyramine had been identified
as a strong candidate for replacing PANI due to its superior stability, therefore electrodes
were cleaned and deposition of PTyr was executed as outlined in Chapter Two, the results
of which are shown in Figure 3-13. In this trace, after initial oxidation of tyramine at
around 0.5 V in the first scan, a smaller scan was observed for the second scan. This
implies that tyramine is oxidised onto the electrode surface, forming an insulating film, a
property which has been previously identified (Pournaras et al., 2008; Tsuji et al., 1990).
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Figure 3-13: Electropolymerisation of polytyramine film. Tyramine was dissolved in
methanol with 0.3M NaOH to act as a counter ion consecutive CV scans are shown Scan 1
(black) and scan 2 (red).
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The stability of Polytyramine (PTyr) was then assessed and compared with previous data
from PANI: 2-ABA Copolymer. As previously, incubation of a polymer coated electrode in a
variety of different buffers was followed with consecutive EIS scans (Figure 3-14).
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Figure 3-14: The stability of PTyr. Stability of the polymer was assessed as in figure 3-12,
EIS scans were run with consecutive 10 s incubations in the following buffer: acid 100 mM
glycine pH2.0 ( ), Alkali 10 mM NaOH :N2HPO4 Buffer pH 12.0( )and 10 mM PBS
pH 7.4 ( )
From these data it can be seen that the three electrodes interrogated formed distinct
datasets with a clear distinction between those exposed to acid, alkali and PBS. Though
there is a difference between the electrodes themselves, for the purposes of this
experiment it is really the change occurring at each electrode which is critical.
In order to investigate this factor in isolation, the change in charge transfer resistance was
calculated (Figure 3-15) to assess the effect of the various environments on the polymer.
From the figure, it can be observed that PTyr is a much more stable polymer than PANI.
This suggested that PTyr was a more viable choice for of biosensor regeneration across the
pH range used with acidic glycine regeneration.
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Figure 3-15:Analysed RCT on the stability of PTyr. Polymer coated electrode was exposed
to different conditions for increasing incubation times, acid 100 mM glycine pH2.0
( ), Alkali 10 mM NaOH :N2HPO4 Buffer pH 12.0( )and 10 mM PBS pH 7.4
( )
Considering the data shown in Figure 3-15, it was observed that whilst there was a minor
change in the RCT when exposing the PTyr to an acidic buffer. This helped to confirm the
improvement in stability that had been achieved by changing the polymer layer.
3.2.3.4 Electroregeneration of Myoglobin sensors
As polytyramine had been proven a more stable electropolymer, its suitability for use in
electro-reductive regeneration was assessed. Literature values for the electro-reduction of
nitrate ions state that a potential of -2.8 V causes optimal reduction of nitrate ions. After
one ten second interval of electro-reduction, the PTyr appears to have been stripped. This
can be observed in the Nyquist plot (Figure 3-16) where after the first electro-reductive
cycle the Nyquist plot dramatically drops to resemble data similar to a bare gold electrode.
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Figure 3-16: Stability of PTyr after 10s periods of electroreduction of nitrate. After initial
reading (1), the electrodes were subjected to consecutive electroreductive cycles.
The data was again analysed to assess the change in charge transfer resistance and again
the dramatic decrease in resistance after one 10 s electroreductive cycle was clearly visible
(Figure 3-17).
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Figure 3-17: Analysed RCT of PTyr film after electroreduction of nitrate. The polytyramine
coated electrode was exposed to 10s pulses of electroreductive current before
consecutive EIS interrogations.
As the negative potential of -2.8 V was found to be too aggressive, electro-reduction of
nitrate over a wide potential range was assessed to ascertain whether it could be
modulated. A cyclic voltammogram was taken to monitor this reduction process in
isolation (Figure 3-18). The reduction peak was observed to begin at around -1.7 V. By
moderating the reduction voltage to -2.0 V, it was hoped that a more gentle reduction
could be achieved and perhaps a milder alkali pulse generated which could in turn prevent
stripping of the electrode and the resultant drop in resistance which had been previously
observed.
120
By exposing a polytyramine coated electrode to the less aggressive electro-reduction
regime, at a potential of only -2.0 V and monitoring after a 5 S reductive pulse it was
expected that the tyramine might remain on the surface. However, as can be seen in
Figure 3-19, even after 5 s there was considerable stripping of the polymer from the
electrode.
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Figure 3-18: Monitoring the electroreduction of nitrate. CV was done from 0 down to -2.8 V
reduction can be observed at all voltages lower than a~ -1.7V.
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Figure 3-19: Electro-reduction of nitrate at -2.0 V. Consecutive Nyquist plots of a
Polytyramine coated electrode after deposition of Polytyramine film ( ) and then
following 5 s ( ) and 10 s ( ) electroreduction of Nitrate at -2V, the two plots
show data collected from each working electrode of a dual sensor Dropsens electrode.
Since it was clear that even by limiting the reduction of nitrate by both the potential and
the time, this method was too harsh, this approach was abandoned. Though it has been
proven in certain biosensor systems (Abbady et al., 2011; Bhalla et al., 2010; Choi & Chae,
2009; Liron et al., 2002), it remains unsuitable for the type of transducers and tethering
layers attempted here.
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3.2.3.5 Fabrication of sensors using PTyr
Once the stability of PTyr had been confirmed, a myoglobin biosensor was constructed as
with the previous PANI:2-ABA sensor used. This was again constructed using biotinylated
anti-myoglobin antibodies following the functionalization of the amine containing surface
with Biotin-NHS and the addition of NeutrAvidin. Similarly to previous work in Figure 3-3,
construction of the sensor was monitored using EIS (data shown in Figure 3-20). From this
data it is noted that the polytyramine layer deposited has an increased resistance and
capacitance, thus supporting previous findings that an insulating layer is deposited.
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Figure 3-20: Nyquist plots of PTyr based sensor construction. EIS Scans were conducted for
Bare gold electrode ( ), deposited PTyr film( ) and fully constructed myoglobin
sensor( ).
Once constructed, the myoglobin sensor was calibrated by incubating the sensor with
consecutive concentrations (10-11-10-5 M myoglobin) and interrogating the sensor using
EIS. From the Nyquist plots (data not shown) the change in RCT was used to calibrate the
sensor. It can be seen from the data in Figure 3-21 that the signal of the sensor is
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comparable to that of the PANI sensor, with a slightly higher signal generated for the same
concentration of analyte.
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Figure 3-21: Calibration of a PTyr based immunosensor for myoglobin. RCT was generated
using the modified Randle’s cell, (n=8 ± SE)
3.2.4 Return to chemical approach using a complex regeneration buffer
When returning to a chemical buffer based approach to regeneration, the literature was
re-assessed and the buffer composition was altered to include other components in order
to satisfy the needs of regeneration and minimise alteration of the transducer surface. As
discussed in Chapter One, regeneration involves altering the thermodynamic state at the
biosensor interface to overcome the thermodynamic interactions and induce de-binding of
the two.
To achieve this, the chaotrope DMSO was included as well as propylene glycol to reduce
the effect of Van der Waals forces between the analyte and the receptor. A low level of
the detergent SDS was also included to promote solvation of the analyte receptor
interface. Using this improved buffer at pH 2.75 as before, regeneration as repeated using
the fluidics cell, the overall composition of the regeneration buffer was therefore 100 mM
glycine in 50% propylene glycol pH 2.75 1%DMSO .
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3.2.5 Verification of incubation times, using fluidics.
Using the above regeneration buffer, a study was executed with an initial incubation time
of 20 s. After PTyr was deposited a myoglobin biosensor was constructed and interrogated
using EIS to obtain a baseline signal. The sensor was then incubated with 10-6 M myoglobin
and interacted before being exposed to regeneration buffer for 20 s and rinsed in PBS. EIS
interrogation was then repeated to assess the level of regeneration, this process was
repeated 8 times to investigate the success of repeat regeneration cycles. In Figure 3-22, a
clear difference between the “On” and ”Off” signal can be seen though the off signal
rapidly decreases and positive signal from the binding of analyte can only be seen for 3
cycles.
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Figure 3-22: Regeneration of a myoglobin sensor using complex regeneration buffer.
Regeneration was executed with 20s incubation in 100 mM Glycine in 50% propylene
glycol pH 2.75 1%DMSO data shows Binding ( ) and Debinding( ) (n=8 ± SE)
The incubation time of the sensor in the regeneration buffer was decreased to 10 s in
order to provide milder regeneration conditions and see if the number of successful cycles
could be extended. From the Nyquist data (Figure 3-23), a clear difference can be seen
between interrogations made when the analyte was bound vs. unbound interrogations
following biosensor regeneration. This difference was observed for the first five repeats
before additional repeats yielded no signal change.
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Figure 3-23: Nyquist plots of the successful regeneration of a myoglobin sensor. 5
successful cycles were observed. After baseline sensor signal acquisition ( )
regeneration was executed with 10s incubation in 100 mM glycine in 50% propylene glycol
pH 2.75 1% DMSO data shows data obtained after consecutive analyte exposure ( )
as well as those obtained after regeneration( ).
This trend was also observed when analysing the change in change transfer resistance
(Figure 3-24). As in Figure 3-22, the difference signal acquired after analyte binding and
after regeneration can be clearly seen. In Figure 3-24 however the decay of the signal
between successive regeneration cycles is much less pronounced. In this experiment, a
total of five regeneration cycles were achieved before the signal collapsed.
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Figure 3-24: Successful regeneration of a myoglobin biosensor. Regeneration was executed with 20s
incubation in 100 mM glycine in 50% propylene glycol pH 2.75 1%DMSO data shows binding
( ) and debinding( ), (n=8 ± SE)
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3.3 Discussion
Based on observations made at AbCam, the re-folding of antibodies after binding to an
immunogen was routinely achieved. It was shown that these methods can be used to
successfully regenerate an electrochemical biosensor. Though previous work had shown
that antibodies could be successfully regenerated in other types of biosensor (Drake &
Klakamp, 2011) such as optical sensors (Wijesuriya et al., 1994) and in non-antibody
electrochemical biosensors (Bhalla et al., 2010; Choi & Chae, 2009). This work has
demonstrated the successful regeneration of an electrochemical immunosensor. This was
achieved using 100 mM glycine at pH 2.75 in 50% propylene glycol pH 2.75 1% DMSO for
10 seconds which in a controlled fluidics setup this could be effectively extended to five
repeats. Although the current protocol showed poor reproducibility, this work remains a
good proof of concept and worth of further investigation because if a reliable method
could be established, it would be of great interest for both research and commercial work.
A crucial factor in the use of electrochemical sensors is the electronic state of the
baselayer, particularly in the case of polymer based electrodes. Although acid conditions
may be effective at de-binding antigens from the sensory antibodies, they may cause a
charging effect of the surface and cause a large non-specific signal.
A microfluidics study which could enable parameters to be controlled much more tightly.
When considering the incubation time in acid and rinsing, automatic control could assist in
improving the reliability of results and increase the number of regenerated cycles which
can be achieved. Automatic control may also help in the development of a point of use
system, where computer controlled microfluidic packaging may be preferable for reducing
the need for user expertise and ensuring consistency.
Polyaniline is a poor substrate for regeneration in electrochemical sensors as it has
multiple electronic states. Though the regeneration of optical sensors on this substrate
had been previously demonstrated (Nakamura et al., 2013), its multiple states lead to a
change in its signal and interference with interrogation techniques. This reinforces the fact
that the choice of substrate is a key consideration for electrochemical sensors if we aim to
fabricate re-useable sensors.
Electro-reduction of NO3- was successful as shown from cyclic voltammetry experiments.
However, the process proved too harsh and led to the stripping of PTyr. Electro-reduction
is an elegant solution for the generation of localised regions of high pH but has been
shown to require very stable surfaces so may not be appropriate for many biosensor
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tethering layers. In a limited number of studies, this approach has been used to strip the
electrode permitting reconstruction of the sensor entirely (Choi & Chae, 2009).
After an in-depth literature review a more complex buffer achieved regeneration. This
allowed the transient denaturation of the antibodies on the biosensor to achieve five
regeneration cycles. The recipe of the regeneration buffer was; 100mM glycine in
50%popelyne glycol +1% DMSO at pH 2.75. If we assess the thermodynamic activity of the
individual ingredients of this buffer it can help underline their active role in the
regeneration process. First, glycine was used to enable a buffered low pH solution to be
created, in this case pH 2.75. As discussed in 1.6.3 the shift of the pH away from the
isoelectric point of the receptor protein may help denature the protein and induce
decoupling of the analyte form the receptor. The next component, propylene glycol is a
miscible diol, carbohydrate, its carbon basis and the negative charges associated with the
alcohol moieties mean that it can behave as a very weak detergent enabling the screening
of Van-der-vaals forces and compensate for any positive charges in a system. Dimethyl
sulphoxide was included as a strong aprotic solvent which also behaves as a kosmotrope,
this means that in an aqueous solution the DMSO will preferentially interface with
biomolecules and restore interactions between water molecules. As hydration caging can
be a vital component of antigen antibody interaction, DMSO provides a method of
interrupting this process and assists in the decoupling of the analyte form the receptor.
Through action of these different components there is an overall net shift in the
thermodynamic state of the system in which the change in Gibb’s energy favours the
unbound state of the analyte which results in debinding at the sensor interface
consequently allowing the regeneration and reuse of the biosensors.
Though there was a gradual signal loss, for instances where positive: negative signal
determination is large, this provides a more than adequate solution as it would still allow
for measurement. Another solution would be to have a calibration reading taken in
parallel to ensure that any loss in signal could be accounted for and accurate
measurements could continue to be taken.
4 Chapter Four: Results:
Nanobody production,
optimisation
and characterisation
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4.1 Antibodies
Work in this chapter focuses on the development of novel bioreceptors to detect rabbit
IgG. The analyte IgG was selected due to the availability of bioreceptors for detection and
the commercial needs of AbCam Plc. As well as providing a useful tool for quality control
and process management the development of this sensor would represent a valuable tool
for use in research environments as well as a sensor to assist in the management of
various immunological disorders. Throughout this chapter, conventional antibodies
against rabbit IgG, a goat anti rabbit polyclonal IgG, was used as the benchmark by which
to compare other bioreceptors. A summary of the receptors used in both this chapter and
the next is shown in Figure 4-1
A B C
D
E
Figure 4-1: Schematic of different bioreceptor constructs used. Including (A) full IgG (1igt), and
nanobody (B)(1MEL) with 5, 10 and 15 amino acid linker arm, respectively (C,D and E). Alongside
complete camelid single domain antibody (F) (for comparison).
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4.2 Nanobodies.
Nanobodies to rabbit IgG were used as a novel bioreceptor. Previous work at Abcam had
isolated the DNA sequence coding for the P8D8 nanobody which binds rabbit IgG. This
DNA had been isolated following immunisation of an alpaca and panning using rabbit IgG
in phage display as outlined in Chapter One. During panning the binders showed no cross-
reactivity when tested against IgG from other animals (sheep, goat, mouse and others) an
improvement of antibody technology where this cannot be assessed until after the
production of the antibody.
Once the DNA had been isolated, its sequence was ligated into a plasmid using T4 ligation
as detailed in Chapter Two. The pHEN6 vector used has sites for the restriction enzymes
PstI and BstEII at either side of the nanobody coding region. In addition there is an EcoRII
site in which the coding sequence for a His6-Tag is commonly ligated in order to simplify
purification of the resultant nanobodies. A summary of the plasmid sequence is shown in
Figure 4-2. pHEN6 is useful as it also codes for ampicillin resistance and so allows
downstream selection of colonies when expressing protein.
4.2.1 Vector selection and recombinant molecular biology.
Alongside the pHEN6 vector coding for the P8D8 anti-rabbit IgG (referred to hereafter as
the insert), separate PHEN6 vectors were synthesised by replacing the His-tag region with
a polynucleotide coding for the peptide spacer arm ( 5, 10 or 15 aa based on a GGGGS
repeating motif) followed by a His-tag again in order to simplify purification. A summary of
the plasmids used can be seen in Figure 4-2.
Plasmids were digested as described in Chapter Two and an Agarose gel cartridge (E-gel®)
was run to confirm digestion and well as isolate the fragments. The gel was imaged before
removal of the DNA, Data shown in Figure 4-3. The running of the gel was continued to
enable collection of the Vector in the lower well. The times taken to retrieve the DNA
Fragments were 10 min for the nanobody insert and approx. 40 min for the vectors.
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Upon removal from the gel, the vectors were eluted sequentially, in order of ascending
base pair length. The unmodified pHEN6 vector coding for the P8D8 nanobody with only a
his6-tag between BstEII and EcoRII sites was removed the first. The Modified pHEN6
vectors coding for P8D8 nanobodies with spacer arms were sequentially removed from the
gel with a gradual increase in the time taken for the DNA to reach the collection well up to
the final vector, coding for a 15 amino acid spacer. By the time that the vectors were
collected from the agarose gel, some lateral shift could be seen in the lanes as the vector
DNA progressed through the agarose gel. This may be due to heating of the gel or
depletion of ions (Wilson & Walker, 2010).
Nanobody His- tag
Spacer PeptideHis- tag
Nanobody His- tag Spacer Peptide
4 kbp
307 bp 39 bp
39 bp
39 bp307 bp
0-42 bp
0-42 bp
A
B
C
Pst I
Pst I
Pst I
Bst EII
Bst EII
Bst EII
Eco RII
Eco RII
Eco RII
Figure 4-2: Map of pHEN6 vector used for expression of nanobodies in E.Coli. (A) pHEN6 containing the
nanobody insert (green) with restriction sites displayed, (B) Modified pHEN6 with spacer arm (blue)
and his tag (orange), (C) successfully transformed plasmid containing both P8D8 coding vector and
insert coding for nanobody with spacer arm.
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L P8D8 P8D82 pHEN6 pHEN6-s5 pHEN6-s10pHEN6-s15
pHEN6 Vector
Nanobody insert
Figure 4-3: E-gel image of vectors after digestion. The gel was run to remove nanobody
insert and check for contaminants. Lanes show: P8D8, control pHEN6 vector coding for
‘P8D8’ nanobody from Abcam verified stock; P8D82, pHEN6 vector digested from new
stocks; B vector, vector coding for his tag only, P8D8-S5 coding for nanobody with 5 aa
spacer; P8D8-S10 coding for nanobody with 10 aa spacer P8D8-S15 coding for nanobody
with 15 aa spacer.
After removal from the gel (Figure 4-3) , plasmids were then ligated according to methods
in Chapter Two. Stable plasmids were then quantified using a Nanodrop® micro
spectrophotometer to ensure sufficient yield had been achieved, the plasmids were then
stored at ‐20 ⁰C before use. To confirm successful plasmid ligation, transformation of E.Coli
was performed using the heat shock technique with competent Nova blue cells, in order to
increase plasmid yield. The resulting cells were then plated onto ampicillin plates and
allowed to grow under antibiotic selection. Colonies were then selected and grown in TB
media with ampicillin ready for miniprep. Plasmid DNA was extracted using a Qiagen
Miniprep kit according to manufacturer’s protocols and the yielded DNA concentration
was verified using a Nanodrop micro spectrophotometer before being sent for sequencing.
4.2.2 Sequencing data
Plasmids were sent to Source Bioscience for sequencing, full sequence data confirmed the
inclusion of peptide spacer and successful ligation of the nanobody scaffold with correct
CDR sequences. DNA and amino acid sequence data have been omitted due to commercial
sensitivity. Access can however be applied for by contacting Abcam Plc.
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4.2.3 Expression of nanobody peptide.
Once plasmid identity had been confirmed, plasmids were transformed into competent
WK6 cells using the heat shock technique and cultured as described in Chapter Two. The
periplasm was then extracted and nanobodies were purified as outlined.
To assess the purity of the extracted proteins, aliquots of the peak concentration were run
on a MES gel under both reducing and non-reducing conditions. Results are shown in
Figure 4-4. Not only can the overall purity of the samples be observed but it can be seen
that the nanobodies with peptide spacers had formed dimers which were reduced when
the gel was run under reducing conditions.
Dimers
Monomers
Figure 4-4: SDS-PAGE of nanobodies. Under both non-reducing (A) and reducing (B)
conditions. M= marker, Nb= control P8D8D nanobody, B= basic P8D8D nanobody (spacer),
5, 10 and 15 =P8D8D nanobody with respective amino acid linker. On the left panel the
formation of dimers can be observed. Whereas the inclusion of 10 mM DTT led to their
almost complete removal b reduction (right hand panel).
The presence of these native dimers meant that to enable any directed sulfhydryl
chemistry, e.g. for conjugation at a biosensor interface the dimers had to be reduced. If we
consider the sequences obtained, it is also crucial to note that there is another pair of
cysteines within the structure of the nanobody scaffold itself. Though the DTT may be
A B
135
good for the reduction of dimers, its aggressive nature may mean that it could reduce this
disulphide bond too and affect the function of the nanobody.
4.2.4 Disulphide cleavage using TCEP beads
Using previous protocols from the Millner lab (Ahmed et al., 2013; Billah et al., 2010;
Caygill et al., 2012) tris(2-carboxyethyl)phosphine (TCEP) was initially investigated as
method of disulphide reduction. By incubating the nanobody dimers with TCEP beads
separation was simplified as simple centrifugation was permitted as an adequate method
for separation of the TCEP, a necessary step for the downstream use of reduced
monomers. After 90 min incubation with 10 mM TCEP beads in degassed PBS-EDTA, the
samples were immediately placed in a non-reducing SDS-PAGE sample buffer along with
untreated nanobodies and nanobodies which had been incubated with DTT to ensure
reduction. Data from this is shown in Figure 4-5.
Figure 4-5: SDS-PAGE of nanobodies subjected to TCEP reduction. SDS-PAGE was
conducted using non reducing conditions after TCEP Reduction (B). This was compared to
non-reducing SDS-PAGE (A) and Reducing SDS-PAGE (C), M= Marker, B= basic P8D8D
nanobody (no spacer), 5, 10 and 15 = P8D8D nanobody with respective amino acid linker.
On the left panel the formation of dimers can be observed. Whereas the inclusion of 10
mM DTT led to their almost complete removal by reduction (right hand panel).
A B C
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From this data, it can be seen that though TCEP had been proven to be a strong enough
reducing agent in similar studies, in the case of nanobodies there is still a significant
proportion of dimers present in the sample. Densitometry analysis was done on the gel
from Figure 4-5 and whilst in the positive control it can be seen that over 90% of dimers
had been reduced when DTT was used, in the case of TCEP only 30% of dimers were
successfully reduced.
4.2.5 Disulphide cleavage using β-MEA 
In order to provide effective reduction of nanobody dimers, a stronger reducing agent β‐
mercaptoethylamine (also known as cysteamine or 2-MEA) was selected. As with previous
protocols, buffers were degassed and EDTA was included to minimise the reformation of
dimers after separation from residual MEA. Again, a non-reducing SDS PAGE gel was run
to assess the reduction of nanobody dimers, Samples were compared with untreated
nanobodies and those incubated with DTT. Data from these experiments are displayed in
Figure 4-6.
Figure 4-6: SDS-PAGE of nanobodies subjected to 2-MEA reduction. SDS-PAGE was
conducted using non reducing conditions after 2-MEA Reduction (B). This was compared to
non-reducing SDS-PAGE (A) and Reducing SDS-PAGE (C), M= Marker, B= basic P8D8D
nanobody (no spacer), 5, 10 and 15 = P8D8D nanobody with respective amino acid linker.
On the left panel the formation of dimers can be observed. Whereas the inclusion of 10
mM DTT led to their almost complete removal by reduction (right hand panel).
B CA
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From Figure 4-6 we can see that the 2-MEA has been much more successful in the
reduction of nanobody dimers, with results comparable to reduction using DTT, a strong
reducing agent. Again, taking densitometric data 2-MEA reduced between 100-80 % of
dimers. Interestingly, dimer reduction was slightly less successful (~80%) when studying
nanobodies with the longest peptide spacer. This trend was observed in nanobodies
treated with both DTT and 2-MEA. Percentage cleavage can be seen below in Table 4-1.
Conditions Receptor B 5 10 15
No Treatment
Monomer 100 24 30 29
Dimer 0 76 70 71
2-MEA
Monomer 100 100 85 80
Dimer 0 0 15 20
DTT
Monomer 100 100 87 97
Dimer 0 0 13 3
Table 4-1: Densitometry data from 2-MEA reduction of nanobody dimers.
In order to understand this phenomenon a higher resolution approach was taken to
investigate the reduction of nanobody dimers using 2-MEA. After incubation with 2-MEA
at 37 ⁰C  for 90 min, samples were subjected to size exclusion chromatography, by running 
on a Superdex® column, in an Akta® Explorer HPLC system. Running samples at 1ml.min-1
absorbance at both 280 nm and 220 nm was monitored in order to allow more accurate
quantification than previous densitometry experiments. Absorbance data at both 280 nm
(for aromatic residues) and 220 nm (for peptide bonds) is shown in Figure 4-7
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Figure 4-7: Size exclusion chromatography of reduced nanobody dimers. The absorbance
over an 30 ml injection course (collected 1ml fractions, red) is shown, absorbance was
measured at, 280 nm ( ), 260 nm( )and 220 ( ) nm. Dimers eluted first at 10-12ml
with monomers eluting later. The larger monomer peak was observed between 14-16 ml
fractions and the overall purity observed in Figures 4-5 – 4-7 indicate that these peaks can
only be due to the presence of nanobodies.
This data supports previous studies and confirms the successful reduction of nanobody
dimers using MEA. From calculations, the reduction of monomers was 80% successful.
Therefore when considering the nanobody concentration on a sensor surface, 120% of the
required concentration was used to account for the unreactive nanobody (i.e. that in
dimeric form). It is important to remember however that this was time dependant and
that once monomers were separated from the 2-MEA, given enough time will reform
dimers. This highlights the importance of working quickly to ensure the receptor
concentration can be effectively controlled.
4.2.6 Immunoprecipitation of rabbit IgG from serum.
As reduction comparable to that of DTT was observed in the previous investigations, it was
essential to confirm that the reduction has not irreparably damaged the nanobody or that
analyte recognition has been interrupted, particularly when considering the presence of a
disulphide bond in the nanobody scaffold structure. In order to do this, a two-elution step
Immunoprecipitation experiment was planned, in which eluates could be interrogated
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using immunoblotting. A schematic of the experimental approach can be seen in Figure
4-8. Western Blot was not attempted as by using immunoprecipitation, sulfolink chemistry
could be easily employed to ensure both cysteine residues of the spacer arm were
functional for conjugation as well as the immunogenicity of the nanobody.
Beads used for immunoprecipitation were either NHS carboxy ester tagged (for basic
nanobody) or Sulfolink® (for nanobodies with peptide spacer arms) allowing amine
containing or cysteine residues to be exploited respectively. The nanobodies were
conjugated to the beads using the appropriate chemistries, in the case of Sulfolink beads,
dimers were reduced using 2-MEA as above before being applied to the beads. An outline
of the methods used is given in Chapter Two.
After the nanobodies had been conjugated to the beads, they were incubated with 10%
(v/v) rabbit serum in PBS containing rabbit IgG. After appropriate and multiple washing
steps (as outlined in Chapter Two), a first acid elution was conducted in order to elute
immunogenically bound rabbit IgG, Fractions were immediately neutralised in Tris to
prevent damage to the IgG. After a brief wash step, a DTT elution was executed in order to
reverse the Sulfolink binding and release bound nanobodies from the beads.
140
1)
Glycine
Elution
2)
DTT
Elution
Figure 4-8: Schematic for immunoprecipitation experiments. After Sulfolink conjugation of
the bead with the modified nanobody construct, rabbit serum was applied and unbound
proteins were washed away. A two-step elution was then executed with (1) primary acidic
glycine elution pH 2.0 (orange) to liberate bound IgG and then (2) a DTT elution (magenta)
to release Nanobody bound by Sulfolink chemistry.
The fractions of these different eluates were collected and analysed by running on an SDS-
PAGE gel which was stained using Coomassie blue Figure 4-9 (A). Alongside the elutions,
rabbit serum was run to enable comparison between eluted samples and sera proteins.
This helped to confirm the presence of rabbit IgG in the glycine elution lane and confirm
that the lower band seen (12-15KDa) was the nanobody as it was absent in rabbit sera
samples. In addition to a Coomassie staining, proteins were further identified by western
blotting. Fractions which had been run on an SDS-PAGE gel were transferred to a
nitrocellulose membrane and interrogated in one of two ways. Either a goat anti rabbit –
HRP conjugate was used to interrogate the membrane as in Figure 4-9 (B) or an anti his-
tag –HRP Conjugate was used Figure 4-9(C). When interrogating using the anti-rabbit HRP,
it was observed that signal was generated in both sera lanes and lanes for the glycine
elution this confirms that rabbit IgG had eluted using an acidic buffer and therefore that
the rabbit IgG had successfully bound to the nanobody which had been attached to the
bead.
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Figure 4-9: Blotting experiments from immunoprecipitation fractions. Coomassie stain (A) and immunoblot using anti rabbit IgG secondary Dako cat# P0448 (B) and anti
His6 -tag secondary Abcam ab1187 (C). Across all panels diluted sera (s) are compared with fractions yielded from immunoprecipitation elutions, both glycine (gl) and
DTT (dtt) respectively. In each panel B, 5,10, 15 are the respective nanobody constructs with 5,10 and 15 amino acid spacer respectively alongside a non-specific (C)
control where Sulfolink® beads were blocked with buffer containing cysteine as a negative control (-ve)
A B C
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In the second immunoblot experiment, the nanobody was identified using an anti-His6-HRP
conjugated secondary antibody (Figure 4-9 (C)). In the lanes where DTT Elution had been
executed, a clear band can be seen (12-15Kda) along with weaker bands corresponding to
nanobodies which have reformed dimers upon elution (24-50KDa); this clearly shows the
elution of the Sulfolink conjugated nanobodies in the presence of DTT. In addition to the
bands indicative of nanobody elution a regular ladder of proteins is observed in the lanes
associated with glycine elution of the bound IgG. These bands do not adequately
correspond to the mass of IgG fragments so must be protein of another source. As these
bands cannot be observed on the Coomassie stain however they may represent low
concentrations of protein which have bound the Anti-His6 – HRP Conjugated antibody. As
signal generated using an enzyme reporter amplifies the signal generated by the protein
this may explain their presence as visible bands in the immunoblot.
It is important to highlight the presence of other bands in this blot; this is possibly due to
the use of an anti-His6- HRP antibody which may bind to other negatively charged sera
proteins present in the glycine elution which have co eluted with the antibodies. It is likely
that they are at very low analyte concentrations as the directly quantitate method of
Coomassie staining has failed to generate a signal at these molecular weights. As this
signal in western blot is developed by the action of the HRP conjugated antibody the signal
is amplified rather than directly proportional so even low levels of bounding can generate
a signal. This would indicate that the proteins eluted are at a much lower concentration
than the nanobodies which reflected in the signal intensity from. The band for these
contaminants is much lower than the Band observed for the eluted nanobodies in the DTT
elusion lanes.
The data obtained so far in this chapter has confirmed that nanobodies can be produced
with a peptide spacer arm allowing for oriented conjugation. Whilst dimers of these
nanobodies form natively, they can be selectively reduced and this does not negatively
impact upon their binding capacity.
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4.3 Analysis of binding parameters using BLI
In order to assess the binding parameters of the nanobodies which had been expressed
and compare the different binding constructs an optical biosensor system was used. All of
this work was done using a Fortebio Blitz system in which binding is assessed in terms of
change in the optical thickness at the biosensor interface as explained in chapter one. The
Fortebio® Octet system uses interferometry with the bioreceptor immobilised at the end
of a fibre optic probe. As well as comparative data for later electrochemical studies this
allowed an investigation into key binding parameters of both the antibody and the
nanobody). As a control, the goat anti-rabbit IgG antibody receptor was first conjugated
to Forte Bio amine reactive probes (ARP2) using EDC-NHS conjugation chemistry, following
manufacturer’s protocols. Real time binding data from this experiment is shown Figure
4-10. From this data we can see the steep association curve followed by a much shallower
dissociation curve. When comparing specific to non-specific signal (i.e. using sheep IgG for
analyte) the difference can clearly be seen.
0 2000 4000
0.0
0.6
1.2
1.8
sheep IgG
42 nM
83 nM
166 nM
333 nM
B
in
di
ng
(n
m
)
Time /s
666 nM
Figure 4-10: Real time binding data for an antibody based rabbit IgG sensor. A Fortebio
probe was functionalised with goat anti rabbit IgG antibody. Association data was collected
for 600 s before allowing 3600 s for dissociation data to be collected. After receptor
conjugation and baseline measurement probes were incubated with rabbit IgG at: 666 nM
( ) 333 nM ( ), 166 nM ( ), 83 nM ( ), 42 nM ( ), as well as Sheep IgG at 666 nM
( ).
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As the control used was sheep IgG, this confirms that the antibody used shows no cross
reactivity to the sheep IgG. Another feature of the data is that is important to observe is
the binding signal reached at every concentration. Using this data it is possible to calibrate
a sensor and compare the signal yield from each bioreceptor used. Using this technique
with data obtained from the previous figure, Figure 4-11 was generated.
The same experiment as before was repeated for each of the nanobody. P8D8 nanobodies
were attached to the probe surface using the same amine to carboxyl conjugation
chemistry as when using IgG as the receptor (EDC-NHS). After initial scoping work, the
concentration of the nanobody was optimised on the probe surface to minimise artefacts
from nanobody aggregation on the surface of the probe which could be observed as a
distinct curvature in the dissociation curve. The nanobody concentration was therefore
optimised at 60 nM. A full analyte concentration range was run using 60nM P8D8
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Figure 4-11: Calibration using Rmax data from the Octet. Maximum binding signal was taken from the
association curve and plotted against the concentration of analyte for that given experiment. As can
be observed a positive correlation was achieved, Error bars represent Δerror [Rmax] a figure which is
generated in the Fortebio analysis software.
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nanobody in the conjugation step. The sensor to rabbit IgG was then run using amine
reactive probes in the Fortebio Octet as before. Data from these experiments are shown in
Figure 4-12.
Again from this data a clear difference could be seen between non-specific and –specific
analytes as well as a gradual increase in the level of signal reached at each concentration.
The total size of the signal generated was also broadly comparable to that observed when
using IgG as the receptor. He signal obtained in both nanobnody and antibody receptor
systems was then compared shown in Figure 4-13.
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Figure 4-12: Real time binding data from a full titration of nanobody based sensor. Association
data was collected for 600 s before allowing 3600 s for dissociation data to be collected. After
receptor conjugation and baseline measurement probes were incubated with rabbit IgG at: 666
nM ( ) 333 nM ( ), 166 nM ( ), 83 nM ( ), 42 nM ( ), as well as Sheep IgG at 666 nM
( ).
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Figure 4-13: A comparison of Rmax for the detection of IgG using various receptors. Probes
were all interrogated with the same analyte range the receptors used were IgG ( ),
P8D8 ( ),Rmax was obtained using Fortebio software
From this data, it was observed that when using IgG and P8D8, both attached using EDC-
NHS chemistry to couple the receptor using the amine moiety a relatively large amount of
signal was generated. In the particular case of nanobody, the size of signal generated
exceeded that of IgG at every concentration which may indicate that a more sensitive IgG
biosensor was achieved.
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4.4 Bioreceptor parameters
The binding data can also be used to assess binding parameters (Ka, Kb and eventually KD).
In calculating these figures we can compare the different bioreceptors used. By looking at
both the association and dissociation data which was obtained in the Fortebio system it
was possible to calculate these values and eventually the KD, for each receptor system.
As introduced in chapter one, the binding of an analyte to an antibody, in particular a
monoclonal antibody should follow a one-site binding saturation model. As the
nanobodies we have used are monoclonal with respect to the CDR sequence this should be
a valid model to use.
However it was also discussed, in Chapter One how true one–site binding vary rarely
occurs in biological samples, this is due to heterogeneity within protein samples. Whilst
100% homogeneity is always the aim, in practise proteins are labile and even the best
samples contain a small proportion of damaged protein. For this reason, a two-site binding
model was adopted where essentially the binding parameters for the second site reflect
the binding parameters of the damaged receptors. As there is only one binding site it
therefore perhaps more convenient to refer to this binding model as a two-stage binding
process, the equations for this process have been outlined in Chapter One.
The allocation of two binding constants allows for the model to account for both optimal
and sub optimal binding mechanisms which are simulated by each of the two binding sites
in the model. By modelling the data from the kinetic experiment using nanobodies
conjugated directly to the amine reactive probes(using EDC-NHS chemistry) the difference
between measured and simulated data using either the One site binding or two stage
binding models could be assessed, this data is shown in Figure 4-14. By changing the
model used, the χ 2 value decreased from 7.367 down to 0.01 and r2 increased from 0.554
to 0.998.
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Figure 4-14: Comparison of one-site and two stage binding model to fit data. Using both
One site (A) in which the analysis gave statistical values of R2= 0.554 and χ2= 7.367. In the
Two stage binding (B) Statistical values were R2= 0.998 and χ2= 0.001. Data modelled was
from unmodified P8D8 nanobody conjugated to the probe surface using EDC-NHS
chemistry In both panels. Sensors were incubated with rabbit IgG at: 666 nM ( ) 333 nM
( ), 166 nM ( ), 83 nM ( ), 42 nM ( ), non-specific data was subtracted before
fitting, fitted data is shown overlaid ( ).
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As well as providing a better simulation, when extracting values for Ka and Kb, it allowed
the identification of values for each parameter which described the ‘fast–on, slow-off’
model of antibody antigen binding. Numbers for Ka were 2-6.105 and Kb were 2.10-5-7.10-6.
Comprehensive data is given in
Table 4-2 and Table 4-3. From the data fitting which is modelled by equation in Chapter
Two, the output also included a percentage function describing the weighting of each site
towards the overall Kd value, these are also shown.
From these tables we can see that whilst the model is fitted with a weighting of 85-99%
towards optimal binding, by including sub optimal binding the data can be much more
accurately fitted.
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One site binding
Receptor Ka Kb Kd R2 χ 2
IgG 1.71 ₓ105 4.46 ₓ10-6 2.70 ₓ10-11 0.657 3.217
P8D8 1.82 ₓ105 3.15 ₓ10-6 3.61 ₓ10-11 0.554 7.367
Table 4-2: Data from one site binding model. Using the one site binding model, the R2 and χ2 values reflected the poor fit seen in Figure 4-14. After initial
comparison of IgG receptor and P8D8 nanobody, one-site binding was abandoned
Table 4‐3: Data from two site binding model. Using the two site binding model both R2 and χ2 values were improved. The parameters for optimal (site 1) 
and sub optimal (site 2) binding can be seen along with the relative percentages which weight the total binding constant Kd.
Binding site 1 Binding site 2 Global parameters
Receptor Ka1 Kb1 Kd1 Ka2 Kb2 Kd2
x,
% site 1
y,
% site 2 Kd total R
2 χ 2
IgG 5.95 ₓ10
5
 5.42 ₓ10
-4
 9.12 ₓ10
-10
 1.65 ₓ10
5
 1.10 ₓ10
-1
 6.67 ₓ10
-7
 96.6 3.4 2.32 ₓ10
-8 0.996 0.035
P8D8 1.35 ₓ10
5
 7.45 ₓ10
-5
 4.61 ₓ10
-10
 7.46 ₓ10
4
 4.99 ₓ10
-3
 6.69 ₓ10
-8
 92.4 7.6 5.52 ₓ10
-10 0.989 0.084
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Using the two –site binding model, the overall affinity constant KD was calculated for each
receptor. Values are compared in Figure 4-15 alongside the KD derived using one site
binding, it can be seen that this value is much lower and highlights the potential pitfalls of
using one site binding to model kinetic data.
P8D8 P8D8 IgG
1E-12
1E-11
1E-10
1E-9
1E-8
1E-7
1E-6
K
D
Receptor Identity
Using K1 only
Using K1 & K2
Figure 4-15: Comparison of binding constants of different bioreceptor systems. Data has
been included for both one site binding model ( ) and two site binding model ( ) for
the P8D8. Alongside two mode binding data for IgG ( ).
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4.5 Discussion
When producing nanobodies it is important to consider the impact that any modifications
may have for a given application. Whilst work in this chapter has focussed on the
characterisation of nanobodies it has highlighted some issues which arose from
modification at the molecular level.
Primarily there was the formation of dimers. Whilst this introduction of the cysteine
residue is particularly useful for allowing a variety of conjugation routes, the formation of
the disulphide bond was thermodynamically favoured and led to the formation of dimers.
As the sequencing data confirmed the presence of a separate integral cysteine pair, it was
necessary to reduce the disulphide bond between nanobodies whilst leaving the
disulphide bonds within the nanobody undamaged. It is likely that the internal disulphide
was more stable due its internal location and shielding from the buffer (Hagihara &
Saerens, 2014). This meant that a less agressive reducing agent, 2-MEA could be used to
semi‐selectively reduce nanobody dimers Figure 4‐6. By incubating for 90 min at 37 ⁰C a 
rate of around 80% reduction was achieved, though DTT was found to reduce almost 100%
of dimers it is also likely that such a strong reductant would cleave the internal disulphide
bond which could cause unfolding of the nanobody and a loss in biological activity.
Immunoprecipitation experiments were executed to ensure the immunogenicity of the
nanobodies remained after the reduction of dimers as well as confirming that the
engineered cysteine could be used as a conjugation route for the protein.
When the unmodified nanobodies were assessed using interferometry, the signal that they
generated was considerably higher (in terms of signal per unit analyte) than when using
IgG as the receptor. This may be due to the smaller size of the nanobody which may allow
a higher packing density of receptors on the surface. When this is exposed to the analyte it
can therefore bind a much higher number of analyte molecules and generate a higher
signal.
When characterising the receptors by their binding affinities, a clear difference was seen
between the Kd for IgG and those measured for nanobody systems, as the antibody is a
polyclonal and the nanobody was previously panned using phage display and the optimum
binder was selected this result is not surprising. The values for  both antibody (2 ₓ10-8) and
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nanobody (4.7ₓ10-10) fall within the typical values which are commonly observed (Abbady
et al., 2011; Conroy et al., 2009; Harlow & Lane, 1999). It is particular important to note
the difference in data fits achieved when using one-site and two-site binding models. By
using the two-site binding fit although the second-sub optimal binding accommodated for
only a small percentage of the population a much better fit was achieved and a more
representative Kd value could be obtained for each receptor.
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5 Chapter Five: Results:
Using nanobodies in
electrochemical
biosensors
155
5.1 Introduction
Once nanobodies had been successfully synthesised from bacteria and reengineered to
possess the variable length peptide spacer arm, they were applied to impedimetric
biosensors. The nanobody based sensors were constructed similarly to sensors in Chapter
Three, based on an electropolymerised thin film of tyramine. As in previous work in
Chapter Three, sensor signal is represented as a change in the charge transfer resistance
upon addition of increasing analyte concentration. Resistances were calculated using the
modified Randles’ Cell in
Figure 5-1 and modelled to Nyquist plots for each concentration (data not shown).
Figure 5-1: Sample Nyquist Plot, measured data (points) with simulated data overlaid (Arc)
(left) using the modified Randles’ cell (Right) Note: Left is a screen capture from Nova
Software by Autolab®
In this Chapter, the nanobodies raised against rabbit IgG were again used. This was driven
by the needs of the commercial sponsor for a rapid test for rabbit IgG. It may also have
implications in the testing of various immunosuppressive conditions such as the
assessment of immunodeficiency in HIV or monitoring of a patient during chemotherapy.
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5.2 Antibody based sensors
As a comparator, an immunosensor was constructed using a goat – anti rabbit IgG
polyclonal IgG receptor. To save confusion throughout this chapter the ‘analyte’ will refer
to rabbit IgG unless otherwise stated. By first looking at the Nyquist plots measured upon
increasing analyte concentration a clear and sequential increasing arc upon analyte
addition can be observed as in Figure 5-2.
The change in charge transfer resistance of this sensor can be observed in Figure 5-3. As is
commonly seen, the recognition of the analyte by the receptor causes an increase in the
resistance across the biosensor interface.
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Figure 5-2: Nyquist plot of antibody based sensor for rabbit IgG. Sensor ( ),
increasing analyte concentration; 10-13 M ( ), 10-12 M ( ), 10-11 M ( ), 10-
10 M ( ), 10-9 M ( ), 10-8 M ( ), 10-7 M ( ).
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Figure 5-3: The calibration of a rabbit IgG sensor using IgG receptor. Signal is displayed as a
% change in RCT from the bare sensor (n=8 ±SE). Fabricated sensor was incubated with
analyte for 30 min prior to EIS interrogation as outlined in Chapter 2.
This increase in resistance/impedance corresponds to a physical slowing of the transport
of charge carriers across the electrolyte and to the electrode. This slowing is caused by the
presence of the analyte protein which impedes the free path of charge carriers when it is
bound. This feature is a common theme in the literature covering impedimetric
immunosensors (Guan et al., 2004; Lvovich, 2012; Prodromidis, 2010; Teles, 2011).
5.2.1 Control data
To ensure that signal measured was specific to rabbit IgG and to measure the sensitivity of
the biosensor, a negative control was run. This time, sheep IgG, a structurally very similar
protein to rabbit IgG, was used as the analyte. IgG is known to have a sticky tendency and
this experiment helped to eliminate the possibility of non-specific protein aggregation on
the interface generating an increase in resistance. The clear difference between specific
signal generated by rabbit IgG and non-specific signal, when the sensor is incubated with
the same concentration of Sheep IgG can be seen in Figure 5-4.
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Figure 5-4: Calibration of a rabbit IgG biosensor constructed using IgG receptor. Specific,
rabbit IgG ( ),sheep IgG non-specific ( ), (n=8 ±SE). Fabricated sensor was
incubated with analyte for 30 min prior to EIS interrogation as outlined in chapter 2.
These experiments gave an idea of what was possible using standard immunosensor
construction techniques with the standard receptor system, IgG. This data serves as a
baseline to compare sensors fabricated with novel bioreceptors (nanobodies) reported in
this thesis.
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5.3 Nanobody based biosensor
As discussed in Chapter One there are currently many alternative bioreceptors emerging
for use in biosensor fields. As orientation has previously been demonstrated as a key
performance parameter (Billah et al., 2010; Makaraviciute & Ramanaviciene, 2013),
existing conjugation techniques were used to assess the nanobody when used in a non-
oriented manner. Nanobodies were biotinylated following the protocols in Chapter Two.
The smaller molecular weight of the nanobodies meant that there were fewer amine
groups for biotinylation which in itself may bring a degree more order to the system by
restricting the number of potential orientations of the nanobody on the sensor surface.
After nanobody biotinylation and separation, biotinylation was confirmed using a dot blot
and the sensors were fabricated, again on a polytyramine matrix using biotin NeutrAvidin®
crosslinking.
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Figure 5-5: Initial calibration of a nanobody based sensor for rabbit IgG (n=8 ±SE). Fabricated sensor
was constructed using 600 nM receptor which was then incubated with analyte for 30 min prior to
EIS interrogation as outlined in Chapter 2.
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The first experiments were executed to assess if using standard approaches could lead to
the simple creation of a biosensor for rabbit IgG. Using identical protocols for the
fabrication of an IgG sensor but only changing the receptor resulted in a sensor which
displayed no significant change in signal over a wide concentration range as in Figure 5-5.
5.3.1 Optimisation
As has been previously demonstrated, receptor concentration is a critical parameter which
determines the successful generation of signal by a biosensor (Zourob, 2009). Therefore
sensors were made using serial dilutions to optimise the concentration of receptor used on
the biosensor. Data from these experiments can be seen in Figure 5-6.
From Figure 5-6, a receptor concentration of 6 nM was chosen as the optimum
concentration. This was due to the improved reproducibility and reasonable sensitivity of
RCT Measured. Though data obtained using 60 nM showed a larger change in signal at
10-8 M analyte, the calibration was less linear and the reproducibility was lower.
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Figure 5-6: Optimising nanobody concentration. In the development of nanobody based
sensor for rabbit IgG, initial studies (A) were conducted using 6μM  receptor, the 
experiment was then repeated using 600 nM (B), 60 nM (C) and 6 nM (D) receptor (n=8 ±
SE)
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5.3.2 Controls
After having optimised the receptor concentration, it was clear that this was a primary
determinant of the sensor signal. It can be observed that the reducing resistance was not
an artefact, this was confirmed by looking at the Nyquist plot as shown in Figure 5-7.
Here, it can be seen that after sensor construction, sequential addition of the analyte
resulted in a decreasing arc which corresponds to the lower resistances previously
observed.
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Figure 5-7: Nyquist plots of a nanobody based sensor with increasing analyte. Bare sensor
( ), increasing analyte concentration; 10-13 M ( ),10-12 M ( ),10-11 M
( ), 10-10 M ( ),10-9 M ( ),10-8 M ( ),10-7 M ( ).
To confirm that this negative trend was indicative of the specific binding of analyte, non-
specific controls were performed, again using sheep IgG. The results of these experiments
can be seen in Figure 5-8 . There was a clear difference between specific and nonspecific
signal and the negative trend is analyte dependant.
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Figure 5-8: Calibration of a rabbit IgG biosensor using biotinylated P8D8 nanobodies.
Specific, rabbit IgG ( ), sheep IgG non-specific ( ), (n=8 ±SE). Fabricated sensor
was incubated with analyte for 30 min prior to EIS interrogation as outlined in chapter 2.
This work confirmed that the decrease in signal was specific to the analyte. Whilst a valid
measure for calibrating a sensor, the result seemed counter intuitive. Work was therefore
done to identify if this was a feature which could be seen across other biosensors
fabricated using nanobody as the bioreceptor.
Nanobodies raised against green fluorescent protein(GFP) were kindly supplied by
commercial sponsors, Abcam plc. These were then used to fabricate a similar sensor. For
the positive control, GFP was added at a comparable molarity to that of the IgG to ensure
that any effects observed were not due to a drastic change in the sampling concentration
of the analyte. Meanwhile for the negative control, rabbit IgG was used. As the specific
analyte for the original sensor this allowed investigation of whether the rabbit IgG may
have been binding non-specifically to any other component of the biosensor. The results of
the GFP sensor experiments can be seen in Figure 5-9.
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Figure 5-9: Comparison of specific and nonspecific signal for a GFP biosensor. Sensor was
constructed using nanobodies screened against GFP. Specific, GFP ( ),rabbit IgG
nonspecific ( ), (n=8 ±SE). Fabricated sensor was incubated with analyte for 30 min
prior to EIS interrogation as outlined in chapter 2.
Again, this decrease in the charge transfer resistance was observed, the initial hypothesis
was that it was due to a change in the Tyramine tethering layer, a concept discussed in
depth later on however initial experiments were executed using self-assembled monolayer
based sensors to see if this could be confirmed. A 4-aminothiophenol layer was deposited
on an electrode to enable conjugation of the nanobody to the surface in a manner which
could not permit its movement upon binding. As this could not be done on the Dropsens
electrodes, owing to their uneven surface and the inherent unsuitability for self-assembled
monolayer deposition (as outlined in Chapter One), these sensors were made on bespoke
gold wire electrodes. Due to electrode variability and poor quality of manufacture
however these results were inconclusive so sensors could not be meaningfully calibrated.
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5.4 Oriented nanobody biosensors
The use of nanobodies with a peptide spacer was then investigated as a method of
rectifying the reduction in resistance observed when tethering nanobodies on the
biosensor using more traditional approaches. It was hypothesised that not only would
orientation improve signal generation a concept which has been widely demonstrated
(Spitznagel & Clark, 1993; Bonroy et al., 2006; Makaraviciute & Ramanaviciene, 2013), but
also that by providing a degree of freedom away from the electrode surface that any
disruption in the tethering layer could be minimised and the optimal sensor configuration
could be achieved.
Accordingly nanobodies were re-engineered to possess a 5, 10 or 15 amino acid spacer
arm (based on a GGGGS motif, repeating respectively with a terminal cysteine. Effectively
this allows the nanobody to be positioned approximately 2, 4 or 6 nanometres above the
electrode surface. The relevance of these dimensions will be discussed accordingly.
Following data from Figure 5-6, the concentration of nanobody was maintained at 6 nM, as
the nanobodies required reduction, the quantity applied to the surface was greater, to
ensure that 6nM was the effective concentration. This was achieved using data from
Chapter Four in which the relative concentration of monomer and dimer were obtained via
chromatography experiments.
5.4.1 P8D8-S5 Based biosensor interrogation
Native nanobody dimers were reduced using 2-MEA and conjugated to a polytyramine
tethering layer following protocols from Chapter Two. The resulting biosensors were
incubated with either specific rabbit IgG analyte or non-specific sheep IgG as previously
described. The first nanobody receptor to be investigated had a five amino acid spacer as
described in Chapter Three. Results from interrogation of the impedimetric
immunosensors are shown in Figure 5-10.
166
-16 -15 -13 -12 -11 -10 -9 -8 -7 -6
-60
-40
-20
0
20
40
60
80
100
//R
ct
%
log [IgG]
//
Figure 5-10: Calibration of a sensor using P8D8-S5 nanobody. Specific, rabbit IgG ( ),
sheep IgG nonspecific ( ), ( n=8 ±SE). fabricated sensor was incubated with analyte
for 30 min prior to EIS interrogation as outlined in chapter 2.
From this graph it can be observed that the decrease in resistance is reversed when using a
peptide spacer arm and that RCT increased, with a maximum of ~70% greater than that
observed when using standard antibody as the receptor as in Figure 5-4. This data in
Figure 5-10 shows that by allowing a degree of freedom and some physical spacing away
from the surface, a large impedimetric signal maybe generated. If we consider the spacer
arm length, calculated to be 2 nm above the transducer surface this places the antibody
binding at a distance which roughly corresponds to the Debye layer as set out in Figure
5-15.
5.4.2 P8D8-S10 Based biosensor interrogation
A repeat of the approach used for the five amino acid spacer nanobody was performed
replacing the receptor for a nanobody with a ten amino acid spacer to investigate the role
of spacer length from the biosensor interface. It was thought that by allowing more spacer
freedom binding may be more easily mediated so a longer spacer arm was therefore used.
Data from this experiment is shown in Figure 5-11.
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Figure 5-11: Calibration of a sensor using P8D8-S10 nanobody. Specific, rabbit IgG ( )
,sheep IgG nonspecific ( ), ( n=8 ±SE). Fabricated sensor was incubated with analyte
for 30 min prior to EIS interrogation as outlined in chapter 2.
From Figure 5-11 we can see that whilst an operational sensor has been successfully
produced, the size of the signal was significantly lower than when using the bioreceptor
with a five amino acid spacer. Along with this observation, it can also be seen that the size
of the non-specific signal was also larger.
5.4.3 P8D8-S15 Based biosensor interrogation
The investigation into the distance away from the biosensor interface that the nanobody
was placed was continued by investigating sensors where the nanobody had a fifteen
amino acid spacer arm. Data from this experiment, as shown in Figure 5-12 shows that the
signal generated by the sensor was negligible when compared to the non-specific control.
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Figure 5-12: Calibration of a sensor using P8D8-S15 a nanobody. Specific, rabbit IgG
( ) ,sheep IgG nonspecific ( ), ( n=8 ±SE). Fabricated sensor was incubated
with analyte for 30 min prior to EIS interrogation as outlined in chapter 2.
Data from Chapter Four showed that this receptor is functional and successfully binds the
analyte protein when it has been conjugated using similar chemistry. It is therefore
unexpected to see such a low increase in signal. One feature which is unique to this data
set is the relatively large signal generated by the non-specific analyte.
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5.5 Comparison of bioreceptor systems
By combining much of the data present within this Chapter a direct comparison of
bioreceptor systems can be achieved. In Figure 5-13, signal has been displayed as a result
of total binding minus non-specific binding, in each case using the sheep IgG control to
assess this.
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Figure 5-13: Comparison of the specific signal generated different receptors. Biotinylated
P8D8 sensor ( ), Biotinylated IgG ( ), P8D8-S5 ( ), P8D8-S10 ( )
P8D8-S15 ( ), data generated from figures 4, 8, 11-13 (n=8 ± SE).
This figure shows the clear difference between biotinylated IgG and biotinylated nanobody
as the receptor which highlights the unpredictable nature of signal generation at the
biosensor interface. When comparing the receptors with different peptide spacer arms
the 5 amino acid proved to generate more analyte specific signal than when using IgG
however as the peptide spacer arm length was increased this advantage rapidly
disappeared. By the time the spacer arm was increased to a length of 6 nm (15 amino acid
spacer) the sensor provided no significant signal change upon analyte addition. Though the
data from Figure 5-12 indicated an increase in charge transfer resistance, it was no longer
analyte dependant.
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5.6 Testing of optimised nanobody biosensor
After having confirmed that the biosensor constructed using a two nanometre or five
amino acid spacer was the optimal configuration, the biosensor was tested in the presence
of serum, a medically relevant sample matrix. For these experiments, screened human
sera was used as it would contain no residual rabbit IgG. The sera was then either used
undiluted, spiked with rabbit IgG or diluted 10% (v/v) in PBS, before being spiked with
rabbit IgG and interrogated. The data from these experiments is shown in Figure 5-14
alongside non-specific controls of sheep IgG in PBS (as in Figure 5-10) and additionally
serum which contained no rabbit IgG due to its human origin. The latter of these two
controls confirmed the specificity of the sensor and the lack of cross reactivity with other
serum proteins.
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Figure 5-14: Testing of the P8D8-S5 biosensor in serum; rabbit IgG in PBS ( ), rabbit
IgG in 100% human sera ( ),rabbit IgG in 10% human sera ( ), sheep IgG in
PBS ( ), human sera with no rabbit IgG ( ), note: in this case consecutive runs
do not correspond to a direct concentration of IgG and merely represent sequential
interrogation cycles with a 30 min incubation in sera between readings. (n=8 ±SE).
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From this range of controls we can see that the biosensor constructed using the
bioreceptor with five amino acid spacer was sensitive down to pM levels, and though a
linear calibration was not obtained within the sample size ( n=8) there was a significant
trend across the data. The lack of reactivity with negative controls is also a key goal in
biosensor development and from this data in Figure 5-14 we can see there was a
significant difference between all negative and positive control experiments.
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5.7 Discussion
Data presented in this Chapter has highlighted the importance of controlling the spatial
orientation of the bioreceptor at the interface of a biosensor. Whist there is a push
towards the use of non-antibody binding proteins and other small receptor systems the
data has shown the caution with which such approaches should be taken.
The unexpected decrease in charge transfer resistance may be explained by the relative
sizes of the receptor and analyte. As the receptors are very much smaller than their target
analyte proteins. This may lead to a high packing density of receptor which cannot be
maintained upon analyte recognition. Though commonly the transducer and tethering
layer are seen as solid/ semi –solid they are potentially quite mobile (Barlett & Cooper,
1993) and more akin to a spongy matrix. This means that when the relatively large analyte
(IgG) binds, the polymer also shifts on the sensor surface. It is believed that it is this
process of stretching and shifting of the polymer which becomes the primary source of
signal generation at the interface. In the development of biosensors, particularly those
based on self-assembled monolayers (Campuzano et al., 2006; Rodgers et al., 2010) this
process has previously been describes as a ‘pinholing’ effect. This effect is observed when
rather than the charge carriers having to give up their electrons which then continue to
tunnel though the tethering, conducting polymer layer, channels are opened up and the
charge carriers can directly interface with the underlying gold substrate (Bharathi et al.,
2001). This process reduces the kinetic barriers to charge transfer across the biosensor
interface which corresponds to a lower resistance. In the work presented within this
chapter a similar effect has been observed; however rather than the partial destruction of
a monolayer it has occurred due to the flexing of a semi rigid polymer layer much like the
flexing of wire wool.
By including the oriented spacer arm, a degree of freedom was afforded to the receptor.
This meant that though it was still bound covalently to the transducer layer, the arm itself
could shift without causing the same distortion in the tethering layer. This mechanism
meant that in this instance the decrease in RCT was not observed as there was no shift in
the polymer layer. Instead, the binding caused the normal kinetic barrier to influx of the
charge carriers at the electrode interface, this kinetic barrier can be seen again as the
resistance, RCT which corresponds to an overall reduction in speed of charge transport
across the interface. As is often observed in many biosensor systems, this resistance
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increased proportionally with the analyte concentration and allowed a calibration to be
constructed.
Though the use of the spacer afforded a higher degree of freedom to the receptor, its use
beyond 2 nm showed limited success. According to Guoy-Chapman theory it can be seen
that at 2 nm is at the Debye layer. At this region there is the maximum flux between the
different species of charge carrier (ions). In the Fe(CN)6-3|Fe(CN)6-4system used this
corresponds to a region of maximal flux between the different forms. As it is this flux and
the subsequent charge carriers that get through this layer which cause current flow and
charge to be transported around the electrochemical circuit it is hypothesised that binding
in this region contributes to a greater signal yield from the biosensor overall. It is for this
reason that the signal decrease is observed when using the greater spacer arm length of
four and six nm, though some signal is still generated owing to the flexible nature of the
peptide spacer and the fact that some receptors may still be located closer to the interface
as is displayed on the lower portion of Figure 5-15.
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It is interesting to note that when using the larger spacer arms is the increase in non-
specific signal size. This may be due to the slightly sticky nature of the IgG analyte which
has been previously identified (Fanning et al., 1996; Harlow & Lane, 1999). If we compare
the size of specific and non-specific signal in both the ten and fifteen amino acid spaced
receptor, the correlating increasing non-specific signal of this would seem to support this
hypothesis. Another explanation could be obtained again, by considering the role of the
Debye layer, as, if the length of the spacer arm is at 6 though the binding may still occur, it
does not generate any meaningful electrochemical signal and there is no perceived change
in RCT. Limited signal may also be generated closer to the Debye layer also; this may be
due to the flexibility of the glycine serine spacer as illustrated in Figure 5-15.
Spacer flexibility may result in
limited signal generation
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Figure 5-15: Guoy-Chapman theory in nanobody based sensors. The different layers which
are critical for generation of signal at an electrode interface are shown alongside the
nanobody with peptide spacer.
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6 Chapter Six:
Discussion
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6.1 General Discussion
The limited progress achieved in bringing sensitive, low cost sensors to market is a widely
documented disappointment in a field which has a good track record at the proof of
concept level. This project was aimed at gaining an understanding of the processes needed
to enable eventual commercialisation of reagentless impedimetric immunosensors.
Following previous studies, the receptor was identified as one of the critical components
which determines the output of the sensor (Baniukevic et al., 2013; Bonroy et al., 2006;
Makaraviciute & Ramanaviciene, 2013; Tajima et al., 2011) and in this thesis the majority
of work has concerned investigation of the bioreceptor component.
This was achieved by pursuing two principal areas of investigation. The first area examined
was the regeneration of previously developed biosensors. The second area was the
production and optimisation of nanobodies and their eventual application in impedimetric
immunosensors. In this chapter, a discussion of these two principle areas is provided
alongside an outline of the opportunities and issues which exist in the field of
impedimetric immunosensors.
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6.2 Binding biophysics and regeneration
Whilst the successful regeneration of biosensors had been demonstrated in other systems
(Goode et al., 2014), the work in this thesis has demonstrated the potential for
regeneration in impedimetric immunosensors by exploiting thermodynamic processes of
analyte: receptor binding. Previous studies have shown success in both optical and
mechanical systems but true regeneration has had only limited demonstration in
impedimetric immunosensors (Goode et al., 2014; J. Huang et al., 2010; Queirós et al.,
2013; Yun et al., n.d.). Within the broader category of electrochemical sensors, previous
work had widely demonstrated re-use (Manso et al., 2008; Vidal et al., 2004). The
distinction made between re-use and regeneration is a crucial one which needs to be
more clearly defined within the literature (Goode et al., 2014). For many reported studies
on the ‘regeneration’ of amperometric biosensors, sensor signal was monitored until there
was a return to baseline signal, caused by the gradual catalysis of all of the analyte which
then permitted re-use of the sensor. For active regeneration, a regeneration buffer must
be used to return the sensor to baseline signal in a controlled manner. Though this had
been demonstrated in one enzyme based sensor for heart disease biomarkers (Lu et al.,
2011), it has been most widely demonstrated in immunosensor systems where binding of
the analyte to an antibody or other receptor was reversed (Bryan et al., 2013; Xu et al.,
2013; Yun et al., n.d.). The work done in this thesis demonstrated the possibility of
regenerating impedimetric immunosensors by assessing the on and off signal between
regenerative steps and consideration of the thermodynamic processes governing this was
used to inform, choice of the regeneration buffers.
Through work presented here, the unstable nature of the PANI:2-ABA copolymer was
shown, corroborating evidence form previous studies (Caygill et al., 2012). The use of low
pH to induce regeneration highlighted the effect of the multiple oxidations states of the
polymer on the signal generated. This lead to a re-selection of the base polymer. PTyr was
used as, it has been previously ascertained that by polymerising from alkali-methanol, a
stable, thin insulating film is deposited (Cosnier, 2005) which also bears pendant amine
moieties. This thin film allowed conjugation and subsequent calibration of the previously
demonstrated myoglobin biosensor.
This polytyramine based biosensor generated a signal that was much less sensitive to its
chemical environment, thus allowing for the use of regeneration buffers that could
decouple the receptor from analyte allowing its reuse. By optimising both pH and
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exposure time, as well as including other constituents to assist regeneration by taking into
account both the enthalpy, and entropy state of the biosensor. In this way, five
regeneration cycles were achieved. Whilst this is fairly limited compared to the number of
regeneration cycles claimed in optical sensors, where up to 200 cycles have been reported
(Drake & Klakamp, 2011), this proof of concept already points towards considerable cost
savings. If this technique could be further refined using automated control, further
regeneration may be possible, lowering the cost of testing using impedimetric
immunosensors. The more robust nature of nanobodies (Nicholls, 2007) and purely
artificial receptors such as Adhirons (Tiede et al., 2014) may also enhance the possibility of
regeneration owing to their stability.
Though the realisation of biosensor regeneration may be of clear benefit, it may not be a
practical advantage in certain applications, examples include medical settings where the
use of single-use items is often required in order to minimise clinician exposure to
pathogens (Wilson & Jugner, 1968). Examples where regeneration may be of particular use
are in environmental protection and process sampling where remote monitoring may be
desired as well as home monitoring of a medical condition over a time course. In this
example, the sensor could be used by only one patient ensuring there is no cross
contamination or infection.
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6.3 Nanobodies in reagentless immunosensors
Though reagents such as half antibodies and fragmented antibodies have been used
frequently there had been almost no work published using the novel nanobody binding
protein in impedimetric sensors. Their use had been previously proposed (Hassanzadeh-
Ghassabeh et al., 2013; L. Huang et al., 2010) and to date they have been applied to optical
and amperometric sensor systems (Campuzano et al., 2014). Only recently, a study was
published on their use in impedimetric immunosensors for the detection of apolipoprotein
(Li et al., 2015).
Unique to this project was the development of the peptide spacer arms with engineered
cysteine residues to permit oriented conjugation. Whilst these could be successfully
expressed from E.Coli, they formed disulphide linked dimers when expressed. By following
similar approaches used for the reduction of antibodies (Ahmed et al., 2013; Billah et al.,
2010; Caygill et al., 2012; Harlow & Lane, 1999) it was possible to reduce the nanobody
dimers and then conjugate them to the transducer using the engineered cysteine residue.
When the reduced P8D8 nanobody with spacer was attached to the insulating
polytyramine film using SMCC, an increased resistance was observed upon analyte binding.
This was in contrast to the non-engineered P8D8 nanobodies directly attached to the
polytyramine film using biotin NeutrAvidin cross-linking where a decrease in resistance
was observed with increasing analyte concentration..
As described in Chapter Five, this difference in impedance response is believed to be due
to the distortion of the insulating polytyramine tethering layer. Indeed in the work by Li et
al reporting the use of nanobodies in impedimetric immunosensors (Li et al., 2015), an
increase in resistance was observed. The reduction in RCT has been previously observed in
other systems where a small receptor has been binding something much larger on a
polytyramine surface (Rushworth, Ahmed, et al., 2014). In another study by the Millner
group a similar sensor was constructed in which a small peptide bound a much large
amyloid protein. This lead to the decrease in resistance upon analyte binding (Rushworth,
Ahmed, et al., 2014).
Another key parameter affecting sensor performance identified is optimisation of the
receptor concentration on the sensor surface. This is frequently unreported within the
literature, but is an easy step which could help in the replication and adaptation of
reported work. One issue that merits further investigation is how the optimal receptor
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concentration may be different when detecting different analyte species. It may be that
there is a relationship between the optimum loading of receptors and the size of both the
receptors themselves and the analyte molecules. Though true investigation of this would
require a number of receptor analyte pairs to be investigated, a meta-analysis could be
carried out.
181
6.4 Discovered opportunities
The use of peptide spacer technology for oriented conjugation on the biosensor surface
was novel in this project. Given the increasingly prolific nature of patents in the field of
antibody mimetics, the work presented may provide a commercially and technologically
useful application in the field.
Whilst other patents have focussed on the use of a spacer for functionalization, e.g.
introduction of a glycan region (Aivazian et al., 2012) or the development of heterodimers
for bivalent antibody mimetics (Revets & Hoogenboom, 2010) there have to date been no
patents which protect the concept of varying the length of a peptide spacer arm for use in
biosensor applications; and specifically nothing that discusses the use of a spacer for
increasing the efficacy of the nanobody in a given application. This study illustrates that
the length of this peptide spacer arm may be a critical parameter in the fabrication of
biosensors as well potentially in other applications. Whist work in this project has focussed
on nanobodies; similar effects may be seen when using different small antibody mimetics.
The use of variable length peptide spacer arms could therefore have a far-reaching impact
in the development, adoption and application of antibody mimetic binding proteins in a
variety of systems.
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6.5 Requirements for sensor commercialisation
Whilst the discoveries made within this thesis may increase fundamental understanding of
operation, a range of factors must be considered for the ultimate commercialisation of any
point of care impedimetric immunosensors.
The first consideration is the electrode used; commonly the maximum cost of single use
electrodes is considered to be around $1 (Alocilja & Radke, 2003; Luong et al., 2008). The
gold Dropsens electrodes used in this thesis were €4 ea. ($4.40) and so would be
prohibitively expensive for single use sensors except perhaps for use in critical medicine.
Though the work in Chapter Three has proven the ability to reuse these sensors up to five
times, theoretically reducing the electrode cost per test to 88¢, this would require fluidics
apparatus in order to ensure practical deployment and as discussed may not be suitable
for applications such as multi-patient sampling. Other costs which must be considered are
the cost of materials and human resources for biosensor fabrication. These costs are likely
to fall if mass production can be deployed. For polymerisation this may require connectors
which permit many electrodes to undergo CV in parallel and perhaps custom tanks to be
designed for monomer solutions. It may also require large scale application of cross linkers
and receptors using a robotic system such as a BioDot® or similar (Pataky & Brugger,
2014).
The cross linkers used are another source of expense. Sulfo-SMCC costs £3 .mg-1 so this
may represent a significant cost when scaling up production processes. Similarly, for
receptors conjugated using biotin-NHS, this costs £1.mg-1. One way in which the issues of
production costs have been negated in this thesis is the use of nanobodies which enable
large scale bacterial expression. This could mean that in large scale production, the cost of
receptor used is greatly reduced. As data from Chapter Five has shown, biosensors can be
constructed using a minimal quantity of nanobody, ensuring that the costs represented
with the bioreceptor can be minimised.
Once the cost of biosensor fabrication of has been minimised and assuming that it reaches
an acceptable level, its implementation to point of care for field use must be considered.
As previously outlined the use of fixed frequency analysis would greatly reduce the
instrumentation required. Not only would this permit miniaturisation and lower the cost
but it could also reduce the time taken to interrogate sensors as it removes the need for a
full frequency scan to be taken.
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For any diagnostic device, the newly developed sensor must provide detection equal to
the current gold standard test for the given analyte. For many analytes the gold standard
is an enzyme linked immuno sorbent assay (ELISA) which can commonly identify a target
biomolecule down to the nanomolar range. Though the ELISA is typically performed in a
96-well plate, representing a comparatively low materials cost as samples can be batched,
the real expense is associated in the human resource as it requires a skilled operator and
complex clinical analyses which, all of which take a substantial amount of time and
therefore may represent a significant cost. Another drawback of such systems is the need
to run them in centralised locations, this therefore relies on the collection of samples that
must be sent to a central testing facility such as a pathology lab, adding greater logistic
burden.
Another significant hurdle to the commercial launch of an impedimetric immunosensor is
regulatory approval. Once a sensor has been developed and can be justified both
practically and commercially regulatory approval must be obtained. FDA approval is
commonly seen as the global standard under which biosensors are a category 2 medical
device (excepting category 3 implanted biosensors). For approval, the biosensor must be
compared to existing alternatives, where applicable, to demonstrate its efficacy and
applicability (Liotta & Petricoin, 2012). Within Europe similar regulation is enforced by the
European Medicines Agency (EMA) and work must be done which conforms to ISO
11.100.10: in-vitro diagnostic test systems (ISO, 2010). It is only once approval has been
granted that marketing for point of care diagnostics can begin. This lengthy and costly
process therefore still represents a major hurdle for the translation of proof of concept
work to field or point of care deployment.
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6.6 Future Work
Investigations from this work have indicated that the location of the binding event of the
analyte should be placed within the Debye Layer in a given system to ensure maximum
signal generation. This could be investigated by repeating experiments from Chapter Five
with a different electron mediator solution e.g. hexa-amine ruthenium chloride, or the
same mediator at a different ionic strength where the diffusion layer and accordingly the
Debye layer thickness would be altered.
From these experiments it would be possible to identify whether the nanobody with five
amino acid spacers would still be the optimal binder or whether by changing the Debye
layer thickness another spacer arm became optimal. This would demonstrate the
relationship between the binding location and signal generated in impedimetric sensors.
Throughout the field, there is limited consensus on the interpretation of impedimetric
data. Whilst for many sensors the change in resistance is monitored, for some analytes
capacitance is monitored as the output. Ideally total impedance (Z) at a given frequency
could be used and would allow for fixed frequency analysis. In order to achieve this,
experiments could be conducted in which fixed frequency analysis was conducted to
investigate viability and compatibility with current biosensor instrumentation.
Another avenue which merits further investigation is the use of the anti-GFP nanobodies
from Chapter Five which were used for control experiments. With the development of a
GFP sensor and the binding of GFP analyte to the sensor surface, it may be possible using
super resolution optical microscopy capable of sub 20 nm resolution (e.g. STORM) to
image the GFP directly on the surface of the electrode. As each nanobody binds one
molecule of GFP this could enable direct quantification of the amount of nanobody which
successfully conjugates to the sensor interface and also a way of investigating the real
spacing of receptors at the biosensor surface.
These suggestions would all focus on gaining a clearer picture of the physical parameters
at the biosensor surface and may help inform subsequent biosensor fabrication.
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6.6.1 Limitations within the field
As has been illustrated throughout this thesis, the promising work which has been done
across the field of impedimetric immunosensors is still very far from realising its potential
and from commercial application. One of the complexities is the wide variety of
transducer systems used. Indeed work in this thesis has shown that even within a fairly
specific biosensor assembly, the nature of a polymer film to be a particular source of
signal generation and analysis. It is therefore necessary for a standard approach to be
taken across the field to permit the comparison of different studies. In order to do this a
number of requisite steps must be taken, all of which may be relatively easy to address in
terms of commercialising tools for research.
The primary consideration would be the development of highly reproducible electrodes
with a predetermined geometry, regular surface chemistry and reasonably flat surfaces
which could be used for either SAM construction or the attachment of a more robust
tethering layer. Though many of the commercially available electrodes have reasonable
characteristics for techniques such as amperometry and potentiometry, for the more
demanding technique of impedance, measurement variability is still an issue (Ianeselli et
al., 2014). Another shortcoming in the literature is the propensity for authors to report a
trend in changing resistance or capacitance which is rarely accompanied with a mechanism
to explain the observed trend. Without a consideration of the origins of the signal it
becomes difficult to establish a set of rules by which to measure and compare different
sensors. This shortcoming has been previously identified (Daniels & Pourmand, 2007),
however, there is little evidence of a concerted effort within the field to improve
reporting in this area. The work in this thesis led to the development of a hypothesis on
the shifting of the insulating polymer tethering layer, which may explain the same trend of
decreasing resistance upon analyte addition as has been observed in a similar system
(Rushworth, Ahmed, et al., 2014).
By looking individually at the electrodes and the electrochemical system used as well as
fabrication steps such as the tethering layer used, the conjugation chemistry and the sizes
of both receptor and analyte, it may be possible to establish a framework to more fully
describe the processes which generates the impedance signal. If this could be done across
the field, it could help to explain many of the observed phenomena and streamline the
development process.
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The aim of developing such a framework would be that it could allow the identification of
certain systems which outperform others, assisting in the selection of a standard approach
across the field. This approach has previously been achieved in other methods such as SPR
leading to the emergence of market leaders (e.g. Biacore). However, due to the relative
infancy of reagentless electrochemical techniques, it is unclear whether sufficient data is
yet available to form a field-wide consensus.
Another benefit of standardization of electrodes, and assembly approaches for different
analytes is that it would enable of fixed frequency analysis(FFA). Work in this thesis has
focussed on the analysis of a wide frequency range which has enabled the generation of
Nyquist curves and the c7alculation of RCT values. However, this is an instrumentally and
computationally intensive method, which, whilst superior in a research environment due
to the breadth and robustness of data generated, is unsuitable for point of care or field
use. If the variability of fabricated sensors could be reduced to an appropriate level then
use of FFA could permit a one data point analysis of the impedimetric signal, lowering the
instrumental costs and acquisition time required. Indeed sensors for parathyroid hormone
(Özcan et al., 2014) and of bitter taste molecules (Hui et al., 2013) has demonstrated
proof of concept in this area which may be more widely adopted.
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8.1 Variety of electrodes used
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8.2 Buffers Used
Name Ingredients pH Application
PBS 137 mM NaCl, 2.7 mM KCl, 4.3 mMNa2HPO4, 1.47 mM KH2PO4
7.4 General Use
LB Tryptone (10 mg.ml-1), NaCl (10 mg.ml-1),yeast extract (5 mg.ml-1) 7.5 Cell culture
TB
Tryptone (12 mg.ml-1), yeast extract (24
mg.ml-1), glycerol (0.4% v/v), TB salts (0.17M
KH2PO4 and 0.72M K2HPO4).
7.5 Cell culture
TES 0.2 M Tris-HCL, 0.5 M Sucrose, 0.5 mM EDTA 8 ProteinExtraction
Imidazole Elution
Buffer
0.3 M imidazole, 20mM Tris base and 0.5 M
NaCl 7.9 Ni+ column
Imidazole Wash
Buffer
10 mM imidazole, 20mM Tris base and 0.5 M
NaCl 7.9 Ni+ column
DW PBS + 50 mM NaCl 7.4 Dialysis
Tris-Glycine
Running 25 mM Tris, 192 mM Glycine 0.1 % SDS 8.6 PAGE
MES 50 mM MES, 50 mMTris base, 0.1% SDS, 1mM EDTA 7.3 PAGE
TA 50 mM Tricine, 50 mM Tris base, 0.1% SDS 8.2 PAGE
MOPS 50 mM MOPS, 50 mM Tris base, 0.1% SDS,1mM EDTA 7.7 PAGE
TBST 50 mM Tris, 150 mM NaCl, 0.05% (v/v)Tween 20® 7.6 PAGE
Transfer 25 mM Tris, 192 mM Glycine, 20 % (v/v)methanol 8.3 Western Blot
Ponceau stain Ponceau 1 g.l-1 in 5% acetic acid (v/v) 5 Western Blot
PBS-T PBS + 0.5% Tween 20® 7.4 Western Blot
Coupling Buffer 120 ml, 50 mM Tris, 5 mM EDTA-Na; 8.5 IP
RIPA
50 mM NaCl, 1% (v/v) IGEPAL CA-630®, 0.5%
(w/v) sodium deoxycholate, 0.1% (w/v) SDS
and 50 mM Tris
8 IP
Glycine elution
Buffer 100 mM Glycine 2.0 IP
DTT Elution Buffer PBS + 100 mM DTT 7.4 IP
Regeneration
Buffer
100 mM Glycine, 50% Propylene Glycol (v/v),
1% DMSO (v/v) 2.75 EIS
Interrogation
Buffer PBS +10 mM K3Fe(CN6), K4Fe(CN6) 7.2 EIS
207
8.3 Sequencing data for P8D8 nanobody
P8D8 Sequence:
- Redacted due to commercial sensitivity at the request of AbCam Plc.
Sequence data may be provided upon application to Abcam Plc.
His6-tag Sequence:
ACCACCATCANCATCACGGTTCA
Spacer:
(CAG GTG GTG GTG GTA)n GCG
M13 Primer Sequence :
Forward:
5´-d(GTTTTCCCAGTCACGAC)-3´
Reverse:
5´-d(CAGGAAACAGCTATGAC)-3´
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8.4 Poster presented at BBI 2013
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8.5 Poster Presented at MMT 2015
